Studies on DNA replication fidelity in Saccharomyces cerevisiae by Schmidt, Tobias Thomas
  
 
Dissertation 
submitted to the 
Combined Faculties for the Natural Sciences and for Mathematics 
of the Ruperto-Carola University of Heidelberg, Germany 
for the degree of 
Doctor of Natural Sciences 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
presented by 
Tobias Thomas Schmidt, M.Sc. 
Born in Bad Soden am Taunus 
Oral examination: 10.12.2018 
  
 
 
 
 
 
 
  
 
Studies on DNA replication fidelity  
in Saccharomyces cerevisiae 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Referees:  Prof. Dr. Sylvia Erhardt 
Dr. Hans Hombauer  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 i 
 
SUMMARY 
High DNA replication fidelity is achieved by the interplay of DNA polymerase nucleotide selectivity 
and proofreading activity and the DNA mismatch repair (MMR) system. Moreover, the overall 
concentration and the balance between the different dNTPs influence DNA polymerase fidelity. 
Consequently, deregulations in any of these four processes are frequently associated to increased 
mutagenesis and cancer susceptibility. This work addresses first, whether additional previously 
unrecognized genes support DNA replication fidelity and second, how altered dNTP pools impact 
on DNA replication fidelity in Saccharomyces cerevisiae. 
To identify previously unrecognized genes that prevent the accumulation of mutations, the budding 
yeast non-essential gene deletion collection was screened for increased mutagenesis in the 
presence of either the WT or low-fidelity DNA polymerase active-site mutants used as “sensitized 
mutator backgrounds”. This screen identified that loss of the folylpolyglutamate synthetase Met7 
caused an increased mutator phenotype as well as increased gross chromosomal rearrangements 
(GCRs). GCRs were driven in large by dUTP accumulation and processing of uracil 
misincorporated into genomic DNA. Further characterization revealed that the accumulation of 
uracil alone is not sufficient to cause GCRs in budding yeast suggesting that GCRs in the absence 
of Met7 are the combined result of uracil accumulation and a DNA double-strand break repair 
defect.  
The genome-wide screen also revealed a group of genes that become critically important if DNA 
replication fidelity is compromised. Loss of either the CTP synthetase Ura7 or glutamine deficiency 
due to the absence of the transcription factor Gln3, resulted in reduced de novo CTP production. 
This alteration in the dNTP precursor pool caused a severe dNTP imbalance with a high mutagenic 
potential for which neither the ribonucleotide reductase (RNR) nor any mechanism downstream 
RNR could compensate. Thus, this study highlights the importance of the dNTP precursor 
metabolism on dNTP homeostasis and DNA replication fidelity and suggests that low CTP/dCTP 
pools are the Achilles’ heel of dNTP pool regulation. 
To investigate the effect of different dNTP pool alterations on DNA replication fidelity a RNR1 
random mutagenesis screen was performed. The screen revealed key residues in RNR1, the large 
subunit of RNR, with crucial functions for dNTP homeostasis. The identified rnr1 alleles caused 
highly mutagenic dNTP alterations with different dependencies on DNA proofreading and MMR. 
dNTP imbalances characterized by one limiting dNTP facilitated not only base pair substitutions, 
but also frameshift mutations. In the subset of the identified dNTP alterations, the ones with low 
dATP and strongly elevated dGTP pools were most detrimental for DNA replication fidelity causing 
strong mutator phenotypes even in the presence of WT DNA polymerases and MMR. 
Taken together, this study highlights the pivotal role of the cellular metabolism and dNTP pool 
homeostasis on DNA replication fidelity. The identified genes and conditions may play a role as 
mini-drivers during tumor evolution and potentially represent future drug targets or prognostic 
markers. 
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ZUSAMMENFASSUNG 
Das Zusammenspiel von der Nukleotidselektivität und der DNA-Proofreading Funktion der DNA-
Polymerasen mit der DNA Mismatch-Reparatur ermöglicht die extreme hohe Genauigkeit der DNA-
Replikation. Des Weiteren beeinflussen die Konzentration und das Verhältnis der dNTPs, den 
Bausteinen der DNA-Replikation, die Genauigkeit der DNA-Polymerasen. Dementsprechend kann 
die Deregulation der vier Mechanismen zu erhöhter Anzahl von Mutationen und 
Krebsprädisposition führen. Diese Arbeit beschäftigt sich daher mit den Fragen, ob erstens weitere, 
bis jetzt unbekannte Gene die Genauigkeit der DNA-Replikation erhöhen und zweitens, wie 
veränderte dNTP Konzentrationen die Genauigkeit der DNA-Replikation in Saccharomyces 
cerevisiae beeinflussen. 
Um bis jetzt unbekannte Gene zu identifizieren, die die Anhäufung von Mutationen verhindern, 
wurde die nicht-essentielle Gendeletionskollektion der Bäckerhefe in der Gegenwart von entweder 
WT oder DNA-Polymerasemutanten, die durch Mutationen im katalytisch aktiven Zentrum mehr 
Replikationsfehler generieren und deswegen im Experiment als „sensitiver Hintergrund“ dienen, auf 
erhöhte Mutationen hin untersucht. Die Abwesenheit der Folylpolyglutamatsynthetase Met7 
verursachte nicht nur Mutationen, sondern auch „gross chromosomal rearrangements“ (GCRs). 
Zum Großteil wurden diese durch die dUTP-Akkumulation und der Verarbeitung von genomischen 
Uracil ausgelöst. Weitere Untersuchungen zeigten, dass die dUTP-Anhäufung alleine nicht 
ausreichend für einen GCR-Phänotyp in Bäckerhefe ist, was darauf hindeutet, dass die GCRs in 
der Abwesenheit von Met7 durch eine Kombination aus Uracilakkumulation und einem 
Doppelstrangbruchreparaturdefekt ausgelöst werden. Untersuchungen im „sensitiven 
Mutationshintergrund“ identifizierte eine Gruppe von Genen, deren Funktion insbesondere dann 
wichtig ist, wenn die Genauigkeit der Replikation beeinträchtigt ist. In der Abwesenheit der CTP-
Synthethase Ura7 oder in Situationen, in denen Glutamin limitierend ist, wie in der Abwesenheit 
des Transkriptionsfaktors Gln3, ist die de novo CTP-Synthese stark reduziert. Dieses NTP-
Ungleichgewicht führt zu einem schwerwiegenden dNTP-Ungleichgewicht, das weder durch die 
Ribonukleotidreduktase (RNR) noch durch irgendeinem anderen RNR nachgeordneten 
Mechanismus ausgeglichen werden kann. Deshalb hebt diese Studie die Wichtigkeit des NTP-
Gleichgewichts für das dNTP-Gleichgewicht und für die Genauigkeit der DNA-Replikation hervor 
und deutet an, dass niedrige CTP/dCTP-Konzentrationen die Achillesferse der dNTP-
Gleichgewichtsregulation sein könnten. 
Um den Effekt von verschiedenen dNTP-Konzentrationsveränderungen auf die Genauigkeit der 
DNA-Replikation zu untersuchen, wurden zufällig generierte rnr1 Mutanten auf erhöhte 
Mutationsphänotypen getestet. So konnten Schlüsselaminosäuren in Rnr1, der großen 
Untereinheit von RNR, für das dNTP-Gleichgewicht identifiziert werden. Die gefundenen rnr1 Allele 
verursachten stark mutagene dNTP-Konzentrationsveränderungen mit unterschiedlicher 
Abhängigkeit für DNA Polymerase Proofreading und DNA Mismatch-Reparatur. Die dNTP-
Ungleichgewichte mit einem limitierenden dNTP verursachten nicht nur Basenpaarsubstitutionen, 
sondern auch Leserastermutationen. Unter den identifizierten dNTP-Konzentrationsveränderungen 
waren diese mit niedrigen dATP- und stark erhöhten dGTP-Konzentrationen am verheerendsten 
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für die Genauigkeit der DNA-Replikation und führten sogar in der Gegenwart von WT DNA 
Polymerasen und der DNA Mismatch-Reparatur zu starken Mutationsphänotypen. 
Zusammenfassend zeigt diese Arbeit die herausragende Rolle des zellulären Metabolismus, 
insbesondere des dNTP-Gleichgewichts, für die Genauigkeit der DNA-Replikation. Die 
identifizierten Gene und Konditionen könnten eine Rolle als „Mini-Driver“ in der Krebsevolution 
spielen und könnten potentielle zukünftige Kandidaten für die Arzneimittelforschung darstellen oder 
als prognostischer Marker dienen. 
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1 INTRODUCTION 
1.1 Eukaryotic DNA replication fork 
One fundamental principle of life is that all living organisms have to copy their genome prior mitotic 
cell division. For this, the genetic information encoded within the DNA is replicated during the 
synthesis phase (S phase) of the cell cycle in a semiconservative manner. By doing so, each 
parental DNA strand serves as template for DNA polymerases (Pol), which synthesize the daughter 
strand according to the Watson-Crick model (WATSON AND CRICK 1953). In eukaryotes, the genome 
is organized as linear chromosomes. Due to the size of the eukaryotic genomes (e.g. ~12 million 
base pairs for haploid Saccharomyces cerevisiae (S. cerevisiae) cells (GOFFEAU et al. 1996) and 
~3 billion base pairs in haploid human cells (INTERNATIONAL HUMAN GENOME SEQUENCING et al. 
2001; VENTER et al. 2001), DNA replication is initiated at multiple replication origins per 
chromosome (RAGHURAMAN et al. 2001; WYRICK et al. 2001). To assure that each DNA is replicated 
only once per cell cycle, origin licensing during G1 phase and origin firing during S phase are highly 
regulated by different protein complexes and cell cycle regulated kinases (BELL AND LABIB 2016). At 
an activated origin, the two head-to-head loaded CMG helicases (Cdc451 (SANCHEZ-PULIDO AND 
PONTING 2011; MAKAROVA et al. 2012), Mcm2-7 (DAVEY et al. 2003; BOCHMAN AND SCHWACHA 
2008), and GINS (Sld5 and Psf1-3)(TAKAYAMA et al. 2003)) pass each other (DOUGLAS et al. 2018) 
and unwind the DNA double-strand forming two divergent DNA replication forks (BURGERS AND 
KUNKEL 2017). The resulting single-stranded DNA is coated and stabilized by the single-strand 
binding protein replication protein A (RPA (Rfa1-3))(BRILL AND STILLMAN 1991; ALANI et al. 1992; 
LONGHESE et al. 1994). As DNA polymerases can only replicate genetic information in a 5’ to 3’ 
orientation, DNA replication forks are asymmetric (LUJAN et al. 2016). The leading strand is 
synthesized continuously, whereas the lagging strand is replicated discontinuously in ~100-200 
nucleotide (nt) long Okazaki fragments (OKAZAKI et al. 1968; SMITH AND WHITEHOUSE 2012). At 
each origin and Okazaki fragment DNA synthesis is initiated by the Pol α-primase complex (Pol1, 
Pol12, Pri1 and Pri2)(BELL AND LABIB 2016). Primase synthesizes a 7-10 nt long RNA primer, which 
is than further extended up to 20 deoxynucleotides by Pol α before the high-fidelity DNA 
polymerases Pol δ (Pol3, Pol31 and Pol32)(BYRNES et al. 1976; GERIK et al. 1998) and Pol ε (Pol2, 
Dpb2-4)(HAMATAKE et al. 1990; MORRISON et al. 1990; CHILKOVA et al. 2003) continue to replicate 
the majority of the genome (JOHANSSON AND DIXON 2013; BELL AND LABIB 2016; LUJAN et al. 2016). 
In addition to their polymerase domain, the B-type DNA polymerases Pol  and Pol  possess a 3’ 
to 5’ exonuclease function, required for proofreading of the newly synthesized DNA strand and 
consequently high DNA replication fidelity (BYRNES et al. 1976; MORRISON et al. 1991; MORRISON 
AND SUGINO 1994). Furthermore, Pol ε contributes to origin assembly (MURAMATSU et al. 2010) as 
well as to S-phase checkpoint activation (NAVAS et al. 1995). Pol δ not only proofreads Pol α 
replicated DNA (PAVLOV et al. 2006), but also the leading strand in trans (FLOOD et al. 2015). 
Moreover, Pol δ plays an additional role in DNA strand displacement repair, whereby a nicked 
strand is separated from the complementary strand by the advance of Pol δ creating a flap which is 
then further removed by the flap endonuclease Rad27 (PRINDLE AND LOEB 2012). The ring-shaped 
                                                     
1 All gene nomenclature refers to Saccharomyces cerevisiae if not differentially stated. 
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homotrimeric sliding clamp proliferating cell nuclear antigen (PCNA)(Pol30 in budding 
yeast)(BAUER AND BURGERS 1990; KRISHNA et al. 1994) supports Pol δ and Pol ε processivity by 
binding them and anchoring them to DNA (CHILKOVA et al. 2007). Furthermore, PCNA acts as 
loading platform for various other proteins and allows coupling of different processes, including 
DNA repair and nucleosome assembly to DNA replication (MAILAND et al. 2013). PCNA is loaded 
on double-stranded DNA by the replication factor C (RFC) clamp loader complex (Rfc1-5)(BOWMAN 
et al. 2004).  
 
 
Fig. 1.1 The eukaryotic replication fork. 
The CMG helicase unwinds the DNA double strand. Primase initiates replication at each origin and Okazaki 
fragment by synthesizing a short RNA primer (orange), which is further elongated by Pol α with up to 20 nt 
DNA (red). Pol ε replicates the leading strand in a continuous manner, whereas Pol δ synthesizes the lagging 
strand discontinuously as Okazaki fragments. The single-strand binding protein RPA binds and stabilizes 
single-stranded DNA. The sliding clamp PCNA supports DNA polymerase fidelity and serves as loading 
platform to couple various processes to the replication fork. 
 
Whereas it is widely accepted that the minimal eukaryotic replisome consists of the CMG helicase, 
the Pol α-primase, the sliding clamp PCNA, the RFC clamp loader complex, the high-fidelity DNA 
polymerases Pol δ and Pol ε, as well as the single-strand binding protein RPA (ZHANG AND 
O'DONNELL 2016), the contribution of Pol δ and Pol ε to leading- and lagging-strand synthesis is still 
under debate. The most accepted model for DNA replication is the “division of labor” model (LUJAN 
et al. 2016), in which Pol ε (catalytic subunit Pol2) is the leading-strand polymerase (PURSELL et al. 
2007) and Pol δ (catalytic subunit Pol3) synthesizes the lagging strand (NICK MCELHINNY et al. 
2008) (Fig. 1.1). The Kunkel lab proposed this model based on the characterization of active-site 
mutant alleles of Pol ε (pol2-M644G) (PURSELL et al. 2007) and Pol δ (pol3-L612M) (NICK 
MCELHINNY et al. 2008) in budding yeast. These low-fidelity DNA polymerase alleles confer a weak 
mutator phenotype and a specific mutational signature. Mutational hotspot analysis of a reporter 
(URA3) placed in two orientations next to a well-characterized origin (autonomous replicating 
sequence (ARS) ARS306) (STINCHCOMB et al. 1979; POLOUMIENKO et al. 2001) allowed to link Pol δ 
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to lagging-strand and Pol ε to leading-strand replication. Several lines of evidences have further 
supported these initial findings and the “division of labor” model. First, low-fidelity DNA polymerase 
alleles, which incorporate ribonucleotides with a higher frequency, were introduced in S. cerevisiae 
(NICK MCELHINNY et al. 2010a) and S. pombe (MIYABE et al. 2011). Based on the genome-wide 
distribution of misincorporated ribonucleotides Pol δ and Pol ε were assigned to the lagging and 
leading strand, respectively (CLAUSEN et al. 2015; KOH et al. 2015; REIJNS et al. 2015) (DAIGAKU et 
al. 2015). Second, Pol δ was specifically linked to the lagging strand and Pol ε to the leading strand 
using eSPAN (enrichment and sequencing of protein-associated nascent strand DNA). For this, 
chromatin immunoprecipitation of Pol δ and Pol ε was followed by the enrichment for the BrdU 
marked and thus nascent single-stranded DNA. Subsequent DNA sequencing and mapping 
revealed strong enrichment for Pol δ at the lagging strand and Pol ε at the leading strand (YU et al. 
2014). Third, biochemical reconstitution experiments of the eukaryotic replisome using a 
nucleotide-biased forked substrate also supported the “division of labor model” and indicated a role 
of the CMG helicase in dividing the labor (GEORGESCU et al. 2015). Despite the growing evidence 
for Pol ε as leading-strand DNA polymerase, one study questioned whether Pol ε functions as 
major leading-strand DNA polymerase (JOHNSON et al. 2015). This study proposed that Pol δ is the 
major DNA polymerase for both the leading and lagging strand. According to this model, Pol  
functions in DNA proofreading of the leading strand and in the activation of the S-phase 
checkpoint. Nonetheless, there is a general agreement that Pol α and Pol  replicate the lagging 
strand. Due to the strong supportive data for the “division of labor” model, Pol  will be assigned as 
leading strand DNA polymerase in this thesis. However, further studies are needed to clarify the 
contribution of Pol  and Pol  to leading-strand synthesis.  
Besides the essential DNA polymerases Pol α, Pol  and Pol  (also referred to as replicative DNA 
polymerases), other specialized error-prone DNA polymerases, termed translesion synthesis (TLS) 
DNA polymerases, contribute to DNA replication under certain conditions (MCCULLOCH AND KUNKEL 
2008; LANGE et al. 2011). These TLS polymerases are recruited to stalled replication forks to 
bypass sites of exogenous or spontaneous DNA damage and to complete DNA replication. 
Alternatively, the newly synthesized sister chromatid and template switching is used for error-free 
DNA damage bypass (BOITEUX AND JINKS-ROBERTSON 2013). The pathway choice for both 
branches of post-replicative repair (PRR) depends on the ubiquitination status of PCNA: TLS 
polymerases are recruited by PCNA mono-ubiquitination whereas template switching is induced 
upon PCNA poly-ubiquitination (HOEGE et al. 2002). 
1.2 DNA replication fidelity 
Eukaryotic cells have to replicate their genomes fast and with high accuracy to allow efficient cell 
proliferation and to pass high quality genetic information to their progeny. Remarkably, S. 
cerevisiae replisomes progress with approximately 50 nucleotides per second (RAGHURAMAN et al. 
2001) and generate in diploid wild-type cells less than one mutation per ten billion replicated 
nucleotides (1.7 x 10-10 average genome-wide base mutation rate per base pair) (LYNCH et al. 
2008; LANG et al. 2013; LUJAN et al. 2014). Human cells replicate their genome with similar fidelity 
(10−9 to 10−11) (DRAKE et al. 1998; LOEB 2001). The high replication fidelity in eukaryotic cells is 
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achieved by the interplay of DNA polymerases’ nucleotide selectivity and proofreading function and 
the post-replicative DNA mismatch repair (MMR) system (ARANA AND KUNKEL 2010; KUNKEL AND 
ERIE 2015). Furthermore, the levels and balance of the deoxynucleoside triphosphates (dNTPs) 
influence DNA polymerases’ fidelity (Fig. 1.2) (KUNZ et al. 1994; PAI AND KEARSEY 2017). 
Accordingly, defects in any of these four processes have been linked to increased mutagenesis 
and cancer predisposition (PELTOMAKI 2003; BOLAND AND GOEL 2010; BRIGGS AND TOMLINSON 2013; 
MATHEWS 2015). Furthermore, 66% of all mutations found in cancers worldwide were proposed to 
originate from DNA replication errors (TOMASETTI et al. 2017). Replication errors are frequently 
base substitution mutations, which are either transitions (purine-purine and pyrimidine-pyrimidine 
mispairs) or transversions (purine-pyrimidine mispairs) (ARANA AND KUNKEL 2010). Their frequency 
depends on the nucleotide selectivity of the replicating DNA polymerase and the balance between 
the different dNTPs. Insertion and deletion (indels) frameshift mutations are another type of 
replication error. Frameshift mutations originate from DNA polymerase slippage events and occur 
most frequently at repetitive sequences like tandem repeats or mononucleotide runs, so called 
microsatellites (KROUTIL et al. 1996).  
 
 
 
 
Fig. 1.2 The four pillars of high-fidelity DNA 
replication.  
High-fidelity DNA replication depends on DNA 
polymerase proofreading activity and nucleotide 
selectivity, both influenced by the levels and balance 
of the dNTP pools. In addition, the DNA mismatch 
repair (MMR) pathway corrects replication errors, 
increasing about 100-1000x DNA replication fidelity. 
Consequently, mutations affecting DNA polymerase 
proofreading activity or nucleotide selectivity as well 
as mutations inactivating MMR function are known 
drivers of genome instability and human cancer. 
 
Even though not necessarily a mutagenic, the most frequent DNA replication error is the 
misincorporation of ribonucleotides (WILLIAMS et al. 2016). During each round of DNA replication 
replicative DNA polymerases insert approximately one ribonucleotide per 1200 incorporated 
nucleotides in S. cerevisiae (NICK MCELHINNY et al. 2010b) and one ribonucleotide per 7600 in mice 
(REIJNS et al. 2012). Misincorporated ribonucleotides are normally efficiently removed from 
genomic DNA by ribonucleotide excision repair (RER)(WILLIAMS et al. 2016). However, in the 
absence of RER topoisomerase 1-dependent removal of ribonucleotides can lead to 2 to 5 bp 
deletion events in tandem repeats and genome instability (NICK MCELHINNY et al. 2010a; KIM et al. 
2011). 
1.3 DNA polymerase nucleotide selectivity and proofreading 
Replication errors are counteracted by two intrinsic properties of eukaryotic DNA polymerases - 
high nucleotide selectivity and DNA proofreading. Among all factors that determine the high DNA 
replication fidelity in eukaryotes (one replication error per 109 - 1011 synthesized nucleotides 
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(DRAKE et al. 1998; LOEB 2001; LYNCH et al. 2008; LANG et al. 2013; LUJAN et al. 2014)), the largest 
contribution is set by the DNA polymerase nucleotide selectivity (Fig. 1.2) (KUNKEL 2009). 
Remarkably, S. cerevisiae DNA Pol α, δ and ε generate just one replication error per 104 to 105 
synthesized nucleotides in vitro (KUNKEL et al. 1989; SHCHERBAKOVA et al. 2003; FORTUNE et al. 
2005). This high stringency of the DNA polymerase active-site to discriminate against incorrect 
dNTPs and to prevent their incorporation is achieved by the concerted action of three processes: 
Hydrogen bonding of the template and incoming nucleotide (KOOL 2002), enthalpy-entropy 
compensation (PETRUSKA AND GOODMAN 1995) and the complementary architecture of the 
nucleotide binding pocket, which binds the four canonical Watson-Crick nucleotide pairs without 
steric clashes (ECHOLS AND GOODMAN 1991; GOODMAN 1997; MCCULLOCH AND KUNKEL 2008). 
Furthermore, the balance between the different dNTP pools influences nucleotide selectivity (PAI 
AND KEARSEY 2017).  
Mutation studies of the highly conserved mofif A in the active-site of the bacteriophage T4 DNA 
polymerase revealed mutant polymerase alleles that possess a modest mutator phenotype, but are 
proofreading proficient and moreover result in sensitivity to the viral DNA polymerase inhibitor 
phosphonoacetic acid (REHA-KRANTZ AND NONAY 1994; STOCKI et al. 1995), Based on this 
pioneering work the homologous active-site mutations have been introduced in the budding yeast 
DNA polymerases Pol α (pol1-L868M), Pol δ (pol3-L612M) and Pol ε (pol2-M644G). These active-
site mutations allow normal growth in vivo and, in case of Pol  and , do not compromise the DNA 
proofreading function. However, the mutant alleles confer a mild mutator phenotype and a 
characteristic mutational signature (NIIMI et al. 2004; PAVLOV et al. 2006; VENKATESAN et al. 2006; 
PURSELL et al. 2007; NICK MCELHINNY et al. 2008). The pol3-L612M allele shows elevated T-A to C-
G transitions and generates T-dGTP mismatches ≥28 fold more frequently than A-dCTP 
mismatches. Furthermore, G-C to A-T transitions and single A/T base deletions are also increased 
in pol3-L612M and driven by G-dTTP mismatches and T deletions, respectively (NICK MCELHINNY 
et al. 2007; NICK MCELHINNY et al. 2008). In contrast, the pol2-M644G mutational signature is 
characterized by T-A to A-T transversions and the allele generates T-dTTP mismatches ≥39 fold 
more frequently than A-dATP mismatches (PURSELL et al. 2007). These mutational biases for 
certain mismatches have been utilized in combination with reporter (PURSELL et al. 2007; NICK 
MCELHINNY et al. 2008) or genome-wide sequencing (LUJAN et al. 2014) to propose the “division of 
labor model” (LUJAN et al. 2016). Besides some similarities between the active-site DNA 
polymerase mutant alleles (pol1-L868M, pol2-M644G and pol3-L612M), one major difference is 
that only pol2-M644G requires an active S-phase checkpoint and elevated dNTP levels for survival 
(WILLIAMS et al. 2015; SCHMIDT et al. 2017).  
Strikingly, previous reports have identified DNA polymerase active-site mutations have been 
identified in human cancer patients (BRIGGS AND TOMLINSON 2013; MERTZ et al. 2015). Moreover, 
the analysis of inherited biallelic MMR-deficient tumors revealed in some of them acquired somatic 
mutations in Pol  and Pol  resulting in ultra-hypermutated cancers (SHLIEN et al. 2015). 
Interestingly, one of the identified Pol  driver mutations was POLD1-L606M, which is the exact 
homologous mutation to the budding yeast pol3-L612M allele. Furthermore, in mice the 
replacement of the homologous residue L604G/K in murine Pol  is homozygous lethal and the 
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heterozygous mutation causes increased genome instability and tumorigenesis (VENKATESAN et al. 
2007). Thus, evidence from biochemical to in vivo studies, and from phage T4 to humans, highlight 
the importance of nucleotide selectivity for high-fidelity DNA replication.  
As mentioned earlier, high-fidelity DNA polymerases Pol  and  possess in addition to the 5’ to 3’ 
DNA polymerase domain a second domain with 3’ to 5’ exonuclease function (MORRISON et al. 
1991; MORRISON AND SUGINO 1994). This domain allows proofreading of the last-incorporated 
nucleotide. Therefore, to suppress replication errors by DNA proofreading, the excision of the 
terminal misincorporated nucleotide has to occur before DNA polymerase further extends the 
misincorporated nucleotide. The balance between DNA synthesis and DNA proofreading heavily 
depends on the dNTP concentrations (Fig. 1.3) (ROBERTS et al. 1991; ROBERTS et al. 1993; REHA-
KRANTZ 2010). The next-nucleotide effect describes the influence of the nucleotide that is going to 
be incorporated next on DNA proofreading efficiency of the last-incorporated nucleotide. High 
dNTP levels are mutagenic as they favor DNA synthesis over DNA proofreading. In contrast, low 
dNTP levels slow down DNA replication and increase DNA replication fidelity by giving more time 
for DNA proofreading and repair (REHA-KRANTZ 2010). Furthermore, in vitro studies suggest that 
DNA proofreading is inhibited by nucleoside 5’-monophosphate (NMPs) / deoxyribonucleoside 5’-
monophosphate (dNMPs) (QUE et al. 1978; FERSHT AND KNILL-JONES 1983). As dNMPs are the 
products of the 3’ to 5‘ exonuclease reaction, this may represent a product inhibition mechanism to 
prevent excessive excision of the newly synthesized strand. 
 
 
Fig. 1.3 The dNTP pool size influences DNA polymerase function. 
dNTPs are the substrates for DNA polymerases polymerization domain (POL). However, the high-fidelity DNA 
polymerases Pol δ and Pol ε also possess a 3’-5’ exonuclease domain (EXO), which allows proofreading of 
the last-incorporated nucleotide. The balance between synthesis and excision (proofreading) strongly depends 
on the dNTP levels, in particular the concentration of the nucleotide that has to be incorporated after the last-
incorporated nucleotide (next-nucleotide effect). High dNTP concentrations promote DNA polymerase 
polymerization on the expense of proofreading, whereas low dNTP pools slow down replication and give more 
time for proofreading. 
 
In S. cerevisiae the DNA polymerase exonuclease-deficient alleles pol2-04 (MORRISON et al. 1991) 
and pol3-01 (MORRISON et al. 1993) cause a mutator phenotype (MORRISON AND SUGINO 1994; 
TRAN et al. 1999). Interstingly, the mutator phenotype of pol3-01 is approximately 10-fold stronger 
than pol2-04 (MORRISON AND SUGINO 1994; TRAN et al. 1999). This difference may be explained by 
reports that Pol  proofreads a higher proportion of the genome than Pol : Pol  not only 
proofreads Pol -replicated DNA, but also DNA synthesized by Pol α (PAVLOV et al. 2006) as well 
as the leading strand in trans (FLOOD et al. 2015). Furthermore, Pol  performs DNA repair 
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synthesis and consequent proofreading of repaired DNA sequences (PRINDLE AND LOEB 2012). 
Moreover, in haploid yeast both pol2-04 and pol3-01 cause synthetic lethality in the absence of 
MMR (TRAN et al. 1999; GREENE AND JINKS-ROBERTSON 2001; WILLIAMS et al. 2013). This type of 
lethal interactions occurs when the mutation rate is so high that at least one essential gene is 
inactivated per round of DNA replication and has been referred to as “error-induced extinction” 
phenotype (HERR et al. 2011). In line with a conserved function of DNA proofreading in mutation 
avoidance, DNA proofreading deficiency in mice causes increased tumorigenesis and shorter 
lifespan (GOLDSBY et al. 2001; GOLDSBY et al. 2002; ALBERTSON et al. 2009). Furthermore, 
sequencing of human cancer patient genomes revealed DNA proofreading-deficient polymerase as 
driver of cancer progression (BRIGGS AND TOMLINSON 2013; CHURCH et al. 2013; PALLES et al. 2013; 
SHLIEN et al. 2015). In summary, both Pol  and Pol  DNA proofreading function contribute to 
eukaryotic DNA replication fidelity.  
1.4 DNA mismatch repair 
Unrepaired replication errors become permanent mutations during the next round of DNA 
replication. To counteract the propagation of replication errors that escaped DNA polymerase 
proofreading, most living organisms possess a spell-checking mechanism named DNA mismatch 
repair (MMR). This post-replicative MMR system recognizes and repairs replication errors, 
increasing replication fidelity approximately 100-fold (LANG et al. 2013; LUJAN et al. 2014). 
Interestingly, the MMR correction efficiency in vivo is proportional to the frequency of generated 
DNA replication errors (KUNKEL AND ERIE 2015). Thus, MMR is most effective in the suppression of 
frequently generated frameshift mutations. Consequently, defects in MMR results not only in an 
overall increased mutator phenotype, but specifically in increased frameshift mutations. The 
seminal discovery that increased mutations rates caused by defects in human MMR genes are 
responsible for the predisposition to develop an early-onset form of colon cancer called hereditary 
nonpolyposis colorectal cancer (HNPCC) or Lynch syndrome (BOLAND AND GOEL 2010; BOLAND AND 
LYNCH 2013; KOLODNER 2016), further stresses the importance of MMR as genome stability 
mechanism. Of note, HNPCC is the most prevalent human hereditary cancer predisposition and 
HNPCC tumors as well as tumors, which have sporadically inactivated MMR, show a microsatellite 
instability (MSI) phenotype (PELTOMAKI 2003). 
The MMR mechanism is best understood in Escherichia coli (E. coli) (IYER et al. 2006). In E. coli, 
the mismatch is recognized by the MutS homodimer (where “Mut” stands for mutator). This MutS 
recognition complex recruits a MutL homodimer to the site of the mismatch. Next, the MutL repair 
intermediate complex recruits MutH, a DNA methylation-sensitive endonuclease. Upon activation 
by MutL, MutH introduces a nick in the newly synthesized strand. In E. coli, hemi-methylation of 
d(GATC) sites is the strand discrimination signal (PUTNAM 2016). Directly after DNA replication the 
newly synthesized DNA strand is transiently unmethylated which allows the MutH endonuclease to 
discriminate the daughter from the parental strand and specifically introduce the nick in the 
daughter strand (LANGLE-ROUAULT et al. 1987; WELSH et al. 1987). The generated nick acts then as 
entry site for single-strand specific exonucleases that excise part of the newly synthesized strand. 
Repair is completed by DNA PolIII-dependent re-synthesis.  
INTRODUCTION 
10 
 
 
 
 
 
 
Fig. 1.4 The S. cerevisiae 
MSH and MLH complexes. 
Arrows represent the functional 
interaction and the potential role 
in vivo. Thick arrows indicate 
major roles in the process, 
whereas thin arrows represent 
minor contributions. Dashed 
arrows indicate functional 
relevance for the process only 
in certain genetic backgrounds. 
Figure is adapted from (REYES 
et al. 2015) 
 
Key aspects of the MMR mechanism are conserved between bacteria and eukaryotes and as in 
bacteria MutS-homolog (MSH) and MutL-homolog (MLH) family members play critical roles in the 
eukaryotic repair process (Fig. 1.4) (IYER et al. 2006; REYES et al. 2015). In eukaryotes, several 
MSH proteins exist which are active as heterodimers. Mismatches in eukaryotes are recognized by 
Msh2-Msh6 and Msh2-Msh3, as well as by Msh2-Msh7 in plants (CULLIGAN AND HAYS 2000). 
Furthermore, an additional MSH complex called Msh4-Msh5 has been reported (ROSS-MACDONALD 
AND ROEDER 1994) (HOLLINGSWORTH et al. 1995). However, in contrast to the previously mentioned 
complexes it does not play a role in MMR but during meiotic cross-over (SANTUCCI-DARMANIN et al. 
2002; SNOWDEN et al. 2004; KOLAS et al. 2005). In contrast to human cells, in which the Msh2-
Msh6 complex is the major mismatch recognition complex, Msh2-Msh6 and Msh2-Msh3 play a 
more balanced role in S. cerevisiae (MARSISCHKY et al. 1996; SIA et al. 1997). However, the two 
yeast complexes differ in their substrate specificity. Yeast Msh2-Msh6 recognizes seven out of the 
eight possible base substitutions (C-C mispairs are poorly recognized), as well as one and two 
nucleotide indels (SRIVATSAN et al. 2014). In contrast, yeast Msh2-Msh3 functions preferentially on 
smaller and larger indels and to a lesser degree on base substitutions (ACHARYA et al. 1996; 
MARSISCHKY et al. 1996; HARRINGTON AND KOLODNER 2007; SRIVATSAN et al. 2014). Msh2-Msh3 
and Msh2-Msh6 recruit heterodimeric MLH repair intermediate complexes to the mismatch site. 
Three repair intermediate complexes exist in eukaryotes – Mlh1-Pms1 (human Mlh1-Pms2), Mlh1-
Mlh2 (human Mlh1-Pms1) and Mlh1-Mlh3. The Mlh1-Pms1 complex is essential for the MMR 
reaction (KUNKEL AND ERIE 2015; REYES et al. 2015), whereas Mlh1-Mlh2 (PROLLA et al. 1998; 
HARFE et al. 2000; CAMPBELL et al. 2014) and Mlh1-Mlh3 play only minor roles in MMR (FLORES-
ROZAS AND KOLODNER 1998; CHEN et al. 2005). In contrast to E. coli, eukaryotes do not encode for 
a MutH endonuclease homolog. However, the Mlh1-Pms1 (KADYROV et al. 2006) and Mlh1-Mlh3 
(NISHANT et al. 2008) complexes possess endonuclease activity that is stimulated by the interaction 
with PCNA (KADYROV et al. 2006; PLUCIENNIK et al. 2010).  
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Fig. 1.5 Mechanistic model about the MMR reaction in S. cerevisiae. 
(1) The Msh2-Msh6 heterodimer recognizes the mismatch either coupled or uncoupled to the DNA replication 
fork. (2) Msh2-Msh6 recruits Mlh1-Pms1 to the mismatch site and facilitates the catalytic loading of Mlh1-
Pms1 complexes. (3) Upon activation by the sliding clamp PCNA, Mlh1-Pms1 endonuclease nicks the DNA. 
(4) The newly synthesized strand is excised either in an exonuclease 1 (Exo1)-dependent or in an Exo1-
independent reaction. The latter, was proposed to involve multiple rounds of nicking catalyzed by Mlh1-Pms1. 
(5) Finally, Pol δ resynthesizes the DNA. For details see text. 
 
Taken together, the current model of the eukaryotic MMR reaction (exemplified using the S. 
cerevisiae MMR protein names) can be outlined in five steps (Fig. 1.5)(KUNKEL AND ERIE 2015; 
REYES et al. 2015): (1) Mismatch recognition: Msh2-Msh3 or Msh2-Msh6 either coupled or 
uncoupled to the DNA replication fork recognizes the mismatch. Coupling of mismatch recognition 
complexes to DNA replication forks is achieved by tethering Msh2-Msh3 and Msh2-Msh6 to PCNA 
using PCNA-interacting protein (PIP) motifs present at the N-terminus of Msh3 and Msh6 (CLARK et 
al. 2000; FLORES-ROZAS et al. 2000; KLECZKOWSKA et al. 2001). (2) Mlh1-Pms1 recruitment: 
Mismatch recognition complexes recruit Mlh1-Pms1 to sites of damage and facilitate catalytic 
loading of these repair intermediate complexes on DNA (HOMBAUER et al. 2011a). (3) Incision 
reaction: PCNA stimulates the Mlh1-Pms1 endonuclease that nicks the newly synthesized strand. 
(4) Excision reaction: The exonuclease 1 (Exo1), a 5’ to 3’ exonuclease, uses the generated nick 
as entry site to excise the newly synthesized strand. As the absence of Exo1 causes only a mild 
mutator phenotype in S. cerevisiae (TISHKOFF et al. 1998; AMIN et al. 2001) and mouse (WEI et al. 
2003; EDELMANN AND EDELMANN 2004) and no other exonuclease functioning in MMR has been 
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discovered so far (GOELLNER et al. 2015), it has been proposed that multiple rounds of Mlh1-Pms1-
dependent nicking may substitute for the loss of Exo1 (GOELLNER et al. 2014). Therefore, the 
eukaryotic MMR excision can either be a fast Exo1-dependent or a slower Exo1-independent 
reaction. However, the exact mechanism still remains elusive.  
(5) DNA re-synthesis: MMR reaction is completed by Pol -dependent re-synthesis of the daughter 
strand using the parental strand as template.  
As MMR functions coupled to DNA replication, it has been suggested that strand discrimination is 
accomplished by making use of a transient DNA replication-associated signal, which allows repair 
in a short time frame (KLECZKOWSKA et al. 2001; HOMBAUER et al. 2011a; HOMBAUER et al. 2011b). 
In contrast to E. coli, eukaryotes as well as most of the bacteria that do not belong to the 
gammaproteobacterial, do not use the hemi-methylation status of d(GATC) sites as strand 
discrimination signal (GAO et al. 2009; PUTNAM 2016). Several not mutually exclusive strand 
discrimination signals have been proposed for eukaryotic MMR: transient nicks between Okazaki 
fragments on the lagging strand (HOLMES et al. 1990; THOMAS et al. 1991; FANG AND MODRICH 
1993), transient nicks generated due to the removal of misincorporated ribonucleotides by RER 
(GHODGAONKAR et al. 2013; LUJAN et al. 2013) or loading of PCNA in a specific orientation 
(PLUCIENNIK et al. 2010). However, nicks due to Okazaki fragments do not explain the strand 
discrimination at the continuously synthesized leading strand. Furthermore, the absence of RER 
and ribonucleotide removal does not cause a strong MMR-defect. Moreover, PCNA has been 
shown to be less important for leading strand processivity (GEORGESCU et al. 2014) and therefore 
most likely does not serve as strand discrimination signal during leading strand replication. Hence, 
none of the proposed signals sufficiently explain eukaryotic strand discrimination (REYES et al. 
2015) and further studies are required to unravel the strand discrimination signal in eukaryotes. 
Besides the important role of MMR in DNA replication fidelity, MMR complexes also play non-
canonical roles in various other processes, like the DNA damage response (LI et al. 2016), somatic 
hypermutation of immunoglobulins (ZANOTTI AND GEARHART 2016), triplet-repeat expansion 
(CROUSE 2016), meiotic crossing overs (MANHART AND ALANI 2016) and homeologous 
recombination (THAM et al. 2016).  
In summary, MMR proteins prevent the accumulation of mutations and counteract the development 
of cancer.  
1.5 dNTP pool homeostasis 
dNTPs are the building blocks for genome replication in living organisms. In most organisms, in 
which dNTP pools have been determined, the concentration of different dNTPs is not equimolar but 
rather exist in a natural imbalance that is apparently beneficial for DNA replication fidelity. dTTP is 
the most abundant dNTP pool followed by dATP and dCTP. dGTP is always the least abundant, 
contributing just 5-10% to the total dNTP pool (MATHEWS AND JI 1992; MARTOMO AND MATHEWS 
2002; CHABES et al. 2003). Interestingly, mitochondrial dNTP pools, which represent a physically 
and metabolically distinct compartment, are dominated by dGTP (SONG et al. 2005; NIKKANEN et al. 
2016). This difference between nuclear and mitochondrial dNTP pools has been suggested to be 
an adaptation to the oxidative environment present in the mitochondria, which may potentially favor 
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oxidation of dGTP to mutagenic 8-oxo-dGTP (MATHEWS 2006). Remarkably, the 
underrepresentation of dGTP found in nuclear dNTP pools does not strongly affect replication 
fidelity in comparison to equimolar dNTP concentrations used in in vitro DNA replication reactions 
(MARTOMO AND MATHEWS 2002). Furthermore, the telomere length seems to be positively correlated 
with the dGTP concentration in S. cerevisiae (GUPTA et al. 2013; MAICHER et al. 2017). 
In eukaryotes, dNTP concentrations peak during S phase (CHABES et al. 2003; HÅKANSSON et al. 
2006a; HÅKANSSON et al. 2006b). However, even during S phase dNTP levels are not sufficient to 
allow DNA replication of the whole genome (REICHARD 1988). Thus, to complete genome 
replication dNTPs have to be constantly generated during S phase. In agreement with dNTP pools 
being a limiting factor for the speed of DNA replication, elevated dNTP pools increase replication 
fork progression and shorten S-phase length in S. cerevisiae (POLI et al. 2012; DOVRAT et al. 2018). 
Even though it is still not fully understood why it could be advantageous for eukaryotic cells to 
prolong their S phase by limiting the dNTP pools, there might be several arguments to do so: First, 
elevated dNTP pools cause increased mutagenesis in vitro (ROBERTS et al. 1991; ROBERTS et al. 
1993) and in vivo (CHABES et al. 2003). Thus, lower dNTP levels might increase DNA replication 
fidelity presumably by diminishing the next-nucleotide effect and therefore promoting DNA 
polymerase proofreading. Second, as TLS polymerases require high dNTP concentrations, low 
dNTP pools may restrict the contribution of error-prone TLS polymerases to overall DNA synthesis 
to those situations in which they are absolutely required (PRAKASH AND PRAKASH 2002; LANGE et al. 
2011). Third, high activity of the ribonucleotide reductase (RNR) complex, the rate limiting enzyme 
in the de novo synthesis of dNTPs (NORDLUND AND REICHARD 2006), may cause accumulation and 
incorporation of potentially mutagenic dUTP in situations in which dTTP synthesis is impaired (HU 
et al. 2012; CHEN et al. 2016). Fourth, increased dNTP pools in G1 result in a delayed S-phase 
entry in budding yeast (CHABES AND STILLMAN 2007) and mammalian cells (FRANZOLIN et al. 2013). 
However, the mechanism is not understood. Finally, a longer S phase may give sufficient time to 
not only replicate the genetic, but also the epigenetic information with high accuracy (PAI AND 
KEARSEY 2017).  
However, also dNTP deficiency can lead to impaired chromatin replication (JASENCAKOVA AND 
GROTH 2010; PAPADOPOULOU et al. 2015) and prevent high-fidelity DNA replication (BESTER et al. 
2011). So, low dNTP pools can result in increased misincorporation of ribonucleotides (WANROOIJ 
et al. 2017), stalled replication forks and underreplicated regions which can lead to anaphase 
bridges and chromosome loss (MAGDALOU et al. 2014). Thus, dNTP levels are a critical parameter 
for high-fidelity DNA replication that balances replication fork progression and DNA proofreading. 
In addition to dNTP levels also the balance between the different dNTP pools is of outmost 
importance for high-fidelity DNA replication. In in vitro DNA replication reactions, imbalanced dNTP 
pools not only result in increased base pair substitutions (ROBERTS AND KUNKEL 1988; MARTOMO 
AND MATHEWS 2002) but also promote the generation of frameshift mutations (BEBENEK et al. 1992). 
Furthermore, dNTP pool imbalances in vivo lead to increased mutagenesis and characteristic 
changes in the mutation spectra in E. coli (LU et al. 1995; MILLER et al. 2002; TSE et al. 2016), S. 
cerevisiae (KUMAR et al. 2010; KUMAR et al. 2011; WATT et al. 2016) and mammalian cells 
(WEINBERG et al. 1981; TRUDEL et al. 1984; WEINBERG et al. 1985; MATTANO et al. 1990; RENTOFT et 
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al. 2016). Thus, the relative ratio between different dNTPs influences DNA polymerases’ nucleotide 
selectivity and impacts on DNA replication fidelity. However, why certain dNTP imbalances are 
more mutagenic than others, is still not fully understood.  
1.6 de novo dNTP biosynthesis 
Given the importance of dNTP pool homeostasis for DNA replication fidelity, dNTP biosynthesis is 
highly regulated (Fig. 1.6)(GUARINO et al. 2014). In S. cerevisiae dNTP pools are maintained  
exclusively by de novo dNTP biosynthesis in the cytoplasm, whereas in mammalian cells dNTP 
salvage pathways also contribute to the total dNTP pools (MATHEWS 2015; PAI AND KEARSEY 2017). 
The master regulator of the de novo dNTP biosynthesis and dNTP pools is the RNR complex, 
which catalyzes the reduction of ribonucleoside diphosphates (NDPs) to their corresponding 
deoxyribonucleoside diphosphates (dNDPs) (NORDLUND AND REICHARD 2006; GUARINO et al. 2014). 
Next, NDP kinase (Ynk1) phosphorylates dNDPs to the corresponding dNTPs (JONG AND MA 1991; 
TSUNEHIRO et al. 1993). Whereas dATP, dGTP and dCTP are direct substrates for high-fidelity DNA 
synthesis, dUTP has to be further converted to dTTP. For this, dUTPase (Dut1) dephosphorylates 
dUTP to dUMP (GADSDEN et al. 1993). Next, thymidylate synthase (Cdc21) catalyzes the reductive 
methylation of dUMP to dTMP (TAYLOR et al. 1982). dTMP is than subsequently phosphorylated to 
dTTP by thymidylate kinase (Cdc8) (KUO AND CAMPBELL 1983; JONG et al. 1984) and NDP kinase.  
Furthermore, dCMP deaminase (Dcd1) balances dCTP and dTTP pools downstream of RNR by 
converting dCMP to dUMP (MCINTOSH AND HAYNES 1984). Consequently, dCTP pools are 
increased and dTTP pools decreased in the absence of Dcd1 (KOHALMI et al. 1991; SANCHEZ et al. 
2012) 
 
1.7 The ribonucleotide reductase 
The RNR complex is essential for the de novo dNTP biosynthesis in all living organisms. In 
eukaryotes, the minimal RNR complex (α2β2) is composed of a dimer of two large α subunits (Rnr1-
Rnr1 in S. cerevisiae and Rrm1-Rrm1 in human) and a dimer of two small β subunits (Rnr2-Rnr4 in 
S. cerevisiae and Rrm2-Rrm2 in human) (NORDLUND AND REICHARD 2006; GUARINO et al. 2014). 
Moreover, S. cerevisiae encodes also for an alternative large subunit RNR3, which is only weakly 
expressed under normal growth conditions, but is strongly induced upon DNA replication stress or 
DNA damage (ELLEDGE AND DAVIS 1990). In contrast to S. cerevisiae, the expression of an 
alternative small subunit p53R2 is induced by p53 upon DNA damage in mammals (TANAKA et al. 
2000; GUITTET et al. 2001). 
While the small RNR subunits stabilize the diferric-tyrosyl radical cofactor which is required to 
initiate the radical driven reduction of NDPs at the catalytic site (C-site), each large subunit 
contains one C-site as well as two allosteric sites - the activity site (A-site) and the specificity site 
(S-site) (Fig. 1.7A) (NORDLUND AND REICHARD 2006). The A-site, which is located at the N-terminus 
of Rnr1, regulates the overall activity of RNR by binding ATP or dATP. ATP binding to the A-site 
stimulates RNR activity, whereas dATP acts as negative feedback inhibitor by inducing the 
formation of inactive α6β2 oligomers in yeast and human RNR (Fig. 1.7C) (FAIRMAN et al. 2011). 
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Fig. 1.6 The de novo dNTP biosynthesis pathway in S. cerevisiae. 
Metabolic genes identified in the genome-wide screen are encircled in red. Figure was adapted from 
(MATHEWS 2015) and (SCHMIDT et al. 2017). 
 
Consequently, the expression of a rnr1 allele (rnr1-D57N) in S. cerevisiae that lacks dATP 
feedback inhibition results in an overall increase in dNTP levels, a mild mutator phenotype and an 
increased resistance to exogenous DNA damage (CHABES et al. 2003). The S-site regulates the 
balance between the different dNTP pools by sensing three out of the four dNTPs and priming the 
C-site for binding to specific NDP substrates. So, binding of dATP or ATP to the S-site promotes 
the reduction of CDP and UDP at the C-site, whereas dTTP and dGTP binding to the S-site 
facilitates the reduction of GDP and ADP, respectively (Fig. 1.7B). Two conserved flexible loops 
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play important functions in the S-site allosteric regulation of RNR: loop 1 interacts with the bound 
dNTP effector at the S-site and loop 2 interconnects the S-site of one subunit with the C-site of the 
other subunit (XU et al. 2006a). Based on the RNR crystal structure, loop 2 has been proposed to 
be critical for dNTP homeostasis (XU et al. 2006a). In line with this, expression of rnr1 alleles in S. 
cerevisiae carrying point mutations in the loop 2 cause severe dNTP imbalances, increased 
mutator phenotypes and in some cases growth defects and S-phase checkpoint activation (KUMAR 
et al. 2010; KUMAR et al. 2011). 
In addition to the intrinsic allosteric regulation of RNR, its activity and dNTP pools are controlled on 
three other levels in S. cerevisiae (Fig. 1.7D): First, RNR gene expression peaks during S phase 
(ELLEDGE AND DAVIS 1990; ELLEDGE et al. 1993; TSAPONINA et al. 2011) and is otherwise 
transcriptionally repressed by Crt1 (HUANG et al. 1998). Second, the small unstructured protein 
Sml1 acts as an RNR inhibitor by directly binding to Rnr1 at equimolar concentrations (CHABES et 
al. 1999; ZHAO et al. 2000). Third, outside S phase Dif1 shuttles Rnr2-Rnr4 into the nucleus (LEE et 
al. 2008) where Wtm1 acts as a nuclear anchor for the heterodimer (LEE AND ELLEDGE 2006; ZHANG 
et al. 2006). In this way, the large and small subunits of RNR are spatially separated in the 
cytoplasm and nucleus, respectively, and cannot form an active cytoplasmic complex.  
Recently, another small unstructured protein Hug1 has been implicated to negatively regulate RNR 
in S. cerevisiae. Hug1 binds to Rnr2 and promotes the dissociation of the RNR tetramer. This way, 
Hug1 suppresses RNR activity and may prevent excessive dNTP pool expansion after completed 
DNA replication or repair (AINSWORTH et al. 2013; MEURISSE et al. 2014).  
In mammalian cells, dNTP pools are even more strictly regulated and actively downregulated 
outside S phase by the dNTP triphosphohydrolase sterile alpha motif and histidine-aspartate 
domain-containing protein 1 (SAMHD1) (POWELL et al. 2011; FRANZOLIN et al. 2013). Elevated 
dNTP levels outside S phase in mammalian cells promote viral DNA replication (GOLDSTONE et al. 
2011; LAGUETTE et al. 2011) and genome instability (GUARINO et al. 2014; KOHNKEN et al. 2015). 
Accordingly, mutations in SAMHD1 as well as reduced SAMHD1 expression levels have been 
reported in several cancers (KOHNKEN et al. 2015; RENTOFT et al. 2016).  
dNTP pools are upregulated upon DNA damage or DNA replication stress as part of the DNA 
damage response (DDR) (CICCIA AND ELLEDGE 2010; PARDO et al. 2017) in bacteria (GON et al. 
2011), yeast (CHABES et al. 2003) and to a lesser extend in mammalian cells (HÅKANSSON et al. 
2006b; ZHANG et al. 2011). In S. cerevisiae, Mec1 phosphorylates the mediators Rad9 or Mrc1, 
which phosphorylate the effector kinase Rad53 on multiple sites. One function of Rad53 is the 
activation the Dun1 kinase that phosphorylates the inhibitors of RNR (Sml1, Crt1 and Dif1) and 
mark them for degradation (PARDO et al. 2017). Consequently, RNR expression levels, in particular 
Rnr2, Rnr3 and Rnr4, and RNR activity raise leading to increased dNTP pools. Elevated dNTP 
pools facilitate DNA fork re-start and DNA synthesis by TLS polymerases to bypass replication 
obstacles. Moreover, elevated dNTP pools supply DNA repair processes with sufficient dNTPs in 
particular outside S phase (PAI AND KEARSEY 2017). In conclusion, RNR plays a key role for dNTP 
pool homeostasis and its regulation allows fine tuning of dNTP biosynthesis during normal DNA 
replication as well as under DNA damage conditions. Hence, inhibitors of RNR, like hydroxyurea 
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(HU) or gemcitabine, are potent chemotherapeutics (XU et al. 2006b; WANG et al. 2007; WANG et 
al. 2009; AYE et al. 2014).  
 
 
Fig. 1.7 Regulation of ribonucleotide reductase in S. cerevisiae.  
(A) Model of the Rnr1-Rnr1 homodimer based on the crystal structure (PDB: 2cvv and 3hne). The catalytic site 
(C-site) and the two allosteric sites, the activity site (A-site) and the specificity site (S-site), are labeled in one 
subunit. Loop 1 and the loop 2 are colored in blue and violet, respectively. (B) Schematic representation of the 
regulation of the C-site by the S-site. Depending on which dNTP (right) binds to the S-site, the C-site is primed 
for a specific NDP substrate (indicated by the orange arrows). (C) Model for the regulation of RNR overall 
activity by the A-site. Upon nucleotide binding to the S-site two large subunits (α) (green) form a dimer. 
Together with a small subunit (β) dimer (violet) the minimal active RNR (α2β2) is assembled. dATP binding to 
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the A-site induces catalytic inactive RNR hexamers. In the process of hexamerization a short-lived tetrameric 
intermediate (marked with ?) has been postulated. Figure panel was modified from (FAIRMAN et al. 2011). (D) 
S. cerevisiae RNR activity throughout the cell cycle and upon DNA damage and replication stress. In G1 and 
G2 phase, the RNR dimers are spatially separated and Sml1 inhibits Rnr1-Rnr1 dimers. Consequently, dNTP 
levels are low. During S phase Sml1 levels are reduced, functional cytoplasmic RNR complexes are formed 
and dNTP pools are elevated. Upon damage or replication stress, the DNA damage checkpoint induces the 
expression of RNR subunits and the degradation of negative regulators of RNR, which results in high dNTP 
pools. 
 
1.8 Folate one-carbon metabolism 
The one-carbon metabolism is central for various biosynthetic processes including the biosynthesis 
of dTMP, purines, amino acids, vitamins, and formyl-methionyl-tRNA (fMet-tRNA), which is 
required for the initiation of bacterial, chloroplast and mitochondrial protein biosynthesis (APPLING 
1991; DUCKER AND RABINOWITZ 2017).  
All of these processes have in common that the interconvertible folate cofactors serve as one-
carbon donors (STOVER AND FIELD 2011). Consequently, due to the fundamental role of folates in 
promoting cell proliferation and growth, antifolate drugs have been developed and are widely used 
as chemotherapeutics, in the treatment of chronic autoimmune diseases and as drugs against 
bacterial or parasite infections (VAN TRIEST et al. 2000; NZILA 2006; CHATTOPADHYAY et al. 2007; 
VISENTIN et al. 2012; MURIMA et al. 2014). 
Folate cofactors differ in the oxidation state and position of the one-carbon unit that is either bound 
to N5, N10 or both of tetrahydrofolate (THF) (Fig. 1.8A) (STOVER AND FIELD 2011). In eukaryotic cells, 
the folate one-carbon metabolism is highly compartmentalized (Fig. 1.8B)(APPLING 1991; STOVER 
AND FIELD 2011). In the mitochondria, the one-carbon metabolism is required for glycine 
biosynthesis, formylation of the initiator tRNA and the production of formate for the cytoplasmic 
one-carbon metabolism. In the cytoplasm, one-carbon metabolism facilitates the de novo synthesis 
of purines and thymidylate as well as the remethylation of homocysteine to methionine (FOX AND 
STOVER 2008). Moreover, serine and glycine can be interconverted in the mitochondria and 
cytoplasm by compartment-specific isoforms of serine hydroxymethyl transferase (mitochondrial 
Shm1 and cytoplasmic Shm2)(MCNEIL et al. 1994). Furthermore, in both compartments the 
folylpolyglutamate synthetase (FPGS) (Met7) catalyzes the addition of glutamate chains at the γ-
carboxyl residue of folate cofactors under the consumption of ATP (DESOUZA et al. 2000). Folate 
polyglutamylation is critical for the cellular one-carbon metabolism because it increases intracellular 
retention of folates and enhances the affinity of folates to folate-metabolizing enzymes (SCHIRCH 
AND STRONG 1989). As FPGS not only modifies folates, but also classical antifolates, increasing as 
well their cellular retention and toxicity, inactivation of FPGS has been identified as a common 
resistance mechanism of cancer cells upon antifolate treatment (GONEN AND ASSARAF 2012; 
VISENTIN et al. 2012). 
In contrast to most of the bacteria, yeast and plants, which can synthesize folates de novo, animals 
depend on dietary folate intake (DUCKER AND RABINOWITZ 2017). Therefore, insufficient folate intake 
or defects in one-carbon metabolizing enzymes results in folate deficiency leading to anemia in 
adult humans and to neural tube and congenital heart defects in the developing embryo (BAILEY 
AND BERRY 2005; BEAUDIN AND STOVER 2009). Thus, the folate one-carbon metabolism is crucial for 
cellular proliferation and an attractive drug target for anti-proliferative therapies.  
INTRODUCTION  
19 
 
  
Fig. 1.8 The folate one-carbon metabolism in S. cerevisiae.  
(A) Structure of tetrahydrofolate (THF). The one-carbon unit is bound either to N5, N10 or both at the R1 and R2 
position. Intracellular folates are polyglutamylated with variable chain length by FPGS to increase intracellular 
retention and affinity to folate metabolizing enzymes. (B) Model of folate one-carbon metabolism in S. 
cerevisiae. Folates are utilized in the cytoplasm and in the mitochondria. Metabolic genes are labels in bold 
and italic. Important products of folate one-carbon metabolism in each compartment are highlighted in bold 
and red. 
 
 
  
INTRODUCTION 
20 
 
1.9 Aim of the study 
The interplay between DNA polymerases with high nucleotide selectivity and DNA proofreading 
functions and the post-replicative MMR mechanism enable cells to replicate their genomes with 
extremely high accuracy. Furthermore, the level of and balance between the different dNTPs, the 
building blocks of DNA, influences DNA polymerases’ nucleotide selectivity and proofreading 
function. Defects in any of these DNA replication fidelity mechanisms increase the number of 
mutations generated during each round of DNA replication. Consequently, mutations in DNA 
polymerases and in MMR components increase cancer susceptibility (KUNKEL AND ERIE 2015). 
Moreover, inactivating mutations affecting the DNA polymerase proofreading domain and MMR 
components cause in human familial colorectal/ovarian cancer (BRIGGS AND TOMLINSON 2013; 
CHURCH et al. 2013; PALLES et al. 2013; SHLIEN et al. 2015) and the most frequent hereditary 
cancer predisposition Lynch syndrome (PELTOMAKI 2003; BOLAND AND GOEL 2010), respectively. 
The latter is characterized by increased mutagenesis in particular at repetitive sequences so called 
microsatellites. Thus, mutations caused by DNA replication errors are critical drivers of 
malignancies like cancer (TOMASETTI et al. 2017) but also enable evolution. 
Interestingly, even though the majority of microsatellite-instable tumors can be linked to the 
inactivation of Mlh1, Msh2 or Msh6, around 5-10% of the tumors cannot be explained by mutations 
in or silencing of canonical MMR components (PELTOMAKI 2003) suggesting that additional factors 
may contribute to the suppression of frameshift mutations. In the past, powerful systematic screens 
in S. cerevisiae revealed many genes that prevent the accumulation of mutations (HUANG et al. 
2003; SMITH et al. 2004), which were than further characterized in detail. 
This work investigated DNA replication fidelity mechanisms focusing in particular on the 
identification of previously unrecognized genes that counteract the acquisition of mutations and 
moreover on the impact of deregulated dNTP pools on the generation of mutations.  
In the first part of this study a genome-wide screen in budding yeast using a modified version of the 
synthetic genetic array (SGA) (TONG AND BOONE 2006) was performed to identify previously 
unrecognized non-essential genes that prevent the accumulation of base pair substitutions and 
frameshift mutations. For this, low-fidelity active-site mutants of the three major eukaryotic DNA 
polymerases Pol α, Pol  and Pol  (pol1-L868M, pol2-M644G and pol3-L612M, respectively) that 
confer a weak mutator phenotype by themselves were used as “sensitized mutator backgrounds” to 
detect mutational enhancers that are otherwise buffered in the WT background. Furthermore, 
according to the “division of labor” model of DNA replication (LUJAN et al. 2016), pol1-L868M/pol3-
L612M and pol2-M644G are linked to lagging- and leading-strand replication, respectively. 
Therefore, the screen revealed specific mutator interactions with the leading and lagging-strand 
alleles that suggest differential dependencies of leading- and lagging strand DNA synthesis and 
repair on the identified genes. Thus, in the first part of this study, previously unrecognized non-
essential genes that prevent the accumulation of mutations were identified and their contribution to 
DNA replication fidelity characterized.  
The second part of this study aimed at elucidating the effect of imbalanced or elevated dNTP levels 
on DNA replication fidelity in S. cerevisiae. As the levels and balance of the dNTP pools influence 
DNA polymerases’ nucleotide selectivity and proofreading activity, dNTP pool alterations cause 
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increased mutator phenotypes (CHABES et al. 2003; KUMAR et al. 2010). However, why certain 
dNTP pool alterations are more mutagenic than others is not understood. To address this question, 
a collection of PCR-mutagenized rnr1 alleles was screened for increased mutagenesis under the 
assumption that the mutator phenotypes of these alleles were caused by alterations in the dNTP 
concentrations. Next, the effects of the identified mutagenic rnr1 alleles on the dNTP pools were 
determined and their impact on DNA replication fidelity further characterized.  
Taken together, this study identified previously unrecognized genes that contribute to DNA 
replication fidelity which potentially act as mini-drivers during human cancer evolution. 
Furthermore, this study improved the understanding on how different dNTP pool alterations 
influence DNA replication fidelity in S. cerevisiae. 
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2 MATERIALS 
2.1 Equipment  
Table 2.1 List of equipment. 
Equipment Supplier 
Autoclave Systec DE-65 Systec 
Autoclave VAPOR-Line lite VWR 
BioShake XP, 96-Well Vortex Scientific Industries 
Bunsen burner Labogaz 470 Campingaz 
Cellgard class III biological safety cabin NuAire 
Centrifuge J2-21M/E Beckman 
Centrifuge 5424 Eppendorf 
Centrifuge Heraeus Fresco 21 Thermo Scientific 
Centrifuge 5810 R Eppendorf 
Criterion Blotter Bio-Rad 
Disruptor Genie Scientific Industries 
Dri-block pB3 Techne 
FACS CantoII  BD Biosciences 
Forceps Roth 
Freezer Liebherr 
Fusion Solo S System Vilber 
Gelelectrophoresis chamber Biozym 
Gelelectrophoresis Power Supply, ST606 Gibco BRL Life Technologies 
GelDoc system Bio-Rad 
Gene Pulser Bio-Rad 
Grinder Severin 
Ice machine Hoshizaki 
Imaging System Bio-Rad 
Incubator B6420 Hereaus 
Incubator Heratherm Thermo Scientific 
Incubator shaker, Ecotron Infors HT 
Incubator shaker, Multitron Pro Infors HT 
Light microscope Carl Zeiss 
Liquidator (96-Well Pipet) Mettler Toledo 
Low temperature freezer New Brunswick Scientific 
Magnetic stirrer with heating, MR Hei-Standard Heidolph 
Microscale, PG 503-S Mettler-Toledo 
Microwave AEG 
Microwave Sharp 
Mini Protean® 3 System Bio-Rad 
Mini Protean® Tetra Cell Bio-Rad 
Multichannel pipette, 20 and 200 μL Brand Tech Scientific 
Multipette Plus Eppendorf 
Optimax TR X-ray film processor Protec 
Peristaltic pump Dosierfix Welatec 
Pharmaceutical refrigerator Panasonic 
pH-Meter, inoLab pH 720 WTW 
Pipetboy IBS Integra Bioscience 
Pipetman pipettes 2 µl, 10 µl, 20 µl, 100 µl, 200 µl, 1000 µl  Gilson 
Plate sealer (96-well) 4titude 
PowerPac basic Bio-Rad 
Replica plating block DKFZ 
Reusable bottle top filter unit Thermo Scientific Nalgene 
Roller RM5 V-80 CAT 
RoToR robot Singer Instruments 
Scale, BP 3100 S neoLab 
Scale, DL-501 Denver Instruments 
Scalpel neoLab 
Shaker 3015 GFL 
Sonicator - Sonifier 250 Branson 
Sturdier vertical slab gel electrophoresis chamber Hofer 
Thermocycler C1000 Touch Bio-Rad 
Thermocycler GeneAmp PCR system 9700 Applied Biosystems 
Thermomixer comfort and compact Eppendorf 
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Transilluminator Nippon Genetics 
UV cabinet Grant Instruments 
UV/Vis Spectrometer, Pharmacia LKB Ultrospec III Pharmacia 
Vioflo II, 8 channel multipipette 12,5 µl Integra Bioscience 
Vortex Genie 2 Scientific Industries 
Washing machine Fagor 
 
2.2 Software 
Table 2.2 List of Software. 
Software Supplier 
Adobe™ Illustrator™ CS6 Adobe Systems 
BD FACSDiva™ Software Becton Dickinson Biosciences 
EndNote X7.7.1 Thomson Reuters, USA 
FlowJo, v10.1 Tree Star Inc. 
ImageJ, 1.47v National Institute of Health, USA 
Lasergene 12 DNASTAR 
Office 2011 Microsoft 
OligoCalc 
http://biotools.nubic.northwestern.edu/OligoCalc.html  
Northwestern University 
QuikChange® Primer Design Program 
https://www.genomics.agilent.com/primerDesignProgram.jsp  
Agilent 
R, v3.3.3 https://www.R-project.org/ 
Sigma plot Systat Software Inc. 
 
2.3 Consumables 
Table 2.3 List of Consumables. 
Consumables Supplier 
Cellulose nitrate filter, pore size 0.45 µm Sartorius Stedim Biotech 
Combitips advanced for Multipette Plus, 5 ml, 10 ml Eppendorf 
Cryotube vials, 1.8 mL Thermo Scientific 
Cuvettes Brandt 
Electroporation cuvettes, 2 mm Steinbrenner 
Filter pipette tips, 10 μL, 200 μL Neptune 
Filter pipette tips, 20 μL, 1000 μL Greiner Bio-One 
Falcon tubes, 14 ml Greiner Bio-One 
Falcon tubes, 50 ml Greiner Bio-One 
Gel Saver II Tip, 200µL Starlab 
Glass beads, 0.5 mm Scientific Industries 
Glass beads, acid wahsed Sigma 
Liquidator tips, 20 µl, 200 µl Mettler-Toledo 
Microscope cover glasses 18x18 mm Menzel-Gläser 
Microscope slides ca./env. 76x26 mm Menzel-Gläser 
4-15% Mini-PROTEAN TGX gels Bio-Rad 
Nitrile gloves Microflex 
PCR tubes 0.2 ml Thermo Scientific 
Petridishes, 60x15 mm Sarstedt 
Petridishes, 94x16 mm Greiner Bio-One 
Petridishes, 145x20 mm Greiner Bio-One 
Picks, flat Kögler 
Precision wipes Kimtech Science 
RoToR Plus Plates Singer 
PolyPrep® Chromatograhy column  Bio-Rad 
Tips, 10 µl, 200 µl, 1000 µl Starlab 
Reaction tubes, 0.5 mL Sarstedt 
Reaction tubes, SafeSeal 1,5 ml, 2 ml Sarstedt 
Super RX-N Fuji medical x-ray films  Fujifilm 
Tubes, round-bottom, 14 mL Greiner Bio-One 
96-Well Plate lids Greiner Bio-One 
96-well plate seal, aluminum 4titude 
96-well plate seal, breathable 4titude 
MATERIALS 
27 
 
96-Well Plates, U-bottom Greiner Bio-One 
Chromatography paper 3MM Chr Whatman 
 
2.4 Kits 
Table 2.4 List of Kits. 
Kit Order number Supplier 
Gentra Puregene Yeast/Bact. Kit B 158567 Qiagen 
Immobilon Western chemiluminescent HRP substrate WBKL S0500 Millipore 
QIAprep Spin Miniprep Kit 27106 Qiagen 
QIAquick Gel Extraction Kit 28706 Qiagen 
 
2.5 Chemicals and reagents 
Table 2.5 List of chemicals and reagents. 
Name Order number Supplier 
Acetic acid A0820 AppliChem 
Acrylamide-bisacrylamide solution, 40% (29:1) 10680 Serva Electrophoresis 
Adenine A8626 Sigma 
Adenosine 5-triphosphate (ATP) disodium salt hydrate A26209 Sigma 
α-factor RP01002 GenScript 
Ammonium persulfate (APS) 13375 Serva Electrophoresis 
Agar-agar, Kobe I 5210 Roth 
Agarose 3810 Roth 
Ampicilin 1046 Gerbu 
Arginine A5006 Sigma 
Aspartic acid A9256 Sigma 
β-mercaptoethanol M6250 Sigma 
Butane / propane  CV470 Campingaz 
cOmplete EDTA free protease inhibitor  1169749001 Roche Diagnostics  
BactoTM peptone 211820 Becton, Dickinson 
BactoTM yeast extract 212720 Becton Dickinson 
Bovine serum albumin (BSA) A7030 Sigma 
Bromophenol blue 15375 Serva Electrophoresis 
L-canavanine sulfate C9758 Sigma 
Coomassie brilliant blue G250 17524 Serva Electrophoresis 
Cycloheximide 10700 Serva Electrophoresis 
Difco™ agar 214530 Becton Dickinson 
Difco™ nutrient broth 231000 Becton Dickinson 
DifcoTM yeast nitrogen base without amino acids 291930 Becton Dickinson 
DifcoTM yeast nitrogen base without amino acids without 
ammonium sulfate 
233420 Becton Dickinson 
Dimethyl sulfoxide (DMSO) D8418 Sigma 
dNTP sets, 100 mM each M3015 Genaxxon  
Dithiothreitol (DTT) 6908 Roth 
Ethanol E/0650DF/15 Fisher Scientific 
Ethylenediaminetetraacetic acid (EDTA) 1034 Gerbu 
5-Fluoroorotic acid monohydrate (5-FOA) F5050 Biomol 
GelRed™ nucleic acid gel stain M3199 Genaxxon 
Geneticin (G418) sulfate sc-29065B Santa Cruz Biotechnology 
D(+)-glucose monohydrate 6887 Roth 
Glycerol 15523 Sigma 
Glycine G7126 Sigma 
Glutamic acid monosodium salt  49621 Sigma 
Histidine H8000 Sigma 
Hydrochloric acid, 37% 20252 VWR Chemicals 
Hydroxyurea, 98% H8627 Sigma 
Hygromycin B, 50 mg/mL 10687010 Thermo Scientific 
Imidazole I0125 Sigma 
Isoleucine I2752 Sigma 
Isopropanol 6752 Roth 
Kanamycin sulfate from Streptomyces kanamyceticus K4000 Sigma 
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Leucine L8000 Sigma 
Lithium acetate dihydrate L4158 Sigma 
Lysine L5501 Sigma 
Magnesium chloride M2670 Sigma 
Methanol M/4000/PC17 Fisher Scientific 
Methionine M9625 Sigma 
Ni-NTA agarose 30210 Qiagen 
Nocodazole T2802 Target Molecule 
Nourseothricin, clonNAT 5.0000 Werner BioAgents 
NP-40, IGEPAL® CA-630 56741 Sigma 
Phenol:Chloroform:Isoamylalcohol (25:24:1) A156 Roth 
Phenylalanine P2126 Sigma 
Phleomycin from Streptomyces verticillus P9564 Sigma 
Phenylmethylsulfonyl fluoride (PMSF) 6367 Roth 
Poly(ethylene glycol), 3350 88276 Sigma 
Potassium acetate P1190 Sigma 
Potassium dihydrogen phosphate 4873 Merck 
Salmon sperm AM9680 Invitrogen 
Skim milk powder 70166 Sigma 
Sodium acetate 106268 Merck 
Sodium azide S8032 Sigma 
Sodium chloride 31434 Sigma 
Sodium citrate 71405 Fluka 
Sodium dodecyl sulfate (SDS) 1610302 / 20765 Bio-Rad / Serva 
Electrophoresis 
Sodium hypochlorite solution, 12% Cl 9062 Roth 
Sodium hydroxide 2020 Gerbu 
Sodium dihydrogen phosphate T878 Roth 
di-Sodium hydrogen phosphate·2H2O 4984 Roth 
Sytox Green S7020 Life Technologies 
TEMED T7024 Sigma 
Threonine T8625 Sigma 
Trichloroacetic acid (TCA) A1431 AppliChem 
Triton X-100 T8787 Sigma 
Trizma® base T1503 Sigma 
Tryptone 70172 Sigma 
Tryptophan T8941 Sigma 
Tween-20 P1379 Sigma 
Tyrosine T3754 Sigma 
Uracil U0750 Sigma 
Valine V0500 Sigma 
 
2.6 Markers for electrophoresis 
Table 2.6 Markers for electrophoresis. 
Marker Order number Supplier 
GeneRuler 1Kb, ready-to-use SM0313 Thermo Scientific 
Precision Plus Protein™ Dual Color Standards #1610394 Bio-Rad 
 
2.7 Oligonucleotides 
All oligonucleotides were purchased by Sigma, dissolved in HPLC-H2O at a concentration of 100 
μM. 
Table 2.7 List of oligonucleotides. 
HHP# Name Sequence 5’-3’ 
507 Can1Fx GTTGGATCCAGTTTTTAATCTGTCGTC 
508 Can1Rx TTCGGTGTATGACTTATGAGGGTG 
1018 Nat_fw1 CTAATCTCGAGGCGAATTTC 
1036 Kan_K2 GTCAAGACTGTCAAGGAGGG 
1037 kl-TRP1_rev GACGTTGTTCGATTCTGGTG 
1038 kl-TRP1_fw CAACGGTTTGCAAACCACAC 
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1062 CYH2_3v  GGCTTCCAGATGTTAACTGC 
1063 CYH2_fw GAACAGTCATACTGTCTACTC 
1100 rnr1_3v GCGCATCCTGGGAATCTA 
1276 POL1_L868M_fw GTTTTAGTCATGGACTTTAATTCTATGTATCCATCTATTATCCAGGAATTT 
1277 POL1_L868M_rev AAATTCCTGGATAATAGATGGATACATAGAATTAAAGTCCATGACTAAAAC 
1378 Kan_K3 CGCCTCGACATCATCTGCCC 
1380 hph_JE345fw GGCTGTGTAGAAGTACTCGCCG 
1381 his3_5'test CATTTGTAATACGCTTTACTAGGGC 
1382 his3_3'test CGCATTTTCTTGAAAGCTTTGCAGAG 
1872 pRS425_GAL_PMS1-
FLAG_rev 
GCAAGTGTAGCGGTCACGC 
1949 pMFA1_kl-LEU2_fw AACTGTTTCTCGGATAAAACCAAAATAAGTACAAAGCCATCGAATAGAAATGTCT
AAGAATATCGTTGTC 
1950 pMFA1_kl-LEU2_rev AGCGGAAAAGGAAGATAAAGGAGGGAGAACAACGTTTTTGTACGCAGAAATTAA
GCCAAGATTTCCTTGA 
1955 hom3-10.HIS3_fw ATCCACCTTTCTTCTTCACTTTAATGATAGAATATTAATTTTCCCTTTATGAGCAG
ATTGTACTGAGAGTGCACC 
1956 hom3-10.HIS3_rev ATTAATATATATGTAAATATATGTGCGCGTATATATATATATATATATATCTCCTTA
CGCATCTGTGCGGTATTTC 
2001 pMFA1-
klLEU2.hphLYS2_rev 
GGCGCGCCTTAATTAACCCGGGGATCCGTCGACCTGCAGCGTACGGATCCGCA
GGCTAACCGGAA 
2002 LYS2.hph_S1_300pb 
before ATG 
GTCTATATTCATTGAAACTGATTATTCGATTTTCTTCTTGCTGACCGTACGCTGC
AGGTCGAC 
2003 LYS2.hph_S2_before 
ATG 
TTGAAGAGTTTTCCTCGCTAAAACTGTGCGATGCCTCTAGAAGCGATCGATGAA
TTCGAGCTCG 
2004 pMFA1-
klLEU2.300pb_hphLYS2
_fw 
GTCTATATTCATTGAAACTGATTATTCGATTTTCTTCTTGCTGACCAGGATAGTGT
GCAACGTGG 
2197 URA3_5v GGGAAGACAAGCAACGAAAC 
2198 URA3_3v GGAAACGCTGCCCTACAC 
2201 kl-URA3_fw TGATTTTGTGGACATGGTGC 
2202 kl-URA3_rev GTTGGCAGAGGACTTTTCG 
2220 kl-URA3_downMlh2_fw CTCTAATATTGCATTGTTACGACATCCTGTTGTCATGCGACTAAACAATACAACA
GATCACGTG 
2657 met7_S1 ATTGTCTTATTTCTGAAGCTCACTGAAGAACATTGCTTTATTATGCGTACGCTGC
AGGTCGAC 
2797 scPOL3_NotI_fw  CTGACTGCGGCCGCTCTTCGTTCAACTTGTTTTCCTTG 
2798 scPOL3_SmaI_rev  GGTGACCCCGGGGTTTACAAATTACTGACAATAAA 
2801 met7DM_S4 CAAAGAGTTTAGCGCAGTAACAGCGTCTCGATAAGTTTTTCCAACCATCGATGA
ATTCTCTGTCG 
2876 URA3_fw CGAAAGCTACATATAAGGAAC 
2877 URA3_rev TTAGTTTTGCTGGCCGCATC 
2947 URA3_seq GGAGCACAGACTTAGATTGG 
2973 CAN1_rev GAGCCAATGTAGAAGGTTAAG 
2974 CAN1_fw2 CCTCTTTGATTAACGCTGCC 
2976 RNR1_fw_promoter CAGCTCAGTCACATGAGAC 
3285 pRS315_rev CGATTCATTAATGCAGCTGGC 
3489 rnr1-R256Q_fw GTATTGGTCTACATATCCATAACATTCAATCAACTGGTTCTTACATTGCTGG 
3490 rnr1-R256Q_rev CCAGCAATGTAAGAACCAGTTGATTGAATGTTATGGATATGTAGACCAATAC 
3574 RNR1_D57N_fw GGTGTCACAACAATCGAACTAAACAACTTAGCCGCTG 
3575 RNR1_D57N_rev CAGCGGCTAAGTTGTTTAGTTCGATTGTTGTGACACC 
3678 CAN1_downstream_S1 ACCAAAGACTTTTTGGGACAAATTTTGGAATGTTGTAGCATAGATATGACCGTAC
GCTGCAGGTCGAC 
3679 CAN1.downstream_S2 ATGAGGGTGAGAATGCGAAATGGCGTGGAAATGTGATCAAAGGTAATAAAACAT
CGATGAATTCGAGCTCG 
3700 pRS_RNR1linked_fw GTCGAATAATTTAACATGAACATTTTAAGCTGTCCTTGTAAGAAGGCGAGCAGAT
TGTACTGAGAGTGCACC 
3701 pRS_RNR1linked_rev CAATGTTGCCTAGACCCCATTTCGGGGCAGGGGGGAATCTGTATCATGCTCCTT
ACGCATCTGTGCGGTATTTC 
3861 RNR1-I262V_fw CATTCGTTCAACTGGTTCTTACGTTGCTGGTACAAACGGTACTTC 
3862 RNR1-I262V_rev GAAGTACCGTTTGTACCAGCAACGTAAGAACCAGTTGAACGAATG 
3863 RNR1-N291D_fw CCGTTATGTTGACCAGGGTGGTGATAAAAGACCTGGTGCGTTTGC 
3864 RNR1-N291D_rev GCAAACGCACCAGGTCTTTTATCACCACCCTGGTCAACATAACGG 
4105 URA3_A4 TCATTACGACCGAGATTCC 
4196 DUT1_promoter_BamHI_
fw 
CATGATGGATCCCATGCCCCATCTCCACGCTC 
4197 DUT1_3v CAGACCCTATTAGGAGCCC 
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4198 DUT1_G82S_fw GAAAAACGGTATCCAAACCGGTGCTAGTGTTGTCGACAGAGATTACACCGG 
4199 DUT1_G82S_rev CCGGTGTAATCTCTGTCGACAACACTAGCACCGGTTTGGATACCGTTTTTC 
 
2.8 Plasmids 
All plasmids were stored in E. coli TOP10F’ or E. coli BL21 (DE3) as glycerol stock at -80 °C. 
Minipreps were purified with QIAprep Spin Miniprep Kit and stored at -20 °C.  
 
Table 2.8 Plasmids used in the study. 
Name Relevant genotype rnr1 base  
substitution (s) 
Reference 
pFA6a-
hphNT1 
ampr hphNT1 none (JANKE et al. 2004) 
pFA6a-
kanMX4 
ampr kanMX4 none (WACH et al. 1994) 
pFA6a-
natNT2 
ampr natNT2 none (JANKE et al. 2004) 
pOM13  ampr loxP.klLEU2.loxP.6HA none (GAUSS et al. 2005) 
pRS303 ampr HIS3 none (SIKORSKI AND HIETER 
1989) 
pUG72 ampr loxP.klURA3.loxP none (GUELDENER et al. 
2002) 
pUG73 ampr loxP.klLEU2.loxP none (GUELDENER et al. 
2002) 
pYM22 ampr 3HA.klTRP1 none (JANKE et al. 2004) 
pYM23 ampr 3Myc.klTRP1 none (JANKE et al. 2004) 
pYM-N14 ampr kanMX4.pGPD none (JANKE et al. 2004) 
pYM-N15 ampr natNT2.pGPD none (JANKE et al. 2004) 
pHHB296 pSIC1_SIC1(NTR)_3MYC_(GA)5 (ampR, natNT2, pSIC1-
sic1NTR(aa1-100)-3Myc-(GA)5) 
none This study 
    
pRS316 ampr CEN6 ARSH4 URA3 none (SIKORSKI AND HIETER 
1989) 
pHHB388 pRS316-POL3 (ampr, CEN6, ARSH4, URA3) none (SCHMIDT et al. 2017) 
pHHB560 pRS316-RNR1 (ampr, CEN6, ARSH4, URA3) none This study 
    
pRS315 ampr CEN6 ARSH4 LEU2 none (SIKORSKI AND HIETER 
1989) 
pHHB351 pRS315-POL3 (ampr, CEN6, ARSH4, LEU2) none (SCHMIDT et al. 2017) 
pHHB396 pRS315-pol3-01 (ampr, CEN6, ARSH4, LEU2) none (SCHMIDT et al. 2017) 
pHHB561 pRS315-RNR1 (ampr, CEN6, ARSH4, LEU2) none This study 
pHHB649 pRS315-rnr1-G8D,V278A (ampr, CEN6, ARSH4, LEU2) c.23G > A, c.833T > C This study 
pHHB632 pRS315-rnr1-F15S (ampr, CEN6, ARSH4, LEU2) c.44T > C This study 
pHHB635 pRS315-rnr1-D226G (ampr, CEN6, ARSH4, LEU2) c.677A > G This study 
pHHB648 pRS315-rnr1-D226V (ampr, CEN6, ARSH4, LEU2) c.677A > T This study 
pHHB655 pRS315-rnr1-S117P,D226N (ampr, CEN6, ARSH4, LEU2) c.349T > C, c.676G > A This study 
pHHB650 pRS315-rnr1-I231T,T244A (ampr, CEN6, ARSH4, LEU2) c.692T > C, c.730A > G This study 
pHHB634 pRS315-rnr1-S242T (ampr, CEN6, ARSH4, LEU2) c.724T > A This study 
pHHB628 pRS315-rnr1-K243E (ampr, CEN6, ARSH4, LEU2) c.727A > G This study 
pHHB647 pRS315-rnr1-T244I,V278A (ampr, CEN6, ARSH4, LEU2) c.731C > T, c.833T > C This study 
pHHB651 pRS315-rnr1-A245V,Q671R (ampr, CEN6, ARSH4, LEU2) c.734C > T, c.2012A > G This study 
pHHB721 pRS315-rnr1-A245V (ampr, CEN6, ARSH4, LEU2) c.734C > T This study 
pHHB630 pRS315-rnr1-R256H,Y779C (ampr, CEN6, ARSH4, LEU2) c.767G > A, c.2336A > G This study 
pHHB667 pRS315-rnr1-R256H (ampr, CEN6, ARSH4, LEU2) c.767G > A This study 
pHHB668 pRS315-rnr1-R256Q (ampr, CEN6, ARSH4, LEU2) c.767G > A, c.768T > A This study 
pHHB642 pRS315-rnr1-I262T,M275I (ampr, CEN6, ARSH4, LEU2) c.785T > C, c.825G > A This study 
pHHB678 pRS315-rnr1-I262V,N291D (ampr, CEN6, ARSH4, LEU2) c.784A > G, c.871A > T This study 
pHHB677 pRS315-rnr1-I262V,Q561L (ampr, CEN6, ARSH4, LEU2) c.784A > G, c.1682A > T This study 
pHHB875 pRS315-rnr1-I262V (ampr, CEN6, ARSH4, LEU2) c.784A > G This study 
pHHB637 pRS315-rnr1-T265A (ampr, CEN6, ARSH4, LEU2) c.793A > G This study 
pHHB638 pRS315-rnr1-G267C (ampr, CEN6, ARSH4, LEU2) c.799G > T This study 
pHHB641 pRS315-rnr1-S269P (ampr, CEN6, ARSH4, LEU2) c.805T > C This study 
pHHB652 pRS315-rnr1-G271S (ampr, CEN6, ARSH4, LEU2) c.811G > A This study 
pHHB653 pRS315-rnr1-P274L,N466S (ampr, CEN6, ARSH4, LEU2) c.821C > T, c.1397A > G This study 
pHHB1000 pRS315-rnr1-P274L (ampr, CEN6, ARSH4, LEU2) c.821C > T This study 
pHHB636 pRS315-rnr1-M275T (ampr, CEN6, ARSH4, LEU2) c.824T > C This study 
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pHHB633 pRS315-rnr1-T282A (ampr, CEN6, ARSH4, LEU2) c.844A > G This study 
pHHB676 pRS315-rnr1-R21C,T282S (ampr, CEN6, ARSH4, LEU2) c.61C > T, c.844A > T This study 
pHHB999 pRS315-rnr1-T282S (ampr, CEN6, ARSH4, LEU2) c.844A > T This study 
pHHB654 pRS315-rnr1-A283V,S425L (ampr, CEN6, ARSH4, LEU2) c.848C > T, c.1274C > T This study 
pHHB679 pRS315-rnr1-Y285C (ampr, CEN6, ARSH4, LEU2) c.854A > G This study 
pHHB876 pRS315-rnr1-N291D (ampr, CEN6, ARSH4, LEU2) c.871A > T This study 
    
pRS306 ampr URA3 none (SIKORSKI AND HIETER 
1989) 
pHHB97 pRS306-pol1-L868M (ampr, URA3) none (SCHMIDT et al. 2017) 
pHHB1093 pRS306-DUT1 (ampr, URA3) none This study 
pHHB1094 pRS306-dut1-1 (ampr, URA3, dut1-G82S) none This study 
pHHB424 pRS306-RNR1 (ampr, URA3) none This study 
pHHB718 pRS306-rnr1-F15S (ampr, URA3) c.44T > C This study 
pHHB752 pRS306-rnr1-D57N (ampr, URA3) c.169G > A This study 
pHHB869 pRS306-rnr1-S242T (ampr, URA3) c.724T > A This study 
pHHB682 pRS306-rnr1-K243E (ampr, URA3) c.727A > G This study 
pHHB736 pRS306-rnr1-A245V (ampr, URA3) c.734C > T This study 
pHHB868 pRS306-rnr1-R256H, Y779C (ampr, URA3) c.767G > A, c.2336A > G This study 
pHHB933 pRS306-rnr1-I262V, N291D (ampr, URA3) c.784A > G, c.871A > T This study 
pHHB695 pRS306-rnr1-Y285C (ampr, URA3) c.854A > G This study 
    
pHHB118 pET28c-Sic1 (kanR, 6HIS-SIC1) none Gift of G. Pereira 
 
2.9 Enzymes 
Table 2.9 List of enzymes. 
Enzyme Order number Supplier 
AccuPrime™ Pfx DNA polymerase, 2.5 U/μL 12344 Invitrogen 
Ape I, 10 U/μL M0282 NEB 
BamHI-HF, 20 U/μL R3136 NEB 
BglII, 10 U/μL R0144 NEB 
Bsu36I, 10 U/μL R0524 NEB 
Exonuclease I, 20 U/μL M0293 NEB 
HindIII, 20 U/μL R0104 NEB  
KpnI-HF, 20 U/μL R3142 NEB  
Lysozyme 100834 MP Biomedicals 
NcoI, 20 U/μL R0193 NEB 
NotI-HF, 20 U/μL R3189 NEB 
Phusion® High-Fidelity DNA polymerase 2 U/μL M0530 NEB 
Proteinase K M3036 Genaxxon 
Ribonuclease A 7156 Roth 
Shrimp Alkaline Phosphatase (rSAP), 1 U/μL M0371 NEB 
SacII, 20 U/μL R0157 NEB 
SmaI, 20 U/μL R0141 NEB 
Taq DNA polymerase, 5 U / μL M0273 NEB 
Uracil-DNA Glycosylase (UDG) M0280 NEB 
Velocity DNA polymerase 2 U/μL BIO-21098 Bioline 
XcoI, 20 U/μL R0146 NEB 
Zymolase 100T, 10 mg/mL Z1005 US biological 
 
 
2.10 Antibodies 
2.10.1 Primary antibodies 
Primary antibodies are diluted in either 3% BSA or skim dry milk in PBS-T containing 0.02% 
sodium azide and 0.001% Thimerosal. 
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Table 2.10 List of primary antibodies for Western blotting. 
Antigen Species Clone Dilution Order number Source 
Clb2 rabbit polyclonal 1:1000 sc-9071 Santa Cruz 
Biotechnology 
c-Myc mouse 9E10 1:1000 05-419 Millipore 
Pgk1 mouse 22C5D8 1:20000 459250 Invitrogen 
Rad53 mouse EL7.E1 1:1000 ab166859 Abcam 
Rnr1 rabbit polyclonal 1:60000 AS09576 Agrisera 
Rnr2 rabbit polyclonal 1:30000 AS09575 Agrisera 
Rnr3 rabbit polyclonal 1:1000 AS09574 Agrisera 
Sic1 guinea pig polyclonal  1:10000 - this study 
Tubulin/Rnr4 rat YL1/2 1:40000 92092402 Sigma 
 
2.10.2 Secondary antibodies 
All secondary antibodies are linked to horseradish peroxidase (HRP) and used in a concentration 
of 1:10000 diluted in 0.5% skim dry milk in PBS-T.  
Table 2.11 List of secondary antibodies for Western blotting. 
Antigen Species Conjugate Dilution Order number Source 
guinea pig IgG rabbit HRP 1:10000 A60-211P Bethyl Laboratories 
mouse IgG sheep HRP 1:10000 NA9310 GE Healthcare 
rabbit IgG donkey HRP 1:10000 NA934 GE Healthcare 
anti-rat IgG goat HRP 1:10000 401416 Calbiochem 
 
2.11 Buffers and solutions 
If not other mentioned buffers and solutions are done in H2O. 
 
Table 2.12 List of buffers and solutions. 
Buffer and solutions Composition 
APS 10% APS 
Ampicillin, 1000x 100 mg/mL ampicillin 
Buffer A 2% Triton X-100 
1% SDS 
100 mM NaCl 
10 mM Tris-Hcl pH 8.0 
1 mM EDTA pH 8.0 
Coomassie destaining solution II 10% acetic acid 
20% ethanol 
Coomassie fixing and destaining I solution 10% acetic acid  
40% ethanol 
Coomassie staining solution stock I 0.2% brilliant blue G in 90% ethanol  
Coomassie staining solution stock II 20% acetic acid 
EDTA, 0.5 M, pH 8.0 0.5 M EDTA in H2O, pH 8.0 
Elution buffer, pH 8.0 50 mM NaH2PO4 x H2O  
600 mM NaCl   
250 mM imidazole 
10 mM β-mercaptoethanol 
G418, 1000x 200 mg/mL geneticin 
GSD buffer 3x 335 mM DTT 
6.7% SDS  
33% glycerol 
tip of bromophenol blue  
few drops 1M Tris pH 6.  
GSD/TRIS buffer, 1x 2 volume GSD buffer, 3x 
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1 volume Tris unbuffered 
3 volumes H2O 
Kanamycin, 1000x 50 mg/mL kanamycin sulfate 
LiAc, 10x 1 M LiAc, pH 7.5 
Lysis buffer, pH 8.0 50 mM NaH2PO4 x H2O  
300 mM NaCl   
20 mM imidazole 
10 mM β-mercaptoethanol     
0.1% Tween-20  
1mM PMSF 
1 tablet cOmplete, EDTA free  
1 mg/mL Lysozyme 
Magnesium chloride, 1M 1 M magnesium chloride 
Nourseothricin, 1000x 100 mg/mL nouseothricin 
PBS, 10x 1.37 M NaCl 
27 mM KCl 
82 mM Na2HPO4 x 2 H2O 
15 mM KH2PO4 
PBS-T, 1x 1:10 dilution of 10x PBS in H2O 
0.05% Tween-20 
PEG3350, 50% 50% (w/v) PEG3350 
PMSF stock, 100x 0.2 M PMSF in isopropanol 
Running buffer, 10x 250 mM Tris 
1.9 M glycine 
10% SDS 
Salmon sperm 2 mg/mL salmon sperm 
10 mM Tris/HCl, pH 8.0 
1 mM EDTA 
Sodium citrate, 50 mM 50 mM sodium citrate 
SDS, 20% 20% SDS 
Separating gel buffer, 4x 1.5 M Tris/HCl pH 8.8 
TE, pH 7.5, 10x 1 M Tris/HCl 
10 mM EDTA 
Sodium azide, 1000x 20% sodium azide 
Stacking buffer, 4x 0.5 M Tris/HCl, pH 6.8 
TCA, 50% 50% (w/v) TCA 
Thimerosal, 1000x 1% thimerosal 
Washing buffer, pH 8.0 50 mM NaH2PO4 x H2O  
300 mM NaCl   
20 mM imidazole 
1mM PMSF 
Western blot blocking solution 3% skim dry milk in 1x PBS-T 
Western blot transfer buffer 25 mM Tris 
190 mM glycine 
20% (v/v) methanol 
YEX buffer 1.95 NaOH 
7.5% β-mercaptoethanol 
 
 
2.12 Media 
SD amino acid mix was prepared as described in (AMBERG et al. 2005). For the SGA screen, SD 
amino acid mix was prepared as described in (TONG AND BOONE 2006).  
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Table 2.13 List of media. 
Medium Composition 
CAN plates 0.67% Difco yeast nitrogen base without amino acids  
0.8 g/L arginine- amino acid dropout mix 
60 mg/L canavanine 
2% glucose 
2% agar-agar 
CAN plates + nourseothricin 0.17% yeast nitrogen base without amino acids and without ammonium 
sulfate 
1 g/L glutamic acid mono sodium salt hydrate 
0.8 g/L arginine- amino acid dropout mix 
60 mg/L canavanine 
100 μg/mL nourseothricin 
2% glucose 
2% agar-agar 
5-FOA plates 0.67% Difco yeast nitrogen base without amino acids  
0.8 g/L uracil- amino acid dropout mix 
50 mg/L uracil 
1 g/L 5-FOA 
2% glucose 
2% agar-agar 
GCR plates 0.67% Difco yeast nitrogen base without amino acids  
0.8 g/L arginine- uracil- amino acid dropout mix 
60 mg/L canavanine 
50 mg/L uracil 
1 g/L 5-FOA 
2% glucose 
2% agar-agar 
Minimal plates 0.67% Difco yeast nitrogen base without amino acids  
2% glucose 
2% agar-agar 
SGA diploid selection medium YPD plates 
+ 200 mg/L G418 
+ 100 mg/L nourseothricin 
SGA double mutant selection plates SGA haploid selection plates 
+ 1 g/L 5-FOA 
+ 100 mg/L nourseothricin 
+ 10 mg/L cycloheximide 
SGA haploid selection plates 0.17% Difco yeast nitrogen base without amino acids and ammonium 
sulfate 
1 g/L glutamic acid monosodium salt 
2 g/L leucine- dropout mix (TONG AND BOONE 2006) 
2% glucose 
200 mg/L G418 
2% Difco agar-agar 
SGA presporulation plates 3% Difco nutrient broth 
1% Bacto yeast extract 
5% glucose 
2% Difco agar-agar 
SGA de-condensation plates SGA haploid selection plates 
+ 100 mg/L nourseothricin 
SGA sporulation plates 1% potassium acetate 
0.1% Bacto yeast extract 
0.5 g/L glucose 
0.05 g amino acid supplement powder for sporulation (mix of 2 g histidine, 
10 g leucine, 2 g lysine and 2 g uracil) 
50 mg/L G418 
2% Difco agar-agar 
Sporulation medium, pH 7.0 1% potassium acetate 
0.19 g/L amino acid mix CSM  
Synthetic dropout (SD) medium 0.67% yeast nitrogen base without amino acids  
0.8 g/L amino acid dropout mix 
MATERIALS 
35 
 
2% glucose  
SD medium plates SD medium with 2% agar-agar 
SD medium for drugs 0.17% yeast nitrogen base without amino acids and without ammonium 
sulfate 
1 g/L glutamic acid mono sodium salt hydrate 
0.8 g/L amino acid dropout mix 
2% glucose 
SD medium plates for drugs SD medium for drugs with 2% agar-agar 
YPD 1% Bacto yeast extract  
2% Bacto peptone  
2% glucose 
YPD plates YPD with 2% agar-agar 
YPG plates 1% Bacto yeast extract 
2% Bacto peptone  
3% glycerol 
2% agar-agar 
 
2.13 E. coli strains 
Table 2.14 E. coli strains used in this work. 
Strain Genotype Order number Source 
BL21 (DE3) E. coli B F- dcm ompT hsdS(rb
-mb
-) galλ(DE3) 200131 Agilent  
TOP10F’ F´{lac Iq  Tn10  (TetR )} mcr A Δ (mrr-hsd RMS-mcr 
BC) Φ 80lac ZΔ M15 Δlac X74 rec A1 ara D139 Δ (ara-
leu )7697 gal U gal K rps L end A1 nup G 
C303003 Invitrogen 
 
2.14 S. cerevisiae strains 
For the SGA, the non-essential gene deletion collection TKY3503 (Transomic technologies) was 
used. Yeast strains from this collection correspond to the BY4742 background with the following 
genotype:  Matα his3Δ1 leu2Δ0 ura3Δ lys2Δ yfg::kanMX4. 
 
Table 2.15 S. cerevisiae strains used in this work. 
Name Relevant genotype Reference 
RDKY3686 Matα ura3-52 leu2∆1 trp1∆63 hom3-10 his3∆200 lys2-10A (AMIN et al. 2001) 
RDKY5964 Mata ura3-52 leu2∆1 trp1∆63 hom3-10 his3∆200 lys2-10A (HOMBAUER et al. 2011a) 
   
HHY6484 RDKY5964 MFA::klLEU2 (SCHMIDT et al. 2017) 
HHY6485 RDKY5964 hph.300lys2-10A CAN1::URA3 (SCHMIDT et al. 2017) 
HHY6486 RDKY5964 pMFA1-klLEU2.hph.300lys2-10A, can1::URA3 (SCHMIDT et al. 2017) 
HHY6487 RDKY5964 cyh2-Q38K (SCHMIDT et al. 2017) 
HHY6488 HHY6487 hom3-10.HIS3 (SCHMIDT et al. 2017) 
HHY6489 RDKY3686 pMFA1-klLEU2.hphNT1.lys2-10A, hom3-10.HIS3, cyh2-Q38K (SCHMIDT et al. 2017) 
HHY6490 HHY6489 MLH2.klURA3 (SCHMIDT et al. 2017) 
HHY5298 RDKY5964 cyh2 Q38K hom3-10.HIS3 pMFA1-klLEU2.hphNT1.lys2-10A 
MLH2.klURA3 POL1.natNT2 
(SCHMIDT et al. 2017) 
HHY5292 RDKY5964 cyh2 Q38K hom3-10.HIS3 pMFA1-klLEU2.hphNT1.lys2-10A 
MLH2.klURA3 pol1-L868M.natNT2 
(SCHMIDT et al. 2017) 
HHY5284 RDKY5964 cyh2 Q38K hom3-10.HIS3 pMFA1-klLEU2.hphNT1.lys2-10A 
MLH2.klURA3 pol2-M644G.natNT2 
(SCHMIDT et al. 2017) 
HHY5289 RDKY5964 cyh2 Q38K hom3-10.HIS3 pMFA1-klLEU2.hphNT1.lys2-10A 
MLH2.klURA3 pol3-L612M.natNT2 
(SCHMIDT et al. 2017) 
   
HHY6370 RDKY5964 met7::kanMX4 This study 
HHY6441 RDKY5964 kanMX4.pGPD-DUT1 met7::klTRP1 This study 
HHY6636 RDKY5964 rev3::natNT2 met7::klTRP1 This study 
HHY6650 RDKY3686 dut1-G82S This study 
HHY6707 RDKY5964 dut1-G82S This study 
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HHY1910 RDKY5964 rfa1::TRP1 pKU1-t48 (LEU2) (CHEN AND KOLODNER 
1999) 
   
HHY1794 RDKY5964 exo1::hphNT1 (SCHMIDT et al. 2017) 
HHY6372 RDKY5964 gln3::HIS3 (SCHMIDT et al. 2017) 
HHY6378 RDKY5964 rrm3::kanMX4 (SCHMIDT et al. 2017) 
HHY6374 RDKY5964 shm2::kanMX4 (SCHMIDT et al. 2017) 
HHY6376 RDKY5964 ura7::kanMX4 (SCHMIDT et al. 2017) 
   
HHY6425 RDKY5964 dun1::hphNT1 (SCHMIDT et al. 2017) 
HHY6517 HHY6425 gln3::HIS3 (SCHMIDT et al. 2017) 
HHY6519 HHY6425 ura7::kanMX4 (SCHMIDT et al. 2017) 
   
HHY5746 HHY1794 gln3::HIS3 (SCHMIDT et al. 2017) 
HHY5752 HHY1794 rrm3::kanMX4 (SCHMIDT et al. 2017) 
HHY6415 HHY1794 shm2::kanMX4 (SCHMIDT et al. 2017) 
HHY5743 HHY1794 ura7::kanMX4 (SCHMIDT et al. 2017) 
   
HHY6505 RDKY5964 msh2::HIS3 (SCHMIDT et al. 2017) 
HHY6507 RDKY5964 msh2::natNT2 gln3::HIS3 (SCHMIDT et al. 2017) 
HHY5596 RDKY5964 msh2::natNT2 rrm3::kanMX4 (SCHMIDT et al. 2017) 
HHY6509 RDKY5964 msh2::natNT2 shm2::kanMX4 (SCHMIDT et al. 2017) 
HHY5749 RDKY5964 msh2::natNT2 ura7::kanMX4 (SCHMIDT et al. 2017) 
   
HHY5195 RDKY5964 msh3::HIS3 (SCHMIDT et al. 2017) 
HHY6511 HHY5195 gln3::HIS3 (SCHMIDT et al. 2017) 
HHY2248 HHY5195 rrm3::kanMX4 (SCHMIDT et al. 2017) 
HHY6513 HHY5195 shm2::kanMX4 (SCHMIDT et al. 2017) 
HHY6515 HHY5195 ura7::kanMX4 (SCHMIDT et al. 2017) 
   
HHY780 RDKY5964 msh6::hphNT1 (SCHMIDT et al. 2017) 
HHY6419 HHY780 gln3::HIS3 (SCHMIDT et al. 2017) 
HHY2246 HHY780 rrm3::kanMX4 (SCHMIDT et al. 2017) 
HHY6421 HHY780 shm2::kanMX4 (SCHMIDT et al. 2017) 
HHY6423 HHY780 ura7::kanMX4 (SCHMIDT et al. 2017) 
   
HHY6252 RDKY5964 pol1-L868M.natNT2 (SCHMIDT et al. 2017) 
HHY6428 HHY6252 dun1::hphNT1 (SCHMIDT et al. 2017) 
HHY6379 HHY6252 exo1::hphNT1  (SCHMIDT et al. 2017) 
HHY6381 HHY6252 gln3::HIS3 (SCHMIDT et al. 2017) 
HHY6431 HHY6252 gln3::HIS3 dun1::hphNT1 (SCHMIDT et al. 2017) 
HHY6399 HHY6252 rrm3::kanMX4 (SCHMIDT et al. 2017) 
HHY6387 HHY6252 shm2::kanMX4 (SCHMIDT et al. 2017) 
HHY6393 HHY6252 ura7::kanMX4 (SCHMIDT et al. 2017) 
   
HHY6405 RDKY5964 pol2-04.natNT2 (SCHMIDT et al. 2017) 
HHY6429 HHY6405 dun1::hphNT1 (SCHMIDT et al. 2017) 
HHY6407 HHY6405 gln3::HIS3 (SCHMIDT et al. 2017) 
HHY6433 HHY6405 gln3::HIS3 dun1::hphNT1 (SCHMIDT et al. 2017) 
HHY6413 HHY6405 rrm3::kanMX4 (SCHMIDT et al. 2017) 
HHY6409 HHY6405 shm2::kanMX4 (SCHMIDT et al. 2017) 
HHY6411 HHY6405 ura7::kanMX4 (SCHMIDT et al. 2017) 
   
HHY1993 RDKY5964 pol2-M644G.natNT2 (SCHMIDT et al. 2017) 
HHY1947 HHY1993 exo1::hphNT1 (SCHMIDT et al. 2017) 
HHY6383 HHY1993 gln3::HIS3 (SCHMIDT et al. 2017) 
HHY6401 HHY1993 rrm3::kanMX4 (SCHMIDT et al. 2017) 
HHY6389 HHY1993 shm2::kanMX4 (SCHMIDT et al. 2017) 
HHY6395 HHY1993 ura7::kanMX4 (SCHMIDT et al. 2017) 
   
HHY1996 RDKY5964 pol3-L612M.natNT2 (SCHMIDT et al. 2017) 
HHY1943 HHY1996 exo1::hphNT1 (SCHMIDT et al. 2017) 
HHY6385 HHY1996 gln3::HIS3 (SCHMIDT et al. 2017) 
HHY6435 HHY1996 gln3::HIS3 dun1::hphNT1 (SCHMIDT et al. 2017) 
HHY6497 HHY1996 gln3::HIS3 rad30::hphNT1 (SCHMIDT et al. 2017) 
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HHY6501 HHY1996 gln3::HIS3 rev1::klTRP1 (SCHMIDT et al. 2017) 
HHY6163 HHY1996 gln3::HIS3 rev3::kanMX4 (SCHMIDT et al. 2017) 
HHY6403 HHY1996 rrm3::kanMX4 (SCHMIDT et al. 2017) 
HHY6391 HHY1996 shm2::kanMX4 (SCHMIDT et al. 2017) 
HHY6397 HHY1996 ura7::kanMX4 (SCHMIDT et al. 2017) 
HHY6437 HHY1996 ura7::kanMX4 dun1::hphNT1 (SCHMIDT et al. 2017) 
HHY6495 HHY1996 ura7::kanMX4 rad30::hphNT1 (SCHMIDT et al. 2017) 
HHY6503 HHY1996ura7::kanMX4 rev1::klTRP1 (SCHMIDT et al. 2017) 
HHY6499 HHY1996 ura7::kanMX4 rev3::hphNT1 (SCHMIDT et al. 2017) 
   
HHY6481 RDKY3686 pol3::hphNT1 + pHHB388 (pRS316-POL3) (SCHMIDT et al. 2017) 
HHY6482 HHY6481 ura7::kanMX4 (SCHMIDT et al. 2017) 
HHY6483 HHY6481 msh2::HIS3 (SCHMIDT et al. 2017) 
HHY6526 HHY6481 can1::klTRP1 (SCHMIDT et al. 2017) 
HHY6525 RDKY5964 pol3::hphNT1 + pHHB388 (pRS316-POL3) (SCHMIDT et al. 2017) 
HHY6528 HHY6525 CAN1.natNT2 (SCHMIDT et al. 2017) 
HHY6529 HHY6482 can1::klTRP1 (SCHMIDT et al. 2017) 
HHY6530 HHY6525 ura7::kanMX4 (SCHMIDT et al. 2017) 
HHY6531 HHY6531 CAN1.natNT2 (SCHMIDT et al. 2017) 
HHY6521 MATa/α ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, hom3-10/hom3-10, 
his3∆200/his3∆200, lys2-10A/lys2-10A, pol3::hphNT1/pol3::hphNT1 + pHHB388 
(pRS316-POL3) 
(SCHMIDT et al. 2017) 
HHY6523 HHY6521 ura7::kanMX4/ura7::kanMX4 (SCHMIDT et al. 2017) 
HHY6533 HHY6521 can1::klTRP1/CAN1.natNT2 (SCHMIDT et al. 2017) 
HHY6535 HHY6521 can1::klTRP1/CAN1.natNT2 ura7::kanMX4/ura7::kanMX4 (SCHMIDT et al. 2017) 
   
HHY1941 RDKY3686 exo1::hphNT1 This study 
HHY6620 RDKY5964 lig4::HIS3 This study 
HHY6551 RDKY5964 rnr1::kanMX4 + pHHB560 (pRS316-RNR1) This study 
HHY6553 HHY6551 dun1::hphNT1 This study 
TSY2941 HHY6551 mrc1::natNT2 This study 
TSY2947 HHY6551 rad9::natNT2 This study 
HHY6214 HHY6551 exo1::hphNT1 This study 
HHY6555 HHY6551 exo1::hphNT1 lig4::HIS3 This study 
HHY6556 HHY6551 msh2::HIS3 This study 
HHY6558 HHY6551 msh3::HIS3 This study 
HHY6560 HHY6551 msh6::hphNT1 This study 
HHY6562 HHY6551 pol2-04.natNT2 This study 
HHY6566 HHY6551 pol3-01.natNT2 This study 
HHY6570 HHY6551 rnr3::hphNT1 This study 
   
HHY6572 RDKY5964 rnr1.HIS3 This study 
HHY6574 RDKY5964 rnr1-F15S.HIS3 This study 
HHY6578 RDKY5964 rnr1-D57N.HIS3 This study 
HHY6580 RDKY5964 rnr1-S242T.HIS3 This study 
HHY6582 RDKY5964 rnr1-K243E.HIS3 This study 
HHY6584 RDKY5964 rnr1-A245V.HIS3 This study 
HHY6586 RDKY5964 rnr1-R256H,Y779C.HIS3 This study 
HHY6588 RDKY5964 rnr1-I262V,N291D.HIS3 This study 
HHY6596 RDKY5964 rnr1-Y285C.HIS3 This study 
   
HHY6598 HHY1794 rnr1-F15S.HIS3 This study 
HHY6602 HHY1794 rnr1-D57N.HIS3 This study 
HHY6604 HHY1794 rnr1-S242T.HIS3 This study 
HHY6606 HHY1794 rnr1-A245V.HIS3 This study 
HHY6608 HHY1794 rnr1-R256H,Y779C.HIS3 This study 
HHY6610 HHY1794 rnr1-I262V,N291D.HIS3 This study 
HHY6618 HHY1794 rnr1-Y285C.HIS3 This study 
   
HHY6634 RDKY5964 rnr1-I262V,N291D.HIS3 ura3-52::URA3 This study 
   
RDKY6678 Mata ura3-52 leu2Δ1 trp1Δ63 his3Δ200 hom3-10 lys2ΔBgl ade2Δ1 ade8 
iYEL072W::hph can1::hisG yel072w::CAN1/URA3 
(PUTNAM et al. 2009) 
HHY6491 RDKY3686 iYEL072::hph can1::hisG yel072w::CAN1/URA3 (SCHMIDT et al. 2017) 
HHY6492 RDKY5964 iYEL072::hph can1::hisG yel072w::CAN1/URA3 (SCHMIDT et al. 2017) 
HHY6493 HHY6491 sml1::klTRP1 (SCHMIDT et al. 2017) 
HHY6494 HHY6492 bar1::loxP.klLEU2.loxP (SCHMIDT et al. 2017) 
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HHY6443 RDKY5964 iYEL072W::hph can1::hisG yel072w::CAN1/URA3 
bar1::loxP.klLEU2.loxP 
(SCHMIDT et al. 2017) 
HHY6537 RDKY3686 iYEL072W::hph can1::hisG yel072w::CAN1/URA3 
bar1::loxP.klLEU2.loxP 
(SCHMIDT et al. 2017) 
   
HHY6445 HHY6443 met7::kanMX4 This study 
HHY6447 HHY6443 met7::klTRP1 natNT2.pGPD-DUT1 This study 
HHY6449 HHY6443 met7::klTRP1 ung1::kanMX4 This study 
HHY6638 HHY6443 natNT2.pGPD-DUT1 This study 
HHY6451 HHY6443 ung1::kanMX4 This study 
HHY6640 HHY6443 met7::klTRP1 natNT2.pGPD-DUT1 ung1::kanMX4 This study 
HHY6642 HHY6443 natNT2.pGPD-met7ΔM This study 
HHY6644 HHY6443 met7-3Myc.klTRP1 This study 
HHY6646 HHY6443 dut1-G82S This study 
HHY6648 HHY6443 dut1-G82S ung1::kanMX4 This study 
HHY6713 HHY6443 dut1-G82S dcd1::natNT2 This study 
HHY6716 HHY6443 dcd1::natNT2 This study 
TSY534 HHY6443 natNT2.pSIC1-SIC1NTR(aa1-100)-3Myc-(GA)5-RMI1 This study 
   
RDKY3615 Mata ura3-52 leu2∆1 trp1∆63 his3∆200 lys2∆Bgl hom3-10 ade2∆1 ade8 
yel069c::URA3 
(CHEN AND KOLODNER 
1999) 
HHY6477 RDKY3615 met7::HIS3 This study 
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3 METHODS 
3.1 Molecular biological methods 
3.1.1 Agarose gel electrophoresis 
PCR products or restriction digests were separated according to their size by agarose gel 
electrophoresis using 0.8% - 1.5% agarose gels stained with GelRed (1:20000 diluted). Prior to 
loading, DNA samples were mixed with 6x loading buffer. 1 kb GeneRuler DNA Ladder was used 
as a reference for size estimation of separated DNA fragments. Electrophoresis was carried out in 
0.5 M TBE buffer in running chambers at constant voltage of 130 V. 
 
3.1.2 Polymerase chain reaction (PCR) 
To amplify specific sequences from genomic DNA, polymerase chain reaction (PCR) was used. For 
this, a reaction mix (Table 3.1) was pippeted into PCR stripes on ice, briefly mixed (vortex), spun 
down and transferred to the 95°C pre-heated PCR block. PCR run was run according to Table 3.2. 
 
Table 3.1 PCR reaction mix for one reaction. 
Reagent TAQ PCR [μL] Velocity PCR [μL] Phusion PCR [μL] 
TAQ DNA polymerase 0.25 - - 
Velocity DNA polymerase - 0.5 - 
Phusion DNA polymerase - - 0.5 
TAQ standard buffer, 10x 2.5 - - 
Hi-Fi buffer, 5x - 10 - 
Phusion HF or GC buffer, 10x - - 5 
dNTPs, 2 mM each 2.5 5 5 
DMSO - 1.5 1.5 
primer mix, 5 μM each 2.5 5 5 
genomic DNA 1 1 1 
dH2O 16.25 27 32 
total volume 25 50 50 
 
Table 3.2 PCR programs. 
 TAQ PCR Velocity or Phusion HF PCR 
Step# Temperature [°C] Time [min] Temperature [°C] Time [min] 
1 95 5 98 3 
2 95 1 98 1 
3 55 1 55 1 
4 72 1 / 1 kb length 72 1 / 1 kb length 
5 72 10 72 10 
6 4 ∞ 4 ∞ 
Steps 2 – 4 were repeated for 30 cycles.  
 
3.1.3 Colony polymerase chain reaction 
Colony-PCR was used to test yeast transformants for the presence of the selection cassette at the 
expected genomic integration site. For this, yeast was transferred to PCR stripes, microwaved for 
90 sec and PCR reaction components (Table 3.3) were added on ice. PCR was run as listed in 
Table 3.4. 
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Table 3.3 Colony-PCR reaction mix 
Reagent Colony-PCR [μL] 
TAQ DNA polymerase 0.25 
TAQ standard buffer, 10x 2.5 
dNTPs, 2 mM each 2.5 
primer mix, 5 μM each 2.5 
colony - 
dH2O 17.25 
total volume 25 
 
Table 3.4 Colony-PCR program. 
Step# Temperature [°C] Time [min] 
1 95 5 
2 95 0.5 
3 55 0.5 
4 72 1 
5 72 10 
6 4 ∞ 
Steps 2 – 4 were repeated for 30 cycles.  
 
3.1.4 Cloning 
To clone PCR products or subclone plasmid fragments into plasmids, restriction digest of DNA was 
performed at 37 °C for either 2 h or overnight. Reaction buffer was used as suggested by the 
manufacturer. The composition of the reaction mixture is listed in Table 3.5. 
 
Table 3.5 Composition of restriction digestion mixture. 
Reagent Volume [μL] 
PCR product / mini prep 50 / 10 
restriction enzyme A 0.5 
restriction enzyme B 0.5 
Buffer X, 10x 10 
dH2O up to 100 
total volume 100 
 
A small aliquot of the restriction digest was first checked by agarose gel electrophoresis, and then 
the remaining sample was loaded on a preparative agarose gel. Fragments of correct size were cut 
and extracted from the agarose using QIAquick Gel Extraction Kit following manufacturer’s 
protocol. Purified fragments were run on an agarose gel to determine the volumes needed for a 3:1 
ratio of insert to backbone in the ligation reaction. Ligation reaction was performed either for 1 h at 
RT or at 16 °C, overnight. The composition of the ligation reaction mixture is listed in Table 3.6. For 
every ligation reaction, a re-ligation control missing the insert was run in parallel under same 
conditions. Next, 3 μL of ligation reaction mix was transformed in electrocompetent bacteria as 
described in 3.1.6. Cultures of transformants were grown at 37 °C, overnight and plasmids were 
purified using QIAprep Spin Miniprep Kit following manufacturer’s protocol. Presence of insert was 
checked by restriction test digestion and positive mini preps were sequenced (GATC). 
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Table 3.6 Composition of the ligation reaction mixture. 
Reagent Volume [μL] 
T4 ligase 1 
T4 ligase buffer, 10x 2 
insert x 
backbone y 
dH2O up to 20 
total volume 20 
 
3.1.5 Site-directed mutagenesis 
Plasmids containing specific point mutations were frequently generated by site-directed 
mutagenesis. Mutagenic primers were designed using QuikChange® Primer Design Program. 
Reagents for site-directed mutagenesis PCR were pipetted on ice as listed in Table 3.7 and PCR 
was run as depicted in Table 3.8. 
 
Table 3.7 Site-directed mutagenesis PCR mix. 
Reagent Site-directed mutagenesis PCR [μL] 
Accuprime Pfx DNA polymerase 1 
Accuprime Pfx buffer, 10x 5 
primer A, 100 μM 1 
primer B, 100 μM 1 
plasmid DNA (mini prep) 1 
dH2O 41 
total volume 50 
 
Table 3.8 Site-directed mutagenesis PCR program. 
Step# Temperature [°C] Time [min] 
1 95 5 
2 95 0.5 
3 55 1 
4 68 1.5 / 1 kb plasmid DNA 
6 4 ∞ 
Steps 2 – 4 were repeated for 18 cycles.  
 
Next, 10 μL PCR reaction was digested with 1 μL DpnI in a total volume of 50 μL 1x Cutsmart 
buffer (50 mM potassium acetate, 20 mM Tris-acetate, 10 mM magnesium acetate, 100 μg/ml BSA, 
pH 7.9) for 1 h at 37 °C. Finally, 3 μL DpnI-treated sample was transformed into electrocompetent 
cells as described in 3.1.6. Presence of the desired point mutation and absence of additional 
mutations were confirmed by sequencing (GATC). 
 
3.1.6 Transformation of E. coli 
Thawed electrocompetent E. coli TOP10F’ were diluted 1:5 with cold dH2O and 3 μL of ligation or 
site-directed mutagenesis reactions were added to 100 μL bacteria. The mix was incubated for 15 
min on ice, transferred to a cuvette and electroporated at 2.48 V for 4 sec. Cells were resuspended 
in 1 mL LB medium and incubated for 1 h at 37 °C, shaking. Afterwards, cells were spun down, 
plated on solid LB medium containing the corresponding antibiotic and grown at 37 °C, overnight.  
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To retransform plasmid mini preps into bacteria, chemical competent E. coli were thawed on ice. 
0.5 to 1 μL mini prep was added to competent cells and mix incubated on ice for 10 min. Cells were 
heat-shocked at 42 °C for 35 sec and incubated on ice for 5 min. Cells were resuspended in 1 mL 
LB medium and incubated at 37 °C for 1 h, shaking. Afterwards, cells were spun down, plated 
irregularly on solid LB medium containing the corresponding antibiotic and grown at 37 °C, 
overnight. 
 
3.2 Protein biochemical methods 
3.2.1 Yeast crude cell lysates 
For yeast cell crude cell lysates, 500 μL overnight culture was added to 5 mL fresh medium and 
grown for 3 h at 30 °C, shaking. Cells were pelleted (3000 rpm, 10 min, RT), resuspended in 150 
μL YEX buffer and transferred to a pre-chilled 1.5 mL reaction tube. Samples were incubated on 
ice for 10 min. Next, 150 μL 50% TCA was added to each sample. To mix the sample, the sample 
was vortexed and again incubated for 10 min on ice. To precipitate proteins, sample was spun 
down (14000 rpm, 10 min, 4°C) and the pellet was resuspended in 100 μL 1x GSD+Tris buffer. 
Samples were boiled for 5 min at 95 °C, spun down and either loaded on an SDS-PAGE gel or 
stored at -20 °C.  
 
3.2.2 SDS polyacrylamide gel electrophoresis 
Sodiumdodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) was used to separate 
proteins according to their molecular weight. Yeast crude protein lysates were boiled for 5 min at 
95 °C, spun down and loaded onto the prepared 7, 8, 10 or 12% SDS polyacrylamide gel (Table 
3.9) or commercial 4-15% Mini-PROTEAN TGX gels. SDS-PAGE was run in 1x SDS running buffer 
at 80 V for approximately 20 min and then at 200 V until the running front reached the bottom of the 
gel. For protein size estimation, a prestained Precision Plus Protein™ Dual Color Standards protein 
marker was run on each gel. 
 
Table 3.9 SDS-PAGE recipe for one SDS-PAGE gel. 
Reagent Separating gel Staking gel 
 7% 8% 10% 12% 5% 
dH20 5.65 5.4 4.9 4.4 3.125 
separating buffer 2.5 2.5 2.5 2.5 0 
stacking buffer 0 0 0 0 1.25 
SDS, 10% 0.1 0.1 0.1 0.1 0.05 
Acrylamide-Bis, 40% 1.75 2.0 2.5 3 0.625 
APS, 10% 0,03 0.03 0,03 0.03 0.015 
TEMED 0.015 0.015 0.015 0.015 0.0075 
 
3.2.3 Coomassie staining 
To visualize proteins with Coomassie brilliant blue G250, the SDS-PAGE gel was first incubated in 
fixing solution for 30 min, RT, shaking. Next, the gel was stained with Coomassie staining solution 
(a one to one mixture of stock solution I and II) for 20 min, RT, shaking. Afterwards, the gel was 
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destained in destaining solution I for 30 sec to 5 min and destainig solution II as long as needed. 
The destained gel was washed with dH2O twice and imaged using a scanner.  
 
3.2.4 Western blot 
To transfer proteins present in the SDS-PAGE gel on a PVDF membrane a wet blotting system 
(Bio-Rad) was used. First, the PVDF membrane was activated with methanol. Next, the blotting 
cassette including sponges (one on each side), Whatman 3M paper (two on each side), the 
separating gel and the PVDF membrane was assembled and inserted in the blotting system.  
Transfer was performed for 1 to 4 h at 350 mA. After disassembling the apparatus, the membrane 
was washed with PBS-T once and blocked with in 3% milk dissolved in PBS-T for 1 h at RT with 
shaking. The membrane was washed once with PBS-T and incubated with the diluted primary 
antibody in either 3% milk or 3% BSA in PBS-T for 1 h at RT or overnight at 4 °C. After washing the 
membrane with PBS-T for 5 min at RT (repeat step three-times), the membrane was incubated with 
the secondary antibody coupled to horseradish peroxidase (HRP) in 0.5% milk diluted in PBS-T for 
1 h at RT. Next, the membrane was again washed with PBS-T for 10 min at RT (repeat step three-
times) and then incubated with Immobilon Western Chemiluminscent HRP substrate and imaged 
using Fusion Solo S System or Super RX-N Fuji medical x-ray films and an Optimax TR X-ray film 
processor. All antibodies used for Western blot analysis (including used dilutions) are listed in 
Table 2.10 and 2.11. 
 
3.2.5 Sic1 antibody generation 
To raise antibodies against yeast Sic1 in guinea pigs, first, 6xHis-tagged full-length Sic1 was 
expressed from pET28c-Sic1 (kind gift from Dr. Gislene Pereira) in E. coli BL21 (DE3) and purified 
using Ni-NTA agarose affinity purification. For this, the overnight culture was diluted 1:50 in 1 L 
LB+Kan and growth at 37 °C, shaking (230 rpm) was followed by measuring OD595. At an OD595 of 
0.8 Sic1 expression was induced by addition of IPTG (cfinal = 1mM). After 4 h of incubation at 37 °C, 
230 rpm, the culture was spun down by centrifugation in a Beckman centrifuge (JA-10 rotor, 
5000rpm, 15 min, 4 °C) and the mass of the wet pellet was measured. Pellets were resuspended in 
PBS, transferred in one 50 mL Falcon tubes and centrifuged again (4000 rpm, 15 min, 4 °). Cell 
pellet was resuspended in lysis buffer, lysozyme was added to a final concentration of 1 mg/mL 
and sample was incubated for 30 min on ice. Next, the sample was sonicated on ice for six 10 sec 
bursts with 1 min cooling period between each burst. The lysate was transferred to a centrifugation 
flask and centrifuged at 10000 x g for 30 min at 4 °C to pellet cellular debris. The supernatant was 
transferred to a 50 mL Falcon tube and magnesium chloride and ATP was added to the 
supernatant to a final concentration of 10 mM and 2 mM, respectively. 2 mL 50% Ni-NTA slurry 
was added to a 50 mL Falcon tube and washed twice with 1 mL lysis buffer (1500 rpm, 4 °C, 5 
min). All subsequent steps are carried out in the cold room. The supernatant was added to the 
prepared Ni-NTA slurry and mixed gently on a rotary wheel for 2 h at 4 °C. The lysate Ni-NTA 
mixture was loaded into a PolyPrep® Chromatograhy column, the bottom cap was removed and 
flow through was collected. Column was washed with 4 mL wash buffer, twice and wash fractions 
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were collected. Finally, Ni-NTA-bound proteins were eluted by adding 8 times 250 μL elution buffer. 
All eluates were collected in individual tubes and analyzed by SDS-PAGE followed by Coomassie 
staining. The concentration of purified Sic1 in each eluate was estimated using a BSA standard. 
The different steps of the Ni-NTA affinity purification of 6xHis-Sic1 is shown in Fig. 3.1A. At the 
DKFZ core facility for monoclonal antibodies, two guinea pigs were immunized with 6xHis-Sic1. 
Specificity of serum was tested by immunoblotting (Fig. 3.3B). 
 
Fig. 3.1 Sic1 purification and α-Sic1 serum test. 
(A) Proteins in lysate, flow through, washes and eluate 3 (the most concentrated eluate) were separated on a 
12% SDS-PAGE and stained with Coomassie. (B) α-factor release experiment of TSY534 to test for specificity 
of the α-Sic1 serum. Cells were arrested in G1 by α-factor and released in fresh medium. Samples were taken 
every 15 min. The α-Sic1 serum recognizes Sic1 (1), the Sic1-NTR-Rmi1 fusion protein (2) expressed under 
the control of the Sic1 promoter, as well as one unspecific band (*). Clb2 was used as G2 marker and Pgk1 
was used as loading control. Cropping of the image is shown as dotted lane. 
 
3.3 S. cerevisiae methods 
3.3.1 Growth conditions 
S. cerevisiae strains were grown at 30°C either in yeast extract-peptone-dextrose (YPD) media, or 
in synthetic dropout (SD) media. For plates, media contained 2% agar-agar. Yeast extract-peptone-
glycerol (YPG) media was used to test for petite phenotype (dysfunctional mitochondria). Mutator 
plates and growth medium used to measure mutation rates in strains with plasmid-borne rnr1 
alleles were prepared as described above but lacking leucine (Leu) to select for the rnr1 plasmid 
(ARS-CEN, LEU2). Antibiotics were used at the following final concentrations (unless otherwise 
specified): 200 μg/mL geneticin (G418), 300 μg/mL hygromycin B (hph), 100 μg/mL nourseothricin 
(nat) and 10 μg/mL cycloheximide. The DNA damaging agents Hydroxyurea (HU) and Phleomycin 
from Streptomyces verticillus were used in the indicated concentrations in YPD medium. 
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3.3.2 Generation of competent yeast cells 
To generate competent yeast cells, 2 mL of a saturated overnight culture was added to 50 mL fresh 
media and incubated for 4 h at 30 °C with shaking. Cells were pelleted (3000 rpm, 10 min, RT), 
washed once with 1x LiAc/TE buffer and resuspended in 600 μL LiAc/TE. Cells were incubated at 
30 °C in a shaking incubator for 15 min and stored up to one week at 4 °C. 
 
3.3.3 Yeast transformation 
To transform a PCR product or a plasmid into competent yeast cells, competent cells were 
pelleted. DNA, 40% PEG, 10x LiAc and salmon sperm was added to the pelleted cells (Table 3.10). 
Transformation mix was resuspended and incubated for 30 min at 30 °C followed by 20 min at 42 
°C. Cells were washed once with sterile dH2O and plated on YPD or drop-out plates. In case of a 
transformation of an antibiotic resistance cassette as selection marker, cells were replica plated 
onto an YPD plate containing the antibiotic next day. Alternatively, cells were directly resuspended 
in 5 mL liquid YPD after the transformation, grown for 5 h at 30 °C and plated on YPD containing 
the antibiotic.   
 
Table 3.10 Yeast transformation mix. 
Reagents PCR product [μL] Plasmid [μL] 
competent cells 200 30 
PCR product 25 - 
plasmid mini prep - 0.5 - 1 
PEG3350, 50% w/v 240 60 
LiAc, 1M 36 9 
salmon sperm, 2mg/mL 25 5 
 
3.3.4 Sporulation and random spore analysis 
To obtain diverse genetically modified yeast strain combinations yeast mating followed by random 
spore isolation was used. Mata and Matα haploid yeast cells were mated and diploids were 
selected either following auxotrophic and resistance markers or by testing for mating type with 
mating type tester strains. 1 mL of the diploid overnight culture was washed once with dH2O and 
resuspendend in 3 mL sporulation medium. Cells were incubated at 30 °C with shaking for 5-7 
days, and sporulation was checked visually using light microscopy. To purify spores, 1 mL 
sporulated culture was pelleted. Cells were resuspended in 40 μL zymolase (c = 0.5 mg/mL) and 
incubated at 30 °C for 30 min. 500 μL sterile dH2O was added to the sample and cells were 
pelleted. 70 μL dH2O was added to the sample and the sample was subsequently vortexed in a 
disruptor genie for 5 min, RT.  Supernatant was removed using vacuum and cells were washed 6 
times with 1 mL dH2O. Finally, 1 mL dH2O containing 0.01% NP-40 was added to the sample and 
cells were vortexed for 1 min, RT. Depending on the sporulation efficiency different volumes were 
plated on selection medium plates. Purified spores were patched on YPD agar and tested for the 
presence of auxotrophic/drug resistance markers linked to specific genetic modifications according 
to the desired genotype. 
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3.3.5 α-factor arrest and release 
α-factor arrest and release experiments were performed in a bar1Δ background. Cells were grown 
in YPD overnight. The logarithmically growing control cultures were prepared as described in 
(3.2.1). To arrest cells in G1 with α-factor, 2 mL of the overnight culture was washed with sterile 
water twice and then resuspended in 20 mL YPD medium containing 0.1 μg/mL α-factor followed 
by incubation at 30 °C for 3 h with shaking. Next, cells were washed twice with sterile water, 
released in 20 mL YPD medium containing 15 μg/mL nocodazole and grown at 30 °C with shaking. 
Samples for DNA content analysis and cell lysates were taken every 10 min. Cell cycle progression 
was analyzed by DNA content using flow cytometry and by SDS-PAGE/immunoblotting. 
 
3.3.6 Spotting on solid media 
Proliferation of different yeast strains was compared using the “spotting assay” in which serial 
dilutions of a yeast culture are spotted in a solid media agar plate. Yeast cultures were grown 
overnight in YPD. Next day, cultures were normalized to the lowest OD595 and spotted in 10-fold 
serial dilution on solid YPD plates, YPG plates and on YPD plates containing phleomycin from 
Streptomyces verticillus in the indicated concentration. Plates were incubated at 30 °C and imaged 
using the GelDoc system. 
 
3.3.7 Proliferation assay 
Saturated overnight cultures were diluted to OD600 = 0.1 in fresh YPD. Growth at 30 °C was 
followed by OD600 measurement every hour. For each genotype at least two independent isolates 
were used and determination were done at least in triplicates. The OD600 mean with standard 
deviation was plotted in a log2 scale against incubation time. 
 
3.3.8 DNA content analysis 
For DNA content analysis, saturated overnight cultures were diluted 1:20 in fresh YPD and grown 
for 3 h at 30 °C with shaking. 200 μL culture aliquot was washed with cold dH2O. Cells were 
resuspended in 300 μL cold dH2O and transferred to a 14 mL culture tube. While constantly 
vortexing, cells were fixed by adding 700 μL cold absolute ethanol. Fixed cells were incubated for 1 
h at RT and then either stored at 4 °C or further processed. To prepare cells for DNA content 
analysis, cells were resuspended in 50 mM sodium citrate buffer and sonicated (5 pulses, 1 sec 
break; 30% output). Samples were treated with 1 mg/mL proteinase K and 0.25 mg/mL 
ribonuclease A in 50 mM sodium citrate overnight at 37 °C. Next day, cells were pelleted, 
resuspended in 50 mM sodium citrate containing 1 μM sytox green and incubated in the dark at RT 
for at least 1 h. DNA content was measured at FACS CantoII. 30000 events were recorded per 
sample. Data was analyzed using FlowJo and the percentage of cells in S phase was determined 
using FlowJo cell cycle analysis plug-in. 
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3.3.9 Purification of genomic DNA 
Genomic DNA was prepared either using Qiagen Puregene Yeast / Bact. Kit B following 
manufacturer’s protocol or using phenol-chloroform extraction (HOFFMAN AND WINSTON 1987). For 
the latter, a saturated 5 mL yeast overnight culture was spun down and resuspended in 200 μL 
buffer A. 200 μL TE was added and mixture was transferred to 2 mL safe-lock reaction tube 
containing 400 μL glass beads. In the fume hood, 200 μL phenol-chloroform-isoamyl alcohol 
(25:24:1) was added to the sample, followed by vortexing for 3 min at RT using a disrupter genie. 
Samples were centrifuged (14000 rpm, 10 min, 4 °C) and 50 μL of the upper aqueous phase, 
which contains the genomic DNA, was transferred to a fresh 1.5 mL reaction tube.  
 
3.3.10 Plasmid rescue from yeast cells 
For plasmid rescue from yeast cells, DNA was purified as described in 3.3.9, but instead of 50 μL 
300 μL of the DNA containing aqueous phase was transferred to a new 1.5 reaction tube. To 
precipitate DNA, 1 mL 96% ethanol was added, the sample mixed by inverting the tube and 
centrifuged at 14000 rpm for 2 min. The supernatant was discarded and pellet resuspended in 400 
μL TE. Next, 15 μL 3 M sodium acetate, pH 5.2 was added to the sample, mixed (vortex), followed 
by the addition of 1 mL 96% ethanol and vortexing. Sample was centrifuged at 14000 rpm for 2 
min. The supernatant was removed carefully and pellet air-dried for 10 min. DNA was resuspended 
in 50 μL TE and either incubated at 65 °C for 1 h or at RT, overnight. Finally, 3 μL DNA was 
electroporated into electrocompetent TOP10F’ following protocol 3.1.6. 
 
3.3.11 Uracil accumulation assay 
Uracil accumulation assay was mainly done as described (SEIPLE et al. 2006). Genomic DNA was 
isolated from logarithmic cultures using Puregene Yeast / Bact. Kit B. Genomic DNA was incubated 
overnight at 37 °C in the presence or absence of 10 U uracil DNA glycosylase from E. coli (UDG) 
and 20 U human AP endonuclease (APE I) in 1x NEBuffer 4 (50 mM potassium acetate, 20 mM 
Tris-acetate, 10 mM magnesium acetate, 1 mM DTT, pH 7.9). DNA was precipitated and loaded on 
a 0.8% agarose gel stained with GelRed. Images were taken using the GelDoc system. 
 
3.3.12 Determination of NTP and dNTP pools 
NTP and dNTPs were measured in Dr. Chabes lab as described in (RENTOFT et al. 2016; SCHMIDT 
et al. 2017). 
 
3.3.13 Synthetic lethal interaction with polymerase mutants by plasmid shuffling 
To test for potential lethal interactions between ura7Δ and the DNA proofreading-deficient pol3-01 
allele, plasmid shuffling was performed. For this, first the POL3 vectors were cloned. The POL3 
gene, including 1 kb upstream and 200 bp downstream of POL3, was amplified from genomic DNA 
with primers HHP2797 and HHP2798, introducing a NotI and a SmaI sites to clone the amplified 
fragment into pRS315 and pRS316 (SIKORSKI AND HIETER 1989) to generate pHHB351 (pRS315-
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POL3) and pHHB388 (pRS316-POL3), respectively. To generate pRS315-pol3-01, plasmids 
RDK3097 (DATTA et al. 2000) and pHHB351 were digested with NcoI and BglII. The 2015 bp pol3 
fragment of RDK3097 plasmid containing D321A and E323A mutations, and the 8479 bp fragment 
of pHHB351 were gel extracted and ligated to generate pHHB396 (pRS315-pol3-01). All plasmid 
inserts and junctions were sequenced. Next, the strains used for the DNA polymerase plasmid 
shuffling experiments were generated by mating RDKY3686 and RDKY5964. In this diploid wild-
type strain an hphNT1 cassette (amplified from pFA6a-hphNT1) was used to replace one of the two 
POL3 alleles. Next, strains were transformed with pHHB388 (pRS316-POL3) and sporulated to 
generate HHY6481. In HHY6481, URA7 was deleted with a kanMX4 cassette (amplified from 
pFA6a-kanMX4) and MSH2 with a HIS3 cassette (amplified from pRS303) to generate HHY6482 
and HHY6483, respectively. HHY6481, HHY6482 and HHY6483 were transformed with pHHB351 
and pHHB396. To check for synthetic lethality, transformants (Ura+Leu+) were streaked on 5-FOA 
plates (to select for the loss of WT-POL3-URA3 plasmid) and in SD media lacking Ura and Leu (as 
control). The msh2Δ pol3Δ strain (HHY6483) transformed with pHHB396 (pRS315-pol3-01) was 
used as a positive control for a synthetic lethal interaction (TRAN et al. 1999). Strains were imaged 
after 3 days of growth with a GelDoc system. Homozygous diploid strains HHY6521 and HHY6523 
were generated by mating and used for plasmid shuffling as described above. 
 
3.3.14 Synthetic lethal interactions between rnr1 mutants and DNA replication fidelity or 
checkpoint-compromised mutants by plasmid shuffling 
To investigate genetic interactions between rnr1- and replication fidelity or checkpoint-
compromised mutants by plasmid shuffling, different plasmid shuffling queries were generated by 
mating. All these queries lack the essential RNR1 gene, but are complemented by a low copy 
plasmid expressing WT-RNR1 (pHHB560, pRS316-RNR1) in addition to the indicated additional 
gene deletion/mutation. Plasmids  either expressing the WT-RNR1 or mutant rnr1 alleles (ARSH4-
CEN6, LEU2) were transformed into the query strains. Overnight cultures were spotted in serial 
dilutions on media lacking Leu, in the presence or absence of 5-FOA. Plates were incubated for 4 
days at 30 °C, imaged and scored visually.  
 
3.3.15 Determination of mutation rates in haploid cells 
Mutation rates for the CAN1 inactivation assay, the lys2-10A and hom3-10 frameshift reversion 
assay and the standard and post-duplication gross-chromosomal rearrangement (GCR) assay 
were measured by fluctuation analysis as described previously (MARSISCHKY et al. 1996; AMIN et al. 
2001; PUTNAM AND KOLODNER 2010). Mutation rates were determined based on two biological 
isolates and at least 14 independent cultures. 95% confidence intervals were calculated for all 
fluctuation tests. 
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3.3.16 Determination of mutation rates in diploid cells 
CAN1 inactivation rates in diploid strains were determined by fluctuation analysis in HHY6533 and 
HHY6535 strains after plasmid shuffling as previously described (HERR et al. 2014). Both, 
HHY6533 and HHY6535 were transformed with either pHHB351 (pRS315-POL3) or pHHB396 
(pRS315-pol3-01). The transformants were streaked out for single colonies on Leu- medium 
containing 5-FAO and nat to select for loss of the plasmid expressing WT-POL3 (pHHB388, 
pRS316-POL3). Mutation rates for the CAN1 inactivation assay were determined by fluctuation 
analysis as previously described with the modification that cells were grown in YPD media 
containing nat, plated on YPD containing nat and or CAN1 inactivation assay plates containing nat. 
Each mutation rate was determined by using two biological isolates and at least 14 independent 
cultures. 
 
3.3.17 CAN1 and URA3 mutation spectra analysis 
To determine CAN1 mutation spectra in different yeast genetic backgrounds, individual colonies 
were patched on YPD and replicated on CAN1 mutator plates. CanR clones were re-streaked on 
SD plates containing canavanine and single independent colonies were used for genomic DNA 
isolation. CAN1 gene was amplified with Phusion High-Fidelity DNA polymerase using primers 
HHP507 and HHP508. PCR product was checked by agarose gel electrophoresis and sequenced 
with primers HHP2973 and HHP2974 by GATC. Sequences were analyzed using Lasergene 12 (or 
more recently, Lasergene 15) and mutations were annotated in the CAN1 sequence. A mutational 
hotspot was defined as a specific mutation found in more than 5% of all sequenced CanR clones of 
the genotype. Mutations rates for specific positions were calculated by multiplying the overall CanR 
mutation rate of the strain with the percentage of the specific mutation relative to the overall 
observed mutations. Mutation spectra distributions and mutational hotspots were compared with 
Fisher’s exact test in R. 
To determine the URA3 mutation spectrum of the rnr1-I262V, N291D mutant, two isogenic strains 
(HHY6634 and HHY6635) were generated, in which the ura3-52 allele was replaced by a WT-
URA3 gene by transforming an URA3 cassette lacking the ATG, amplified from pRS306 with 
primers HHP2876 and HHP2877. Next, individual colonies were patched on YPD and replica 
plated on 5-FOA containing plates. 5-FOAR colonies were re-streaked on 5-FOA plates. Single 5-
FOAR colonies were used for genomic DNA isolation. The URA3 gene was amplified with Phusion 
High-Fidelity DNA polymerase using primers HHP2197 and HHP2198 and sequenced with primers 
HHP4105 and HHP2947 by GATC. Sequences were analyzed using Lasergene 12 (or 15) and 
mutations were annotated in the URA3 sequence. URA3 spectrum was compared to WT URA3 
mutation spectrum reported by (LANG AND MURRAY 2008) using Fisher’s exact test in R.  
 
3.3.18 Strain construction 
Gene deletions and gene-tagging were performed using standard PCR-based recombination 
methods, followed by confirmation by PCR (WACH et al. 1994; JANKE et al. 2004). Alternatively, 
strains carrying combination of different genetic alterations were generated by mating and 
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sporulation as described in 3.3.4. Correct insertion of tags, promoters or point mutations, as well as 
absence of additional unwanted mutations, were confirmed by sequencing.  
To generate HHY6642, which overexpresses the cytoplasmic met7ΔM allele that lacks the 
mitochondrial leader sequence (DESOUZA et al. 2000), a constitutive GPD promoter was introduced 
directly upstream of MET7 methionine 63 in HHY6443 using PCR-based recombination method 
with pYM-N15 (JANKE et al. 2004) as PCR template and primers HHP2657 and HHP2801. 
Promoter and junction were confirmed by sequencing. 
Specific mutations were introduced by pop-in/pop-out strategy (polymerase alleles and rnr1 alleles) 
or PCR-based recombination methods (cyh2-Q38K) and the presence of the desired mutations, as 
well as the absence of additional mutations, were verified by sequencing.  
DNA Polymerase active-site mutations: pol2-M644G (PURSELL et al. 2007) and pol3-L612M (LI et 
al. 2005) were introduced in RDKY5964 by pop-in/pop-out strategy as previously described in 
(HOMBAUER et al. 2011a). The pol1-L868M mutation was introduced in RDKY5964 following the 
same strategy, but with BamHI linearized plasmid pHHB97. pHHB97 was generated by site-
directed mutagenesis using primers HHP1276 and HHP1277 and pRS306-POL1 as DNA template, 
which contains the full-length wild-type POL1 gene, including 1 kb of the 5'-UTR and 738 bp of the 
3'-UTR, cloned in between the KpnI and SacII sites of pRS306. 
To generate strains expressing dut1-1 mutant allele integrated at the chromosomal DUT1 locus, 
the DUT1 gene, including 1 kb upstream and 752 nt downstream of DUT1 was amplified with 
primers HHP4196 and HHP4197 from genomic DNA isolated from RDKY5964. The introduced 
BamHI site in combination with an XhoI site downstream of DUT1 was used to clone the amplified 
fragment into pRS306 (SIKORSKI AND HIETER 1989) to generate pHHB1093 (pRS306-DUT1). The 
dut1-G82S mutation (GUILLET et al. 2006) was introduced in pHHB1093 by site-directed 
mutagenesis using primers HHP4198 and HHP4199 to generate pHHB1094 (pRS306-dut1-1). 
Next, the HindIII linearized pHHB1094 was used to introduce the dut1-1 allele (dut1-G82S) at the 
chromosomal DUT1 locus of RDKY3686 by pop-in/pop-out strategy generating HHY6650. The 
presence of the desired dut1-G82S mutation, as well as the absence of unwanted mutations, was 
confirmed by sequencing. Next, HHY6650 was crossed against HHY6441 and HHY6451 to 
generate HHY6707 and HHY6646, respectively.  
To integrate rnr1 alleles into the RNR1 chromosomal locus by pop-in/pop-out strategy, first the 
RNR1 gene (including promoter and 3’ UTR) was amplified from genomic DNA with primers 
HHP1100 and HHP2976, digested with KpnI and partially with BglII, gel extracted and cloned into 
pRS306 (SIKORSKI AND HIETER 1989) to generate pHHB424 (pRS306-RNR1). pHHB424 contains 
the WT-RNR1 gene, 786 nt of the promoter and 135 nt downstream of the RNR1 STOP codon. 
Second, the desired rnr1 mutations were introduced using site-directed mutagenesis or subcloning. 
The resulting integrative plasmids encoding for the specific rnr1 mutations were linearized with 
BglII or with Bsu36I in case of pHHB718 and pHHB752 prior to transformation. To mark the mutant 
rnr1 alleles a HIS3 cassette (amplified from pRS303 (SIKORSKI AND HIETER 1989) with primers 
HHP3700 and HHP3701) was integrated 232 nt downstream of the RNR1 STOP codon.  
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3.3.19 Strain construction post-GCR 
The post-duplication GCR strain HHY6443 was generated in three steps. First, RDKY6678 
(PUTNAM et al. 2009) containing the post-duplication gross chromosomal rearrangement reporter 
was crossed against RDKY3686 (AMIN et al. 2001) containing the lys2-10A allele to generate 
HHY6491 and HHY6492. Next, a TRP1 cassette from Kluyveromyces lactis (klTRP1) was amplified 
from pYM22 (JANKE et al. 2004) and introduced at the SML1 locus in HHY6491 to generate 
HHY6493. In parallel, a LEU2 cassette from Kluyveromyces lactis (klLEU2) flanked by loxP sites 
was amplified from pUG73 (GUELDENER et al. 2002) and introduced at the BAR1 locus in HHY6492 
to generate HHY6494. Finally, HHY6493 was crossed against HHY6494 and sporulated to 
generate HHY6443. 
 
3.3.20 Strain construction to measure mutation rates in diploids 
HHY6533 and HHY6535 were used as query strains to measure mutation rates in diploids as 
described in 3.3.16. HHY6533 was generated as follows: First, a TRP1 cassette from 
Kluyveromyces lactis (klTRP1) was amplified from pYM22 (JANKE et al. 2004) and introduced at the 
CAN1 locus in HHY6481 to generate HHY6526. Second, a natNT2 cassette was amplified from 
pFA6a-natNT2 (JANKE et al. 2004) using primers HHP3678 and HHP3679 and introduced 7 nt 
downstream of the CAN1 STOP codon in the CAN1 3’UTR of HHY6525 (a Mata version of 
HHY6481) to generate HHY6528. Third, HHY6526 was crossed with HHY6528 to generate 
HHY6533.  
HHY6535 was generated as described for HHY6533, with the modification that the initial CAN1 
deletion and the integration of the natNT2 cassette were done in HHY6482 and HHY6530, 
respectively. 
 
3.3.21 SGA query strain construction 
Due to the incompatibility of the selectable markers used in the query of the original SGA protocol 
(TONG AND BOONE 2006) with the genetic markers required for the mutator assays the query was 
modified as follows: First, because the CAN1 inactivation assay requires a functional CAN1 gene 
and strains carrying the lys2-10A allele depend on the lysine permease Lyp1 for survival, 
canavanine and thialysine could not be used to kill diploids cells. Thus, to kill diploids a 
combination of cycloheximide and 5-FOA was used. For this, the cycloheximide-resistant mutation 
(cyh2-Q38K) (KAUFER et al. 1983) was introduced at the CYH2 locus and a URA3 cassette from 
Kluyveromyces lactis (klURA3) was integrated downstream of MLH2 by PCR-based recombination 
method. Second, the LEU2 gene from Kluyveromyces lactis (klLEU2) under the control of the 
mating type a specific MFA1 promoter and an hphNT1 cassette were introduced upstream of the 
lys2-10A allele. The pMFA1-LEU2 cassette allows the selection of haploid Mata progeny, whereas 
the hph resistance marker is used to select for those strains carrying the lys2-10A reporter. Third, 
downstream of the DNA polymerase mutant alleles (pol1-L868M, pol2-M644G and pol3-L612M) 
and the wild-type POL1 gene a natNT2 cassette was integrated, which allows selection for mutant 
or wild-type polymerase alleles by nourseothricin resistance.  
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In detail, the query strains were generated as follows. First, the klLEU2 open reading frame (ORF) 
and 143 nt of the 3’-untranslated region (3’-UTR) was amplified with primers HHP1949 and 
HHP1950 from pOM13 (GAUSS et al. 2005) and the PCR product was used to replace the MFA1 
ORF in RDKY5964 generating HHY6484. In parallel, a hygromycin B resistance cassette (hphNT1) 
from pFA6a-hphNT1 (JANKE et al. 2004) was amplified with primers HHP2002 and HHP2003 and 
inserted upstream of the lys2-10A allele in HHY5218 resulting in HHY6485. Second, the MFA1 
promoter and the klLEU2 gene (pMFA1-klLEU2) were amplified with primers HHP2001 and 
HHP2004 from genomic DNA of HHY6484. This pMFA1-klLEU2 cassette was than inserted directly 
upstream the hphNT1 cassette in HHY6485 to generate HHY6486.  
In parallel, the cycloheximide-resistance cyh2-Q38K mutation was introduced into RDKY3686 by 
transformation of a PCR product amplified from genomic DNA from RDKY7593 (which harbors the 
cyh2-Q38K mutation, generously provided by C.D. Putnam and R. D. Kolodner, Ludwig Institute for 
Cancer Research, San Diego) with primers HHP1062 and HHP1063 creating HHY6487. Then, a 
HIS3 cassette amplified from pRS303 (SIKORSKI AND HIETER 1989) with primers HHP1955 and 
HHP1956 was integrated in the 3’-UTR of the hom3-10 allele in strain HHY6487 to generate 
HHY6488.  Third, HHY6486 was crossed against HHY6488 and sporulated to generate HHY6489. 
Fourth, a klURA3 cassette was amplified from pUG72 (GUELDENER et al. 2002) with primers 
HHP2220 and HHP2221 and introduced in the 3’-UTR of MLH2 resulting in HHY6490. Fifth, the 
active-site polymerase mutations were introduced in RDKY5964 by pop-in/pop-out as described in 
3.3.18. Next, a natNT2 cassette was amplified from pFA6a-natNT2 (JANKE et al. 2004) and 
integrated in the 3'-UTR of DNA polymerase active-site mutant alleles or wild-type POL1. Finally, 
these strains were crossed against HHY6490 to generate the pol1-L868M, pol2-M644G, pol3-
L612M and WT-POL1 SGA queries (HHY5292, HHY5284, HHY5289 and HHY5298, respectively). 
 
3.3.22 SGA 
All the steps until the freezing of the generated double mutant cells were done using RoToR robot.  
The four SGA query strains HHY5298, HHY5292, HHY5984 and HHY5289 (grown on YPD + hph 
agar plates) were crossed to an array of the quadruplicated non-essential BY4742 gene deletion 
collection TKY3503 by pinning onto fresh YPD agar plates. After 1 day of growth at 30 °C, cells 
were subjected to two rounds of pinning onto SGA diploid selection medium and grown for 2 days 
and 1 day, respectively at 30 °C. Afterwards, cells were pinned onto SGA presporulation medium 
and grown for 1 day at 30 °C. 
Next, cells were pinned onto SGA sporulation medium and incubated for 7 days at 23-25 °C. 
Spores were pinned onto SGA haploid selection medium and grown for 5 days at 30 °C followed by 
two rounds of pinning on SGA double mutant selection medium (in the second round of pinning 
medium contained additional 50 μg/mL hph) for 1 day at 30 °C. Next, cells were de-condensed 
from 1536- to 384-format by pinning onto SGA de-condensation medium and grown for 2 days at 
30 °C. Finally, cells were transferred to 96-well plates containing liquid SD medium without Leu 
containing 15% glycerol, G418 and nat, grown for 2 days at 30 °C and stored at -80 °C.  
The generated double mutants were spotted on YPD-agar using Liquidator 96, grown for 2 days at 
30 °C. Then, plates were imaged using the GelDoc system for documentation and replica-plated 
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onto two mutator plates, either lacking lysine (for lys2-10A frameshift reversion assay) or lacking 
Arg and supplemented with canavanine (CAN1 inactivation assay). After 4 days of growth at 30 °C, 
mutator plates were imaged and scored visually. Positive hits were re-checked and those mutants 
that confer an increased mutator phenotype were generated in S288C background (RDKY5964 
and HHY6443) for further analysis. 
 
3.3.23 Strain construction for RNR1 random mutagenesis screen 
The RNR1 random mutagenesis screen was performed in HHY6555, which was complemented by 
pHHB560 (pRS316-RNR1) plasmid. To generate HHY6555, we inactivated the LIG4 gene (to 
prevent non-homologous end joining events) with a HIS3 cassette (amplified from pRS303) in 
RDKY5964 (HOMBAUER et al. 2011a) and crossed it with HHY1941. In the resulting diploid strain 
one of the two RNR1 alleles was replaced by a kanMX4 cassette, amplified from pFA6a-kanMX4. 
The heterozygous diploid strain was transformed with pHHB560 (pRS316-RNR1) and sporulated to 
obtain HHY6555. HHY6124 and HHY6551, which were used for further analysis, were generated 
following the same strategy. 
 
3.3.24 Construction of a rnr1 mutation library 
To generate an rnr1 mutant library, the RNR1 gene was amplified from pHHB424 (pRS306-RNR1) 
using primers HHP3285 and HHP1872 with standard Taq polymerase (3’-5’ exonuclease-deficient) 
for 12 cycles under standard conditions (3.1.2) in 52 independent reactions. Next, all PCR 
reactions were pooled and purified using QIAquick Gel Extraction Kit. The rnr1 PCR products were 
co-transformed with a purified 6 kb fragment of HindIII and NotI digested pHHB561 into HHY6555 
for in vivo gap repair.  Transformants containing the gap-repaired plasmids were selected by 
growth on SD plates lacking Leu and replica plated on SD plates lacking Leu but containing 5-FOA 
to select for the loss of pHHB560 (pRS316-RNR1). 
 
3.3.25 Screening for mutator phenotypes, plasmid rescue and identification of rnr1 
mutations 
To screen for mutator phenotypes in the hom3-10 and lys2-10A frameshift reversion assay as well 
as in the CAN1 inactivation assay, the colonies obtained after plasmid shuffling (Leu+ + 5-FOAR) 
were replica-plated on SD media lacking threonine (Thr) or lysine (Lys) or lacking Arg containing 
canavanine. Cells were grown for 3 days at 30 °C. Colonies, which showed increased papillation in 
at least two mutator assays or multiple small canavanine-resistant colonies were re-tested for 
mutator phenotype. Clones that confer an increased mutator phenotype after re-testing, were 
inoculated for DNA extraction with subsequent plasmid rescue as described in (3.3.10). Plasmids 
were prepared using QIAprep Spin Miniprep Kit and transformed into competent HHY6214. After 
plasmid shuffling in SD media lacking Leu and containing 5-FOA, clones were screened for 
increased mutator phenotypes in the hom3-10 and lys2-10A frameshift reversion assay as well as 
in the CAN1 inactivation assay. Plasmids that consistently increased the mutator phenotype were 
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sequenced to identify rnr1 mutation(s). Next, yeast strains expressing rnr1 mutant alleles were 
used for mutations rate analysis as described in 3.3.15. The identified rnr1 alleles were also 
expressed in a WT-EXO1 background (HHY6551) and the obtained strains were qualitatively 
tested for mutator phenotype.  
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4 RESULTS 
4.1 A genome-wide screen reveals genes that prevent the accumulation of 
mutations. 
To identify non-essential genes that contribute to replication fidelity, a genome-wide screen in S. 
cerevisiae was performed. For this, four query strains expressing either the WT or one of the low-
fidelity DNA polymerase alleles pol1-L868M, pol2-M644G and pol3-L612M were crossed against 
the quadruplicated yeast non-essential gene deletion collection (~4800 different gene deletions) 
following a modified version of the synthetic genetic array (SGA) (TONG AND BOONE 2006)(Fig 
4.1A).  
 
 
 
 
 
 
 
Fig. 4.1 Genome-wide 
screen reveals genes 
that affect DNA 
replication fidelity in S. 
cerevisiae.  
(A) Strategy used to 
cross the nonessential 
gene deletion collections 
against DNA polymerase 
active-site mutants and 
the WT. (B) The forward 
CAN1 inactivation assay 
(+canavanine) and the 
lys2-10A frameshift 
reversion assay (lysine-) 
were used to screen for 
mutator phenotypes in 
96-well format. Cells 
were spotted on YPD, 
grown and replica plated 
on mutator plates. The 
number of colonies is 
indicative for the strength 
of the mutator phenotype. 
In the zoom-in on the 
right side, msh6Δ shows 
elevated papillation in the 
frameshift-specific 
mutator assay and the 
general CAN1 
inactivation assay, 
whereas ubc13Δ showed 
increased number of 
colonies exclusively in 
the CAN1 inactivation 
assay. Figure was 
adapted from (SCHMIDT et 
al. 2017). 
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Table 4.1 List of single gene deletions resulting in increased mutator phenotypes.  
Gene lys2-10A CAN1 WT function Reference 
CCS1  X Copper chaperone, oxidative stress response 1 
CSM2  X Component of Shu complex, error-free DNA repair 1, 2 
ELG1 X X Subunit of RFC1-like complex, DNA replication and genome 
integrity 
1, 2 
EXO1 X X 5’-3’ exonuclease and flap endonuclase, DSB repair, error-free 
PRR and MMR  
3 
MET7  X Folylpolyglutamate synthetase this study 
MLH1 X X MMR  1, 2 
MLH3 X  MMR, meiotic recombination 4 
MMS2  X Ubiquitin-conjugating enzyme, error-free PRR 1, 2 
MPH1  X DNA helicase 2 
MRE11  X Nuclease subunit of MRX complex in DSB 1, 2 
MSH2 X X MMR 1, 2 
MSH3 X X MMR 2 
MSH6 X X MMR 1, 2 
OGG1  X 8-oxoguanine DNA glycosylase, BER 1, 2 
PIF1  X DNA helicase 1 
PMS1 X X MMR 1 
PSY3  X Component of Shu complex, error-free DNA repair 1 
RAD1  X Single-stranded DNA endonuclease, NER, DSB 2 
RAD4  X NER 5 
RAD5  X DNA helicase, PRR 1, 2 
RAD10  X Single-stranded DNA endonuclease, NER, DSB 6 
RAD14  X NER 7 
RAD17  X DNA damage checkpoint 8 
RAD18  X E3 ubiquitin ligase, PRR 1, 2 
RAD27  X 5' to 3' exonuclease, 5' flap endonuclease, DNA replication and 
repair 
1, 2  
RAD50  X Subunit of MRX complex, DSB repair 1 
RAD51  X DSB repair 1 
RAD52  X DSB repair 1, 2 
RAD54  X DSB repair 1, 2 
RAD55  X DSB repair 1 
RAD57  X DSB repair 1, 2 
RNH203  X Ribonucleotide H2 subunit, ribonucleotide excision repair 1 
SHU1  X Component of Shu complex, error-free DNA repair 1, 2 
SHU2  X Component of Shu complex, error-free DNA repair 1 
TSA1  X Thioredoxin peroxidase, oxidative stress response 1, 2 
UBC13  X E2 ubiquitin-conjugating enzyme, error-free PRR 9 
UNG1  X Uracil-DNA glycosylase, BER 1, 2 
XRS2  X Subunit of MRX complex, DSB repair 1 
YAP1  X Transcription factor, oxidative stress response 1 
The following mutants including: sli15Δ, ygr050cΔ, yhl005cΔ, yml083c, ymr166cΔ, and zwf1Δ were identified as false 
positives. Abbreviations: base excision repair (BER), double-strand break (DSB), mismatch repair (MMR), nucleotide 
excision repair (NER), post-replicative repair (PRR).  References:  1 (HUANG et al. 2003); 2 (SMITH et al. 2004); 3  (TISHKOFF 
et al. 1997); 4 (FLORES-ROZAS AND KOLODNER 1998); 5 (HOWLETT AND SCHIESTL 2004); 6 (BERTRAND et al. 1998); 7 (SCOTT 
et al. 1999); 8 (COLLURA et al. 2012); 9 (BRUSKY et al. 2000). 
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The generated double mutants were subsequently screened in a “semi-high-throughput” 96-well 
format for increased mutator phenotypes in the lys2-10A frameshift reversion assay and the 
forward CAN1 inactivation assay (Fig. 4.1B). The lys2-10A assay is specific to one A:T nucleotide 
deletion events in a mononucleotide run of 10 A:T (TRAN et al. 1997). The CAN1 inactivation assay 
is a general forward mutation reporter assay (WHELAN et al. 1979) and scores for events that 
inactivate the CAN1 gene facilitating resistance to the toxic arginine analog canavanine. These 
inactivating events can be base pair substitutions and frameshift mutations, but also more complex 
genetic alterations and gross chromosomal rearrangements (GCRs). 
The active-site mutant alleles of the three major DNA polymerases used in the screen confer a mild 
mutator phenotype (NIIMI et al. 2004; PAVLOV et al. 2006; VENKATESAN et al. 2006; PURSELL et al. 
2007; NICK MCELHINNY et al. 2008) but do not interfere with Pol2/Pol3 DNA proofreading function. 
In the screen, the low-fidelity alleles serve as “sensitized backgrounds” to identify previously 
unrecognized genes that contribute to DNA replication fidelity. Furthermore, due to the postulated 
role in leading- and lagging-strand DNA replication according to the “division of labor” model, the 
comparison of the genetic mutator interactions may reveal mechanistic differences between 
leading- and lagging-strand replication and repair as previously reported for the 5’-3’ double-
stranded exonuclease Exo1 (HOMBAUER et al. 2011a; LIBERTI et al. 2013). 
In the WT polymerase background 8 single gene deletions were identified that showed an elevated 
frameshift mutator phenotype in the lys2-10A reporter assay (Table 4.1). All of them have been 
previously reported (FLORES-ROZAS AND KOLODNER 1998; TISHKOFF et al. 1998; HUANG et al. 2003; 
SMITH et al. 2004) and most of them are well-characterized MMR components (REYES et al. 2015). 
Given that the screen identified not only mutations resulting in strong (mlh1Δ, pms1Δ and msh2Δ) 
but also in weak mutator phenotypes (elg1Δ, and mlh3Δ), it is unlikely that additional non-essential 
single deletion mutants may cause an increased frameshift mutator phenotype.  
Analysis of the CAN1 reporter assay plates revealed 38 single gene deletions that resulted in 
increased CAN1 inactivation in the presence of WT DNA polymerases. Most of them have been 
previously identified in two genome-wide screens (HUANG et al. 2003; SMITH et al. 2004) and have 
known roles in DNA replication and DNA repair (Table 4.1). Interestingly, one gene deletion met7Δ 
has not been previously linked to an increased CAN1 mutator phenotype. Therefore, the role of 
Met7 in mutation avoidance and genome stability was further investigated. A detailed analysis is 
described in section 4.2. 
Analysis of the qualitative mutator phenotypes in the presence of low-fidelity DNA polymerase 
alleles revealed a group of genes (EXO1, GLN3, RRM3, SHM2 and URA7) that showed synergistic 
mutator interactions with at least two of the low-fidelity DNA polymerase alleles in the CAN1 
reporter assay (three representative examples of the screening plates are shown in Fig. 4.2). 
However, besides the previously reported synergistic interaction between low-fidelity DNA 
polymerase alleles and exo1Δ (HOMBAUER et al. 2011a; LIBERTI et al. 2013), no additional gene 
mutation caused an elevated frameshift mutator phenotype in the presence of the low-fidelity DNA 
polymerase alleles, arguing again for no additional, unrecognized single-gene deletion that 
increases frameshift mutations in the subset of the non-essential yeast genes (Fig. 4.2). 
Interestingly, none of the identified gene deletions, except exo1Δ, caused an increased mutator 
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phenotype in the presence of WT DNA polymerases. Moreover, these identified genes have not 
been previously linked to the suppression of mutations. Thus, this group of genes was further 
examined in respect to their role in replication fidelity and the results are described in section 4.3. 
 
 
Fig. 4.2 Representative images of mutator plates (zoom-in) illustrating the synergistic mutator 
interactions in some S. cerevisiae double mutants. 
Inactivation of EXO1, GLN3 or SHM2 in combination with the lagging-strand DNA polymerase active-site 
mutants (pol1-L868M and pol3-L612M) results in a strong increase in the number of colonies on CAN1 
mutator assay plates (+canavanine), whereas increased papillation on the frameshift reporter plates (-lysine) 
was exclusively observed in exo1Δ double mutants. Figure was adapted from (SCHMIDT et al. 2017). 
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4.2 The folylpolyglutamate synthetase Met7 prevents uracil accumulation and 
genome instability. 
4.2.1 Met7 prevents the accumulation of mutations and GCRs. 
The genome-wide screen identified MET7 as the only previously unrecognized gene that prevents 
the accumulation of mutations. MET7 encodes for the cytoplasmic and mitochondrial 
folylpolyglutamate synthetase (FPGS) in S. cerevisiae (DESOUZA et al. 2000). FPGS catalyzes the 
ATP-dependent addition of a glutamate to the terminal glutamate of folates (Fig. 1.8A). 
Polyglutamylated folate show increases cellular retention and higher affinity to their metabolizing 
enzymes (SCHIRCH AND STRONG 1989). In S. cerevisiae, inactivation of MET7 has been shown to 
result in mitochondrial dysfunction (petite phenotype) (CHEREST et al. 2000; MERZ AND 
WESTERMANN 2009), methionine auxotrophy (MASSELOT AND DE ROBICHON-SZULMAJSTER 1975), 
short telomeres (ASKREE et al. 2004; GATBONTON et al. 2006), a non-homologous end-joining defect 
and dNTP imbalance (RUBINSTEIN et al. 2014). However, inactivation of MET7 has not been linked 
to increased mutator phenotypes. Thus, to validate the initial qualitative met7Δ mutator phenotype 
identified in the genome-wide screen, MET7 was inactivated in a WT strain and the CAN1 mutation 
rate was measured. Indeed, loss of Met7 resulted in a 9-fold increase in the CAN1 inactivation 
assay over the WT (Table 4.2). As the CAN1 gene can be inactivated not only by base 
substitutions and frameshifts, but also by GCRs, Met7’s role in the suppression of GCRs was 
investigated using two different GCR assays. These GCR reporters score for the simultaneous 
deletion of a CAN1-URA3 cassette integrated at two different locations in the left arm of 
chromosome V (PUTNAM AND KOLODNER 2017). Inactivation of MET7 caused a 38- and 177-fold 
increase over WT in the standard (CHEN AND KOLODNER 1999) and post-duplication GCR assay 
(PUTNAM et al. 2009), respectively (Table 4.2). Thus, Met7 not only suppresses the accumulation of 
mutations, but is also required to prevent GCRs. 
 
Table 4.2 met7Δ results in accumulation of mutations and gross chromosomal rearrangements 
(GCRs). 
Relevant genotype Mutation Rate CanR  
(fold increase)a 
Standard GCR  
(fold increase)b 
Post-duplication GCR  
(fold increase)b 
WT 7.2 [5.7-9.0] x 10-8 (1) 5.1 [0.0-38.0] x 10-11 (1) 5.6 [3.7-8.3] x 10-8 (1) 
met7Δ 6.4 [4.2-8.8] x 10-7 (9) 2.0 [1.0-3.6] x 10-9 (38) 9.9 [7.4-13.7] x 10-6 (177) 
pGPD-DUT1 met7Δ  2.9 [1.9-5.5] x 10-7 (4) not determined 4.6 [3.6-7.4] x 10-7 (8) 
ung1Δ met7Δ not determined not determined 2.6 [2.0-3.5] x 10-6 (46) 
pGPD-met7Δm not determined not determined 6.3 [4.5-8.1] x 10-8 (1) 
dut1-1 1.3 [1.0-2.5] x 10-7 (2) not determined 1.2 [0.4-1.6] x 10-7 (2) 
rev3Δ met7Δ 3.0 [2.5-3.7] x 10-7 (4) not determined not determined 
a Median rates of inactivation of CAN1 gene (CanR) with 95% confidence interval in square brackets and fold increase 
relative to the WT in parentheses.  
b Median rates of accumulating CanR 5-FOAR progeny in standard and post-duplication GCR with 95% confidence interval in 
square brackets and fold increase relative to the WT in parentheses. 
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4.2.2 Loss of MET7 activates the DNA damage response. 
In the absence of Met7, cells confer a slow growth phenotype (DESOUZA et al. 2000; KOREN et al. 
2010). To investigate, whether met7Δ cells also showed an activated DNA damage response 
(DDR), whole cell lysates of WT and met7Δ cells were analyzed by Western blotting. In the 
absence of Met7, the checkpoint kinase Rad53 showed slower electrophoretic mobility, 
characteristic of Rad53 phosphorylation, and thus the activation of the DDR. Moreover, strong 
induction of the DNA damage inducible alternative large RNR subunit Rnr3 was detected (Fig. 
4.3A). Furthermore, DNA content analysis of logarithmically growing WT and met7Δ cells by flow 
cytometry revealed that cells in the absence of Met7 showed an altered cell cycle profile with cells 
accumulating in S phase (Fig. 4.3B)(KOREN et al. 2010).  
 
 
 
 
 
 
 
 
 
 
 
These observations open up the possibility that Met7 function might be primarily required during S 
phase and that Met7 expression levels may be potentially regulated across the cell cycle. To test 
whether Met7 expression levels are changing during the cell cycle, the MET7 gene was C-terminal 
tagged with 3xMyc tag to follow Met7 protein levels throughout the cell cycle by Western blotting. 
The results indicate that Met7 expression levels were stable throughout the cell cycle (Fig 4.4).  
 
Fig. 4.4 Met7 is present throughout the cell 
cycle. 
Cells expressing C-terminal tagged Met7-3Myc 
from the endogenous chromosomal locus were 
arrested in G1 with α-factor and released in YPD 
containing nocodazole. Samples were taken every 
10 min for whole cell lysates and DNA content 
profiles. Samples were analyzed by SDS-PAGE 
and immunoblotting against Myc for Met7-3xMyc, 
Sic1 as G1 marker, Clb2 as G2 marker and Pgk1 
as loading control. 
 
In summary, inactivation of MET7 results in DNA damage checkpoint activation and accumulation 
of cells in S phase. However, Met7 expression levels were not increased in S phase and relatively 
stable throughout the cell cycle. 
4.2.3 Inactivation of MET7 results in a dNTP imbalance and dUTP accumulation. 
The slow growth phenotype of met7Δ strains (CHEREST et al. 2000; DESOUZA et al. 2000; MERZ AND 
WESTERMANN 2009) and the accumulation of cells in S phase in the absence of Met7 (Fig. 
Fig. 4.3 Inactivation of MET7 causes activation 
of the DNA damage checkpoint. 
(A) Whole cell lysates of logarithmically growing 
WT and met7Δ were analyzed by SDS-PAGE and 
immunoblotting against Rad53, Rnr3 and tubulin. 
As positive control for the activation of the DNA 
damage response, WT cells treated for 3 h with 
200 mM hydroxyurea (HU) were used. (B) DNA 
content profiles of logarithmically grown WT and 
met7Δ cells 
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4.3B)(KOREN et al. 2010) suggested that Met7 supports metabolic reactions important for S phase 
progression. A previous study described a cytoplasmic met7ΔM allele that lacks the N-terminal 
mitochondrial leader sequence, which when overexpressed suppressed the petite phenotype 
described for met7Δ strains (DESOUZA et al. 2000). To test in which compartment Met7 is required 
to suppress DDR activation and GCRs, the cytoplasmic met7ΔM allele was expressed under the 
control of a strong constitutive GPD promoter. This neither resulted in an increased post-
duplication GCR rate (Table 4.2), nor in accumulation of cells in S phase or DNA damage 
checkpoint activation (Fig. 4.7A,B). These findings suggested that the cytoplasmic FPGS activity 
and presumably cytoplasmic folate pools are sufficient to prevent the slow growth phenotype and 
potentially the mutator phenotype in the absence of Met7. As cytoplasmic folate pools are required 
for nucleotide biosynthesis and dNTPs are essential for DNA replication during S phase, NTP and 
dNTP concentrations were determined in logarithmically growing WT and met7Δ mutant strains 
(collaboration with Chabes lab, Umeå University). 
  
Table 4.3 NTP and dNTP concentrations of met7Δ mutants. 
A 
Relevant genotype CTP UTP ATP GTP 
WT 2374 ± 16 (1.0) 5605 ± 32 (1.0) 11339 ± 48 (1.0) 3987 ± 67 (1.0) 
met7Δ 2206 ± 5 (0.9) 4109 ± 60 (0.7) 13697 ± 153 (1.2) 4514 ± 3 (1.1) 
met7Δ pGPD-DUT1 2242 ± 9 (0.9) 3915 ± 13 (0.7) 13676 ± 57 (1.2) 4601 ± 15 (1.2) 
B 
Relevant genotype dCTP dTTP dATP dGTP dUTP 
WT –hDUT1 114 ± 4 (1.0) 203 ± 6 (1.0) 125 ± 4 (1.0) 82 ± 4 (1.0) not detectable 
WT + hDUT1 104 ± 1 (0.9) 203 ± 7 (1.0) 123 ± 4 (1.0) 81 ± 1 (1.0) not detectable 
met7Δ - hDUT1 302 ± 7 (2.7) 125 ± 5 (0.6) 497 ± 1 (4.0) 49 ± 4 (0.6) 9 ± 2 
met7Δ + hDUT1 282 ± 3 (2.5) 125 ± 6 (0.6) 490 ± 9 (3.9) 49 ± 6 (0.6) not detectable 
met7Δ pGPD-DUT1 - hDUT1 314 ± 1 (2.8) 95 ± 2 (0.5) 463 ± 1 (3.7) 38 ± 2 (0.5) not detectable 
met7Δ pGPD-DUT1 + hDUT1 284 ± 1 (2.5) 95 ± 1 (0.5) 444 ± 5 (3.6) 40 ± 2 (0.5) not detectable 
NTP (A) and dNTP (B) concentrations (pmol per 108 cells) are the average of two biological replicates ± standard deviation 
with the fold increase over WT in parentheses. Extracts of + hDUT1 samples were treated for 1 h at 37 °C with 1ng/μL 
recombinant human DUT1 prior the measurement. NTP and dNTP concentrations were measured in collaboration with 
Chabes lab. 
 
In the absence of Met7, NTP purine pools were mildly increased (up to 20%) and NTP pyrimidine 
pools decreased (up to 30%) (Table 4.3A). dNTP concentration measurements revealed that 
inactivation of MET7 caused 2.7-fold increased dCTP and 4-fold increased dATP pools and 40% 
decreased dTTP and dGTP pools, relative to WT levels (Fig. 4.5A, Table 4.3B). The dNTP pool 
measurements were similar to previously dNTP concentrations in met7Δ cells (RUBINSTEIN et al. 
2014). Interestingly, the dNTP pools measured in the absence of Met7 were similar to dNTP pools 
measured in mammalian cells upon antifolate treatment (TATTERSALL AND HARRAP 1973; RITTER et 
al. 1980; YOSHIOKA et al. 1987). Antifolates inhibit folate-dependent metabolic reactions (VAN 
TRIEST et al. 2000; VISENTIN et al. 2012) suggesting that the dNTP pool alterations measured in 
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met7Δ are presumably a consequence of folate depletion due to the absence of Met7. As 
mammalian cells treated with antifolates show not only dNTP imbalance but also dUTP 
accumulation (VAN TRIEST et al. 2000), the consequences of MET7 inactivation on dUTP pools was 
investigated. dUTP pool accumulation is normally efficiently counteracted by the dUTPase Dut1, 
which dephosphorylates dUTP to dUMP (GADSDEN et al. 1993). Consequently, dUTP 
concentrations in WT cycling cells are extremely low. However, analysis of cell extracts obtained 
from met7Δ strains revealed 9 ± 2 pmol dUTP per 108 cells were measured, whereas dUTP 
concentrations in WT was below the detection limit (Fig. 4.5 A, Table 4.3 B). 
 
 
Fig. 4.5 Loss of Met7 results in a dNTP imbalance, accumulation of dUTP and increased uracil 
incorporation. 
(A) dNTP concentration measurement in the indicated strains (Table 4.3B). Error bars represent standard 
deviation (SD). The fold over WT is indicated above each bar and color-coded green or red for increased and 
decreased fold over WT, respectively. Extracts were treated ± recombinant human dUTPase hDUT1 prior to 
the measurement. (B) Total dTTP and dUTP pools in met7Δ. (C) Uracil accumulation assay. Genomic DNA of 
logarithmically growing WT, met7Δ, met7Δ pGPD-DUT1 and dut1-1 cells were treated ± recombinant E. coli 
UDG and human Ape1 and analyzed by agarose gel electrophoresis. Presence of uracil in DNA results in 
fragmentation of the genomic DNA and appears as a smear of lower molecular weight fragments. To enrich 
for genomic uracil the experiment was performed in an ung1Δ background. 
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To verify that the measured dUTP concentration in met7Δ cells was truly dUTP, cellular extracts 
were treated or not with recombinant human DUT1 (hDUT1) prior to the dNTP measurement. 
Strikingly, dUTP was no longer detectable in the hDUT1 treated met7Δ sample, whereas no major 
changes were observed in the other dNTP pools (Fig. 4.5A, Table 4.3B). Likewise, met7Δ cells 
overexpressing the DUT1 gene (pGPD-DUT1) presented undetectable levels of dUTP and 
otherwise identical dNTP concentrations as measured in the met7Δ strain (Fig. 4.5A, Table 4.3B). 
As DNA polymerases cannot discriminate between dTTP and dUTP, the balance between dTTP 
and dUTP directly determines which dNTP will be incorporated during DNA synthesis (SHLOMAI AND 
KORNBERG 1978; WARNER et al. 1981; TINKELENBERG et al. 2002). According to the dNTP 
concentration measurements in met7 cells, dUTP contributes to 7% of the total dTTP and dUTP 
pool (Fig. 4.5B). Previous studies have shown that the alterations in the dUTP/dTTP balance (e.g. 
caused by antifolate treatment) can lead to increased dUTP incorporation into genomic DNA 
(SHLOMAI AND KORNBERG 1978; WARNER et al. 1981; TINKELENBERG et al. 2002). These 
observations and the altered dUTP/dTTP balance detected met7Δ strains suggest that met7Δ cells 
may incorporate dUTP into genomic DNA. 
To test this idea, uracil accumulation in genomic DNA of WT, met7Δ, met7Δ pGPD-DUT1 and 
dut1-1 cells was analyzed. As uracil is efficiently removed from DNA by the BER system (BOITEUX 
AND JINKS-ROBERTSON 2013), the analysis was performed in an uracil deglycosylase-deficient 
background (ung1Δ) (SEIPLE et al. 2006). Genomic DNA of logarithmically growing cells was 
purified, treated (or not) with recombinant E. coli uracil-DNA glycosylase (UDG) and human 
apurinic/apyrimidinic (AP) endonuclease 1 (hAPE 1) and separated by agarose gel electrophoresis. 
Incorporated uracil results in fragmentation of genomic DNA and appears as smear of lower 
molecular weight fragments. In line with low dUTP concentrations (Fig. 4.5A, Table 4.3B), no 
fragmentation was observed in genomic DNA isolated from WT cells. However, in the absence of 
Met7, genomic DNA was strongly fragmented and fragments up to sizes below 250 nt were 
observed (Fig. 4.5C). In agreement with the dUTP measurements (Fig. 4.5A, Table 4.3B), 
overexpression of DUT1 in met7Δ cells strongly suppressed DNA fragmentation. The previously 
reported dut1-1 allele, which confers reduced dUTPase activity and causes increased genomic 
uracil accumulation (GUILLET et al. 2006) was included in the experiment as positive control and 
showed in line with the previous report massive fragmentation of the genomic DNA (Fig. 4.5C). 
Thus, loss of Met7 induces a dNTP imbalance, dUTP accumulation and increased uracil 
incorporation during DNA replication. 
4.2.4 The met7Δ GCR phenotype is driven by dUTP accumulation and processing of 
genomic uracil. 
In order to test whether met7Δ’s GCR phenotype is driven by dUTP accumulation, GCR rate was 
measured in met7Δ pGPD-DUT1 cells, in which neither elevated dUTP pools (Fig. 4.5A, Table 
4.3B) nor accumulation of genomic uracil species (Fig. 4.5C) could be detected. Strikingly, the 
GCR rate was suppressed from 177- to 8-fold over WT in met7Δ cells that overexpressed DUT1 
(Table 4.2) arguing that the GCRs generated in the absence of Met7 were largely consequence of 
the increased dUTP levels. 
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As previously mentioned, genomic uracil is recognized and repaired by BER (BOITEUX AND JINKS-
ROBERTSON 2013). The uracil glycosylase Ung1 removes the uracil base and creates an abasic 
site. AP endonucleases introduce a single-strand DNA break at the abasic site followed by either 
short or long patch repair. Therefore, a high amount of incorporated uracil may not only result in 
transient single-strand breaks but also DSBs, that can eventually result in GCRs. Consequently, 
inhibiting repair of genomic uracil by inactivation of UNG1 should counteract met7Δ’s GCR 
phenotype. Indeed, inactivation of UNG1 in the absence of Met7 partially suppressed the post-
duplication GCR rate by almost 75% (Table 4.2). This indicates that the processing of genomic 
uracil in the presence of an increased dUTP/dTTP ratio results in futile-repair cycles that may lead 
to GCRs. Therefore, the increased GCRs observed in the absence of Met7 are a consequence of 
dUTP pool accumulation followed by futile-repair cycles.  
4.2.5 Increased mutations in the absence of Met7 are a consequence of a dNTP pool 
imbalance and dUTP accumulation.  
Inactivation of MET7 not only resulted in elevated GCRs, but also in an increased CAN1 
inactivation rate (Table 4.2). Abasic sites, as for example produced by the repair of genomic uracil, 
lead to stalled replication forks and recruitment of specialized translesion synthesis (TLS) DNA 
polymerases, such as Polζ (Rev3) (MCCULLOCH AND KUNKEL 2008; LANGE et al. 2011). These TLS 
DNA polymerases are error-prone and may therefore contribute to the mutator phenotype observed 
in met7Δ. In line with this assumption, the CAN1 mutation rate was approximately 50% reduced in 
the met7Δ rev3Δ double mutant in comparison to met7Δ (Table 4.2).  
 
Table 4.4 CAN1 mutation spectrum of met7Δ. 
 Insertion / deletion  Base change  Complex 
Relevant 
genotype 
 
Mutation Occurrence  Mutation Occurrence  Occurrence 
         
WT ΔA A6 → A5 1 (1)  A-T → G-C 6 (7)  8 (9) 
 ΔT T6 → T5 2 (2)  G-C → A-T 18 (20)   
  T2 → T1 2 (2)  G-C → T-A 29 (32)   
 ΔC C2 → C1 1 (1)  A-T → C-G 3 (3)   
  C1 → C0 2 (2)  A-T → T-A 7 (8)   
 +T T6 → T7 3 (3)  C-G → G-C 6 (7)   
  T2 → T3 3 (3)      
 +G G2 → G3 1 (1)      
   15 (16)   69 (75)  8 (9) 
         
met7Δ ΔA A3 → A2 1 (1)  A-T → G-C 5 (3)  19 (10) 
 ΔT T6 → T5 4 (2)  G-C → A-T 54 (29)   
  T4 → T3 4 (2)  G-C → T-A 40 (22)   
  T3 → T2 2 (1)  A-T → C-G 11 (6)   
  T1 → T0 3 (2)  A-T → T-A 14 (8)   
 ΔG G4 → G3 2 (1)  C-G → G-C 19 (10)   
  G2 → G1 2 (1)      
  G1 → G0 1 (1)      
 ΔC  C3 →C2 2 (1)      
  C2 → C1 1 (1)      
 +T T6 → T7 1 (1)      
   23 (12)   143 (77)  19 (10) 
The CAN1 mutation spectra based on DNA sequencing of individual CanR mutants, shown as the number of clones 
containing the indicated mutations, and in parenthesis as the percentage relative to the total (Fig. S7.1 and Fig. S7.2). 
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Moreover, overexpression of DUT1 in met7Δ suppressed the CAN1 inactivation rate to a similar 
degree as the met7Δ rev3Δ double mutant (Table 4.2). Both results together support the idea that 
dUTP accumulation also contributes to the generation of CAN1 inactivation events. 
To further characterize the type of events that lead to CAN1 inactivation, CAN1 mutation spectra 
analysis were performed in WT and met7Δ strains (Table 4.4). Interestingly, the met7Δ CAN1 
mutation spectrum was not significantly different to the WT CAN1 spectrum (Fisher’s exact test, p 
value 0.2275) and no mutational hotspots could be identified. However, increased amount of G-C 
to A-T mutations and decreased G-C to T-A mutations in the met7Δ CAN1 mutation spectrum were 
in line with elevated dATP and dCTP pools and reduced dTTP and dGTP pools (Table 4.3B). 
Hence, in addition to dUTP accumulation, the general dNTP imbalance seems to contribute to the 
CAN1 inactivation.   
4.2.6 A DSB repair defect is required for dUTP-driven GCRs.  
Both, inactivation of MET7 and reduced dUTPase activity (dut1-1) (GUILLET et al. 2006) caused 
increase uracil incorporation during DNA replication (Fig. 4.5C). Surprisingly, in contrast to met7Δ 
cells, dut1-1 expressing cells showed neither an increased CAN1 inactivation rate nor an elevated 
post-duplication GCR rate (Table 4.2) suggesting that uracil incorporation alone is not sufficient to 
cause increased mutations and elevated GCR rates. To search for potential differences that may 
explain the apparent discrepancy between met7Δ and dut1-1 phenotypes, dNTP concentrations 
were measured. Interestingly, dut1-1 expressing cells had slightly elevated, but balanced dNTP 
pools (Fig. 4.6A). Unexpectedly, dUTP was not detectable in dut1-1 samples using the same 
methodology as in Fig. 4.5A (data not shown) presumably due to insufficient sensitivity of the 
method. Furthermore, RNR subunits were not induced in dut1-1 (Fig. 4.6B) and no accumulation of 
cells in S phase was observed (Fig. 4.6C). This is in agreement with the absence of dNTP pool 
limitations observed in the dut1-1 strain. 
The difference between met7Δ and dut1-1 cells could arise from an overall milder and more 
specific defect in the dut1-1 mutant (Fig. 1.6). As dNTP pools in met7Δ cells are severely 
imbalanced and dTTP and dGTP levels are below WT (Fig. 4.6A), met7Δ cells might be unable to 
sufficiently increase dNTP pools for DNA repair. Moreover, the low dTTP levels in the absence of 
Met7 contribute presumably to an increased dUTP/dTTP ratio. In order to test whether the 
combination of dUTP accumulation and low dTTP and dGTP levels is required to cause a dUTP-
driven GCR phenotype, DCD1 was inactivated in dut1-1 cells. DCD1 is the dCMP deaminase in 
budding yeast, which converts dCMP to dUMP, which is further metabolized to dTTP (Fig. 
1.6)(MCINTOSH AND HAYNES 1984). Previous work in fission yeast suggested that Dcd1 contributes 
to 75% of the produced dTTP, as dcd1Δ cells showed decreased dTTP levels and strongly 
increased dCTP levels (SANCHEZ et al. 2012). Hence, inactivation of DCD1 in dut1-1 expressing 
cells presumably further increases the dUTP/dTTP ratio. In a qualitative post-duplication GCR 
mutator assay the dcd1Δ dut1-1 double mutant showed increased papillation (indicative for an 
elevated GCR phenotype) in comparison to WT and dut1-1 cells, however less than met7Δ cells 
(Fig. 4.6D). Interestingly, dcd1Δ dut1-1 cells did not induce RNR subunits (Fig 4.6B) suggesting 
that even in the presence of both mutations, there is no substantial reduction in dNTP pools to 
trigger activation of the DDR. Moreover, DNA content analysis of logarithmically growing dcd1Δ 
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dut1-1 cells revealed no accumulation of cells in S phase, but a strongly increased population of 
cells in G1 (Fig. 4.6C) arguing for a problem in the G1-S transition.  
 
 
Fig. 4.6 Strains expressing the dUTPase mutant dut1-1 depend on Dcd1 to prevent genome instability. 
(A) dNTP concentration measurement in the indicated strains represented as fold over WT. Fold increases are 
colored in green, whereas decreased levels are labeled red. (B) Whole cell lysates of logarithmically growing 
indicated strains were analyzed by SDS-PAGE and immunoblotting against Rnr1-4 and tubulin. WT cells 
treated for 3 h with 200 mM HU were used as positive control for the activation of the DNA damage response. 
(C) DNA content profiles of logarithmically growing strains of the indicated genotypes. (D) Patch test of the 
indicated strains. Increased papillation is indicative of an increased GCR phenotype. (E) Spotting assay of the 
indicated strains in 10-fold serial dilutions on YPD ± the DNA double-strand break inducing agent phleomycin 
and on YPG to test for mitochondrial dysfunction (petite). 
 
As met7Δ and dcd1Δ dut1-1 mutant strains both showed an increased GCR phenotype and DSB 
are required for GCR formation, the GCR phenotype might be linked to a DSB repair defect in both 
backgrounds. To test this, the sensitivity of met7Δ and dut1-1 dcd1 cells to the DSB-inducing 
agent phleomycin was investigated. In line, with the previously reported NHEJ defect of met7Δ 
cells (RUBINSTEIN et al. 2014), the absence of Met7 caused extreme sensitivity to phleomycin. 
While dut1-1 and dcd1Δ cells showed no sensitivity to phleomycin, dcd1Δ dut1-1 double mutant 
cells were sensitive to phleomycin, similar to met7Δ cells (Fig. 4.6E). Furthermore, as met7Δ cells, 
dcd1Δ dut1-1 cells conferred a slow growth phenotype and dysfunctional mitochondria (Fig 4.6E). 
RESULTS 
71 
 
Thus, the dcd1Δ dut1-1 double mutant partially recapitulates met7Δ phenotypes, suggesting that a 
combination of dUTP accumulation and DSB repair defect is required to cause uracil-driven GCRs. 
The DSB repair defect might result from dNTP pool alterations and/or defects associated to the 
petite phenotype. 
4.2.7 dUTP accumulation in met7Δ is not responsible for the DNA damage checkpoint 
activation, phleomycin sensitivity and short telomeres. 
Inactivation of MET7 causes pleiotropic effects including slow growth, DNA damage checkpoint 
activation, DSB repair defects and short telomeres, among others. In order to investigate the role of 
uracil accumulation in these phenotypes, the consequence of either overexpressing DUT1 or 
inactivating UNG1 in met7Δ cells were examined.  
First, the impact of dUTP accumulation on DDR activation and growth in the absence of Met7 was 
investigated. Neither the met7Δ double mutant overexpressing DUT1 nor the met7Δ double mutant 
deficient in UNG1 could rescue the altered cell cycle distribution of logarithmically growing met7Δ 
cells (Fig. 4.6A). Moreover, met7Δ single and double mutants both activate the DNA damage 
checkpoint according to the increased Rad53 phosphorylation and Rnr3 induction (Fig. 4.6B). 
Furthermore, all three met7Δ strains showed a slow growth phenotype. Even though pGPD-DUT1 
met7Δ cells grew slightly better than met7Δ, the met7Δ ung1Δ strain grew worse than met7Δ (Fig. 
4.6C). Thus, the altered cell cycle, the slow growth phenotype and DNA damage checkpoint 
activation in met7Δ strains is not driven by dUTP accumulation or futile-repair attempts to remove 
uracil from DNA. 
Second, the effect of dUTP accumulation on phleomycin sensitivity was examined. In the absence 
of Met7, cells confer a NHEJ defect (RUBINSTEIN et al. 2014) and were sensitive to the DSB-
inducing agent phleomycin (Fig. 4.6). The DSB repair defect in met7 cells could originate from an 
inability to increase dNTP pools to sufficient levels to support DSB repair (CHABES et al. 2003). 
Alternatively, inefficient DSB repair could result from the saturation of the DSB repair machinery. 
One possible explanation for this might be the combination of frequent misincorporation and 
removal of uracil together with DSBs induced by phleomycin treatment. To investigate whether the 
phleomycin sensitivity in met7Δ is due to saturation of the DSB repair machinery, met7Δ cells with 
inactivated UNG1 or overexpressing DUT1 were tested for phleomycin sensitivity. Both double 
mutants were as sensitive to phleomycin as the met7Δ single mutant (Fig. 4.6C). Therefore, the 
DSB repair defect of met7Δ cells is not caused by uracil accumulation in DNA. This indicates that 
the DSB repair defect of met7Δ cells might be linked to the petite phenotype and/or be a 
consequence of the inability to increase dNTP pools in the absence of Met7 to sufficient levels to 
facilitate DSB repair. 
Third, the contribution of genomic uracil to the short telomere phenotype (ASKREE et al. 2004; 
GATBONTON et al. 2006; RUBINSTEIN et al. 2014) of cells lacking Met7 was tested. As budding yeast 
telomeres consist of 5’-C1-3A/TG1-3-3’ repeats (WELLINGER AND ZAKIAN 2012) the accumulation of 
dUTP and an increased dUTP/dTTP ratio should also facilitate uracil incorporation into telomeric 
DNA. Futile-repair cycles of genomic uracil at telomeric regions may cause DSBs at telomeric  
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Fig. 4.7 DNA damage checkpoint activation, phleomycin sensitivity and short telomere phenotype in 
the absence of Met7 is not driven by dUTP accumulation. 
(A) DNA content profiles of logarithmically growing strains of the indicated genotypes. (B) Whole cell lysates of 
logarithmically growing indicated strains were analyzed by SDS-PAGE and immunoblotting against Rad53, 
Rnr3 and tubulin. As positive control for the activation of the DNA damage response, WT cells treated for 3 h 
with 200 mM HU were used. (C) Spotting assay of the indicated strains in 10-fold serial dilutions on YPD ± 
phleomycin. (D) Telomere-specific Southern blot for the indicated genotypes (collaboration Luke lab). 
 
regions leading to telomere shortening. To test the contribution of dUTP accumulation and 
processing of genomic uracil to the short telomere length phenotype observed in met7Δ, telomere 
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length was compared in WT, met7Δ, pGPD-DUT1 met7Δ and ung1Δ met7Δ (Fig. 
4.6D)(collaboration with B. Luke lab, IMB). The met7Δ single and double mutants had shorter 
telomeres compared to the WT. However, no difference in telomere length was observed between 
the met7Δ single and double mutants. Thus, the short telomere phenotype in the absence of Met7 
is not driven by uracil accumulation. 
Taken together, these results indicate that neither the DDR activation, the slow growth phenotype, 
the phleomycin sensitivity nor the short telomere length observed in the absence of Met7 were 
triggered by dUTP accumulation and processing of genomic uracil.  
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4.3 Alterations in cellular metabolism triggered by URA7 or GLN3 inactivation 
cause imbalanced dNTP pools and increased mutagenesis.  
4.3.1 Genome-wide screen reveals genes that are critically important if DNA polymerase 
fidelity is impaired. 
The low-fidelity active-site mutant DNA polymerase alleles pol1-L868M, pol2-M644G and pol3-
L612M were used as “sensitized mutator background” in the genome-wide screen to identify 
previously unrecognized genes that contribute to replication fidelity. A group of genes was identifed 
whose deletion caused an enhanced CAN1 mutator phenotype in the presence of the low-fidelity 
polymerase alleles (Fig. 4.2 and Table 4.5). 
 
Table 4.5 Mutation rate analysis of the mutants identified in this screen in combination with DNA 
polymerase active-site mutant alleles. 
  
Mutation Rate (fold increase)* CanR 
Relevant 
genotype 
WT pol1-L868M pol2-M644G pol3-L612M 
WT 7.2 [5.7-9.0] x 10-8 (1) 3.9 [3.3-4.9] x 10-7 (5) 8.4 [7.3-10.6] x 10-7 (12) 9.3 [7.7-11.6] x 10-7 (13) 
exo1Δ 7.4 [6.3-9.8] x 10-7(10) 5.7 [3.1-8.1] x 10-6 (80) 1.9 [1.1-2.9] x 10-6 (26) 6.5 [3.6-10.8] x 10-6 (91) 
gln3Δ 1.0 [0.8-1.2] x 10-7 (1) 2.1 [1.4-4.5] x 10-5 (293) 3.3 [2.6-6.0] x 10-7 (5) 9.1 [7.3-18.2] x 10-6 (127) 
shm2Δ 1.2 [1.1-1.7] x 10-7 (2) 1.7 [1.0-2.0] x 10-6 (23) 5.5 [3.9-7.3] x 10-7 (8) 3.6 [2.1-4.7] x 10-6 (50) 
ura7Δ 1.0 [0.9-1.5] x 10-7 (1) 2.3 [1.3-4.1] x 10-5 (323) 1.1 [0.7-1.5] x 10-6 (15) 1.6 [1.1-2.6] x 10-5 (218) 
rrm3Δ 1.1 [0.8-1.5] x 10-7 (2) 3.5 [2.1-4.4] x 10-7 (5) 2.8 [1.9-4.8] x 10-6 (40) 3.6 [2.6-6.0] x 10-6 (50) 
* Median rates of inactivation of CAN1 gene (CanR) with 95% confidence interval in square brackets and fold increase 
relative to the WT in parentheses. Table was adapted from (Schmidt et al. 2017). 
 
This group includes the double-stranded DNA exonuclease EXO1 (TISHKOFF et al. 1997), the DNA 
helicase RRM3 (IVESSA et al. 2000) and the three metabolic genes GLN3 (COURCHESNE AND 
MAGASANIK 1988), SHM2 (MCNEIL et al. 1994) and URA7 (OZIER-KALOGEROPOULOS et al. 1991). 
The transcription factor Gln3 controls nitrogen metabolism and is negatively regulated by target of 
rapamycin (TOR) (BECK AND HALL 1999; CRESPO et al. 2002). SHM2 encodes for the cytoplasmic 
serine hydroxymethyltransferase and is part of the folate one-carbon metabolism (Fig. 1.8)(MCNEIL 
et al. 1994), whereas Ura7 is the major CTP synthetase in S. cerevisiae converting UTP into CTP 
under the consumption of ATP and glutamine (OZIER-KALOGEROPOULOS et al. 1991; OZIER-
KALOGEROPOULOS et al. 1994)(Fig. 1.6). Remarkably, with the exception of EXO1, which is a mild 
mutator by its own (TISHKOFF et al. 1997), inactivation of all other identified genes did not result in a 
mutator phenotype in the presence of WT DNA polymerases (Table 4.5), suggesting that the 
potential defects might be buffered by WT DNA polymerases. However, in the presence of low-
fidelity DNA polymerases, strong synergistic increases in the CAN1 mutation rates were measured. 
The strongest mutator interactions were observed in the absence of Gln3 or Ura7 in combination 
with pol1-L868M and pol3-L612M (Table 4.5). For example, the pol1-L868M ura7 double mutant 
showed a 323-fold and 65-fold increased CAN1 mutation rate over the WT and the pol1-L868M 
single mutant, respectively. Interestingly, loss of Exo1, Gln3, Shm2 or Ura7 caused strong 
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synergistic increases in the CAN1 inactivation rate in combination with the lagging-strand DNA 
polymerase alleles pol1-L868M and pol3-L612M, but not with the leadings-strand allele pol2-
M644G (Table 4.5). In contrast, inactivation of RRM3 caused increased mutagenesis exclusively in 
combination with pol2-M644G and pol3-L612M, but not with pol1-L868M (Table 4.5).  
To test, whether error-prone TLS DNA polymerases (Polζ, Pol, Rev1) (MCCULLOCH AND KUNKEL 
2008; LANGE et al. 2011) contribute to the synergistic mutator interactions measured in gln3 and 
ura7 pol3-L612M double mutants, CAN1 mutation rates in the absence of Polζ (rev3), Pol 
(rad30) and Rev1 (rev1) were determined (Table 4.6). CAN1 inactivation rate measured in the 
triple mutants in comparison to the gln3 or ura7 pol3-L612M double mutants were not reduced. 
Thus, the synergistic mutator interactions between gln3 and ura7 and the low-fidelity lagging-
strand DNA polymerase mutant pol3-L612M are independent of TLS DNA polymerases. 
 
Table 4.6 Mutation rate analysis (CAN1 inactivation) in pol3-L612M gln3Δ or pol3-L612M ura7Δ strains 
lacking TLS DNA polymerases. 
Relevant genotype Mutation Rate (fold increase)* CanR 
pol3-L612M gln3Δ 9.1 [7.3-18.2] x 10-6 (127) 
pol3-L612M gln3Δ rev1Δ 2.9 [2.3-3.4] x 10-5 (399) 
pol3-L612M gln3Δ rev3Δ 2.3 [1.3-3.3] x 10-5 (327) 
pol3-L612M gln3Δ rad30Δ 1.8 [0.9-2.8] x 10-5 (247) 
pol3-L612M ura7Δ 1.6 [1.1-2.6] x 10-5 (218) 
pol3-L612M ura7Δ rev1Δ 3.7 [2.7-4.9] x 10-5 (521) 
pol3-L612M ura7Δ rev3Δ 1.9 [1.3-4.0] x 10-5 (264) 
pol3-L612M ura7Δ rad30Δ 4.3 [3.4-6.2] x 10-5 (597) 
* Median rates of inactivation of CAN1 gene (CanR) with 95% confidence interval in square brackets and fold increase 
relative to the WT in parentheses. Table was adapted from (Schmidt et al. 2017). 
 
4.3.2 Loss of Gln3 or Ura7 results in a mutational potential that is buffered by DNA 
polymerase proofreading and MMR. 
The active-site mutations in the low-fidelity DNA polymerase alleles used in the screen compromise 
primarily the nucleotide selectivity of the DNA polymerases. However, besides nucleotide 
selectivity also DNA proofreading of Pol  and Pol  and MMR contribute to high-fidelity DNA 
replication (Fig. 1.2) (KUNKEL 2009; KUNKEL AND ERIE 2015). The observed mutator interactions 
could be specific for the low-fidelity DNA polymerases alleles used in the screen or related to DNA 
replication fidelity-compromised backgrounds. To test this idea, the identified genes were 
inactivated in DNA proofreading defective (pol2-04)(MORRISON et al. 1991), or mutant backgrounds 
that confer a partial (exo1, msh3 and msh6)(MARSISCHKY et al. 1996; TISHKOFF et al. 1997) or 
complete MMR defect (msh2) (REENAN AND KOLODNER 1992) and mutation rates were determined 
(Table 4.7). Loss of either Gln3 or Ura7 strongly increased the CAN1 mutation rate in all tested 
DNA replication fidelity-compromised backgrounds except for msh3 (Table 4.7). For example, 
inactivation of URA7 in an exo1 background resulted in a CAN1 mutation rate 261- and 26-fold 
increased over WT and the exo1 single mutant, respectively. GLN3 inactivation in msh6 caused 
a 334- and 26-fold over WT and the msh6 single mutant, respectively. In contrast, SHM2 and 
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RRM3 inactivation resulted in only a mild increase in the measured CAN1 inactivation rate in an 
msh6 background and no increase was observed in the absence of EXO1 (Table 4.7).  
Loss of Gln3, Shm2, Ura7 or Rrm3 in a completely MMR-deficient msh2 background caused an 
increased CAN1 mutation rate in all double mutants which were, except for the shm2 msh2 
double mutant, significantly higher than the msh2 single mutant (based on 95% confidence 
intervals) (Table 4.7). Thus, the identified genes prevent mutations not only in the presence of the 
low-fidelity active-site DNA polymerase mutant alleles, but also in genetic backgrounds with 
compromised DNA proofreading or MMR. 
 
Table 4.7 Mutation rate analysis of the mutants identified in this screen in combination with 
proofreading or partial MMR-defective alleles. 
 Mutation Rate (fold increase)* 
Relevant genotype CanR Lys+ Thr+ 
WT 7.2 [5.7-9.0] x 10-8 (1) 1.5 [0.8-2.2] x 10-8 (1) 2.1 [1.4-3.2] x 10-9 (1) 
gln3Δ 1.0 [0.8-1.2] x 10-7 (1) 1.6 [1.1-3.7] x 10-8 (1) 2.4 [1.7-3.7] x 10-9 (1) 
shm2Δ 1.2 [1.1-1.7] x 10-7 (2) 3.1 [1.2-5.0] x 10-8 (2) 2.6 [1.7-5.6] x 10-9 (1) 
ura7Δ 1.0 [0.9-1.5] x 10-7 (1) 1.4 [1.0-2.5] x 10-8 (1) 1.9 [1.2-5.6] x 10-9 (1) 
rrm3Δ 1.1 [0.8-1.5] x 10-7 (2) 2.4 [1.3-3.0] x 10-8 (2) 4.6 [2.6-7.9] x 10-9 (2) 
exo1Δ 7.4 [6.3-9.8] x 10-7 (10) 1.4 [0.9-1.8] x 10-7 (10) 8.7 [6.1-15.0] x 10-9 (4) 
exo1Δ gln3Δ 1.1 [0.8-1.4] x 10-5 (146) 1.2 [0.7-1.6] x 10-6 (83) 3.5 [2.7-5.0] x 10-7 (170) 
exo1Δ shm2Δ  8.4 [7.1-10.1] x 10-7 (12) 3.5 [2.4-5.1] x 10-7 (24) 1.8 [1.1-2.5] x 10-8 (9) 
exo1Δ ura7Δ 1.9 [0.8-2.4] x 10-5 (261) 1.3 [0.7-1.9] x 10-6 (89) 6.6 [4.9-8.3] x 10-7 (319) 
exo1Δ rrm3Δ 6.3 [4.3-7.6] x 10-7 (9) 1.3 [1.0-1.8] x 10-7 (9) 2.5 [2.0-3.1] x 10-8 (12) 
msh2Δ 5.4 [4.4-7.2] x 10-6 (75) 9.9 [8.1-10.8] x 10-5 (6771) 6.3 [5.2-12.8] x 10-6 (3053) 
msh2Δ gln3Δ 1.3 [0.8-2.1] x 10-5 (177) 8.7 [6.9-14.9] x 10-5 (5972) 4.5 [3.1-6.5] x 10-6 (2149) 
msh2Δ shm2Δ 7.4 [4.8-8.6] x 10-6 (104) 1.4 [1.1-2.1] x 10-4 (9737) 6.1 [4.4-8.2] x 10-6 (2918) 
msh2Δ ura7Δ 3.5 [2.6-4.2] x 10-5 (492) 6.1 [4.7-8.8] x 10-5 (4161) 5.7 [4.1-8.5] x 10-6 (2738) 
msh2Δ rrm3Δ 1.7 [1.2-2.6] x 10-5 (234) 1.1 [0.9-1.2] x 10-4 (7198) 1.6 [1.1-2.4] x 10-5 (7491) 
msh3Δ 1.1 [0.8-1.2] x 10-7 (1) 2.5 [2.0-3.0] x 10-7 (17) 2.7 [2.0-4.2] x 10-8 (13) 
msh3Δ gln3Δ 1.6 [1.1-2.6] x 10-7 (2) 1.9 [1.4-2.3] x 10-7 (13) 1.8 [1.5-1.9] x 10-8 (9) 
msh3Δ shm2Δ 1.5 [1.3-2.9] x 10-7 (2) 1.2 [1.3-2.6] x 10-7 (12) 2.7 [1.7-3.7] x 10-8 (13) 
msh3Δ ura7Δ 1.5 [1.3-2.0] x 10-7 (2) 1.2 [0.8-2.1] x 10-7 (8) 1.7 [1.1-3.0] x 10-8 (8) 
msh3Δ rrm3Δ 2.6 [1.9-3.4] x 10-7 (4) 3.7 [3.5-4.3] x 10-7 (25) 6.1 [4.9-8.3] x 10-8 (30) 
msh6Δ 9.6 [7.8-11.7] x 10-7 (13) 1.3 [0.9-1.6] x 10-6 (86) 1.3 [0.9-1.6] x 10-8 (6) 
msh6Δ gln3Δ 2.4 [1.7-3.4] x 10-5 (334) 1.2 [0.7-4.0] x 10-6 (80) 1.0 [0.6-1.6] x 10-7 (48) 
msh6Δ shm2Δ 2.1 [1.3-2.6] x 10-6 (30) 1.0 [0.9-1.3] x 10-6 (71) 3.5 [2.7-5.4] x 10-8 (17) 
msh6Δ ura7Δ 3.8 [3.2-8.5] x 10-5 (524) 8.6 [6.6-20.6] x 10-7 (59) 9.2 [4.5-26.2] x 10-8 (44) 
msh6Δ rrm3Δ 4.9 [3.6-7.3] x 10-6 (68) 9.1 [6.1-13.8] x 10-7 (62) 5.5 [3.9-6.8] x 10-8 (26) 
pol2-04 6.2 [4.3-7.6] x 10-7 (6) nd nd 
pol2-04 gln3Δ 1.1 [0.9-1.6] x 10-5 (154) nd nd 
pol2-04 shm2Δ 1.5 [1.1-2.3] x 10-6 (22) nd nd 
pol2-04 ura7Δ 2.5 [1.8-5.2] x 10-5 (354) nd nd 
pol2-04 rrm3Δ 1.4 [0.9-1.8] x 10-6 (19) nd nd 
* Median rates of inactivation of CAN1 gene (CanR) and lys2-10A (Lys+) and hom3-10 (Thr+) reversion with 95% confidence 
interval in square brackets and fold increase relative to the WT in parentheses. "nd" indicates not determined. Table was 
adapted from (Schmidt et al. 2017). 
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According to the qualitative frameshift mutator analysis (lys2-10A), most of the identified gene 
deletions (with the exception of exo1) did not caused an inceased frameshift mutator phenotype. 
Moreover, inactivation of the identified genes in MMR-compromised backgrounds did not result in 
strongly increased frameshift mutator phenotypes according to the lys2-10A and hom3-10 reporter 
assay (Table 4.7). Two exceptions were the gln3 exo1 and ura7 exo1 double mutants that 
resulted in a 170- and 319-fold increase over WT in the hom3-10 frameshift assay, respectively. To 
confirm that the hom3-10 assay is specifically reverted by a single T:A deletion event in a 7 T:A 
mononucleotide run (starting at nucleotide position 646) and not due to base pair or complex 
mutations, the hom3-10 reporter of 50 independent ura7 exo1 hom3-10 revertants were 
sequenced. In line with literature (MARSISCHKY et al. 1996) only single T:A deletions events in the 7 
T:A mononucleotide run gave rise to hom3-10 reversion. In conclusion, loss of Ura7 in an exo1 
background causes a mild hom3-10 frameshift mutator phenotype, which is equivalent to 10% of a 
complete MMR-defect (msh2) and presumably a consequence of saturation of MMR due to 
increased base pair substitutions. 
To test whether mutations induced in the absence of the identified genes are corrected by Pol2 
proofreading activity, GLN3, SHM2, URA7 and RRM3 were inactivated in the Pol2 proofreading-
deficient background pol2-04 and CAN1 mutation rates were measured. Whereas only mild 
increases of 3- to 4-fold over pol2-04 were detected in the shm2 pol2-04 and rrm3 pol2-04 
double mutants, loss of either Gln3 or Ura7 increased the CAN1 mutation rates 26- and 59-fold 
over pol2-04, respectively.  
Despite several attempts the URA7 deletion could not be combined with the Pol3 proofreading 
defective pol3-01 allele (MORRISON et al. 1993). Therefore, the possibility of a synthetic growth 
defect or synthetic lethality was investigated by plasmid shuffling. For this, the chromosomal POL3 
gene was inactivated in URA7 or ura7 haploid (n) cells, which were complemented with WT-POL3 
expressed from a low copy number plasmid (URA3-WT-POL3). Next, cells were transformed with 
either WT-POL3 or pol3-01 expressing low copy number plasmids (LEU2-WT-POL3/pol3-01). 
Striking on 5-FOA containing media selected for loss of the URA3-WT-POL3 plasmid and growth in 
the presence of POL3 or pol3-01 was evaluated. Indeed, the ura7 pol3 mutant complemented 
with a pol3-01 expressing plasmid showed a severe growth defect (Fig. 4.8A). In yeast cells, very 
high mutation rates, which are for example observed in mutants with combined DNA proofreading 
defects and complete MMR deficiency, can result in lethality due to “error-induced extinction” (TRAN 
et al. 1999; GREENE AND JINKS-ROBERTSON 2001; WILLIAMS et al. 2013). Under these 
circumstances, cells die because of the extremely elevated mutation rate that results in the 
inactivation of at least one essential gene is inactivated per cell cycle (1 x 10-3 mutations per cell 
division in haploid yeast cells)(HERR et al. 2014). In line with this, no growth was observed in an 
msh2 pol3 mutant complemented with a pol3-01 expressing plasmid (Fig. 4.8A). To evaluate, 
whether the observed slow growth phenotype of the ura7 + pol3-01 double mutant is linked to the 
high mutational load, homozygous diploid (2n) URA7 pol3 or ura7 pol3 plasmid shuffling strains 
hemizygous for CAN1 (CAN1/can1) were generated. In comparison to the very slowly growing 
haploid ura7 + pol3-01 cells, the homozygous diploid ura7 + pol3-01 cells grew better, which is 
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in line with an approximately 10-fold higher error extinction threshold in diploid cells (Fig. 4.8B). 
However, diploid ura7 + pol3-01 cells still grew slower than diploid ura7 + POL3 cells (Fig 4.8B). 
 
  
Fig. 4.8 URA7 inactivation in Pol3 proofreading-defective background results in severe growth defect 
and synergistic increase in the mutations rate.  
(A) Plasmid shuffling assay in haploid pol3Δ, pol3Δ ura7Δ and pol3Δ msh2Δ complemented with a WT-POL3-
URA3 plasmid and transformed with either WT-POL3-LEU2 or pol3-01-LEU2 plasmid. Cells were streaked out 
on Ura-Leu- SD plates (growth control) and on 5-FOA containing SD plates to counterselect for the WT-POL3-
URA3 plasmid. The msh2Δ pol3-01 double mutant serves as positive control for a synthetic lethal interaction. 
(B) Haploid (n) or diploid homozygous (2n) pol3Δ ura7Δ cells expressing either WT-POL3 or pol3-01 were 
grown as in A. (C) Proliferation curve of homozygous diploids of the indicated genotypes after plasmid 
shuffling. Proliferation was followed by OD600 measurement and the values were plotted as mean of three 
independent isogenic strains ± SD in a log2 scale. (D) Quantification of CAN1 mutation rates in diploids 
hemizygous for the CAN1 locus and homozygous for pol3Δ or pol3Δ ura7Δ complemented with WT-POL3 or 
pol3-01 on a LEU2 plasmid. Error bar represent 95% confidence intervals (CIs) and the number on top 
represents the fold increase in the mutation rate over the WT diploid strain (2.4 x 10-7 CanR mutants per cell 
division). Figure was adapted from (SCHMIDT et al. 2017). 
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To compare proliferation of diploid homozygous pol3 or pol3 ura7 strains either complemented 
with WT-POL3 or pol3-01 expressed from a low copy number plasmid, growth was followed over 
time (Fig. 4.8C). In agreement with the previous qualitative growth analysis (Fig. 4.8B), the diploid 
pol3 ura7 strains complemented with the pol3-01 plasmid grew slower than the diploid pol3 
ura7 strains complemented with the WT-POL3 plasmid and the diploid pol3 strains 
complemented with WT-POL3 or pol3-01 plasmids. Next, the CAN1 mutation rates were measured 
in the ura7 + pol3-01 diploids hemizygous for the CAN1 reporter (Fig. 4.8D). Strikingly, the ura7 
+ pol3-01 diploid showed a CAN1 inactivation rate of 1.6 x 10-3 (6482-fold increase over the WT). 
This mutation rate is at the error-induced extinction threshold for haploid cells (1.0 x 10-3 mutations 
per cell division in haploid yeast cells), but below the threshold reported for diploid cells (1.0 x 10-2 
mutations per cell division in diploid yeast cells). Taken together, mutations induced in the absence 
of GLN3 or URA7 and to a lesser degree in shm2 and rrm3 are counteracted by MMR and Pol2 
proofreading. Moreover, inactivation of URA7 in the absence of Pol3 proofreading results in a 
hypermutator phenotype that compromises cell viability. 
4.3.3 Inactivation of GLN3 or URA7 results in activation of the DNA damage response.  
Three of the here identified gene deletions (gln3, rrm3 and ura7) have been previously 
reported to show a prolonged S phase (KOREN et al. 2010). An extended S phase can be caused 
by either replication stress or DNA damage (ROUSE AND JACKSON 2002; PARDO et al. 2017). Upon 
these stress conditions, the Rad53 kinase is phosphorylated on multiple sites, resulting in Rad53 
activation and Dun1 phosphorylation. Dun1 phosphorylates the negative regulators of RNR Sml1, 
Crt1 and Dif1 and marks them for degradation. Consequently, the expression of RNR subunits and 
the activity of RNR is increased which leads to elevated dNTP levels (Fig. 4.9A). To investigate 
whether the reported extended S phase in gln3 and ura7 is due to activation of the DNA damage 
response (DDR), whole cell lysates of logarithmically growing cells were analyzed by 
immunoblotting for Rad53 phosphorylation (represented by a smear in the Rad53 electrophoretic 
mobility) and induction of the RNR subunits. Indeed, the absence of Ura7 and to a lesser degree of 
Gln3 activated the DDR. Loss of Shm2 did not result in Rad53 phosphorylation and Rnr3 induction, 
but to a mild increase in Rnr2 and Rnr4 expression levels. Interestingly, in contrast to the pol2-
M644G mutant, which was previously reported to depend on DDR activation and concomitant 
elevated dNTP pools for survival (WILLIAMS et al. 2015), the lagging strand DNA polymerase 
mutant alleles (pol1-L868M and pol3-L612M) did not activate the DDR. In agreement with the 
Western blotting results, DNA content analysis of logarithmically growing cells revealed that pol1-
L868M, pol3-L612M and shm2 did not show accumulation of cells in S phase, whereas pol2-
M644G, gln3 and ura7 cells did (Fig. 4.9C). Thus, loss of Gln3 or Ura7 causes activation of the 
DDR and accumulation of cells in S phase.  
Next, to test whether the observed synergistic mutator interaction between DNA replication fidelity-
compromised backgrounds and gln3 or ura7 are dependent on the activation of the DNA 
damage checkpoint, CAN1 mutation rates were measured in the absence of Dun1 (Zhou and 
Elledge 1993). Remarkably, inactivation of DUN1 strongly suppressed the mutator phenotypes 
(Table 4.8). For example, loss of Dun1 reduced the CAN1 mutation rates from 293- to 4-fold and  
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Fig. 4.9 Inactivation of GLN3 or URA7 causes DNA damage checkpoint activation. 
(A) Simplified scheme of the DNA damage response in S. cerevisiae. (B) Whole cell lysates of logarithmically 
growing cells were analyzed by SDS-PAGE and immunoblotting against Rad53, Rnr3 and tubulin. As positive 
control for the activation of the DNA damage response, WT cells treated for 3 h with 200 mM HU were used. 
(C) DNA content profiles of logarithmically growing strains with the indicated genotypes. (D) CAN1 mutation 
rates in mutant strains in the presence or absence of DUN1 (Table 4.8). (E) CAN1 mutation rate in the 
indicated strains grown in YPD supplemented or not with 5 mM glutamine (Gln). Error bars represent the 95% 
CI, and numbers on top are the fold increase in the mutation rate over WT. Figure was adapted from (SCHMIDT 
et al. 2017). 
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from 218- to 26-fold over WT in pol1-L868M gln3 and pol3-L612M ura7, respectively (Fig. 4.9D, 
Table 4-8). Moreover, the CAN1 inactivation rate of the exo1 ura7 double mutant was 
suppressed from 261- to 12-fold over WT in the absence of Dun1 (Fig. 4.9D, Table 4-8). These 
findings suggest that the absence of Dun1 increases DNA replication fidelity in gln3 and ura7 
double mutants. Strikingly, this phenotype is not restricted to DNA polymerase mutant allele 
combinations and most likely caused by the constant activation of the negative regulators of RNR 
and consequently lower dNTP pools (FASULLO et al. 2010). Accordingly, the dun1 ura7 double 
mutant showed an even stronger S phase delay in the DNA content analysis, whereas no 
difference was observed in the dun1 gln3 double mutant (Fig. 4.9C).  
 
Table 4.8 Mutation rate analysis in gln3Δ and ura7Δ double mutants in the presence or absence of 
DUN1. 
 Mutation Rate (fold increase)* 
Relevant genotype CanR Lys+ Thr+ 
WT 7.2 [5.7-9.0] x 10-8 (1) 1.5 [0.8-2.2] x 10-8 (1) 2.1 [1.4-3.2] x 10-9 (1) 
gln3Δ 1.0 [0.8-1.2] x 10-7 (1) 1.6 [1.1-3.7] x 10-8 (1) 2.4 [1.7-3.7] x 10-9 (1) 
ura7Δ 1.0 [0.9-1.5] x 10-7 (1) 1.4 [1.0-2.5] x 10-8 (1) 1.9 [1.2-5.6] x 10-9 (1) 
dun1Δ 5.6 [4.2-9.1] x 10-8 (1) 2.1 [0.9-3.5] x 10-8 (1) 2.4 [1.7-5.2] x 10-9 (1) 
exo1Δ 7.4 [6.3-9.8] x 10-7 (10) 1.4 [0.9-1.8] x 10-7 (10) 8.7 [6.1-15.0] x 10-9 (4) 
exo1Δ ura7Δ 1.9 [0.8-2.4] x 10-5 (261) 1.3 [0.7-1.9] x 10-6 (89) 6.6 [4.9-8.3] x 10-7 (319) 
exo1Δ ura7Δ dun1Δ 8.5 [5.4-11.3] x 10-7 (12) 2.6 [1.8-3.6] x 10-7 (18) 8.3 [4.7-10.7] x 10-9 (4) 
pol2-04 6.2 [4.3-7.6] x 10-7 (6) nd nd 
pol2-04 gln3Δ 1.1 [0.9-1.6] x 10-5 (154) nd nd 
pol2-04 dun1Δ 9.4 [6.5-17.4] x 10-8 (1) nd nd 
pol2-04 gln3Δ dun1Δ 8.6 [6.4-16.5] x 10-8 (1) nd nd 
pol1-L868M 3.9 [3.3-4.9] x 10-7 (5) nd nd 
pol1-L868M dun1Δ 9.6 [5.4-15.0] x 10-8 (1) nd nd 
pol1-L868M gln3Δ 2.1 [1.4-4.5] x 10-5 (293 nd nd 
pol1-L868M gln3Δ dun1Δ 2.9 [1.9-4.5] x 10-7 (4) nd nd 
pol3-L612M 9.3 [7.7-11.6] x 10-7 (13) nd nd 
pol3-L612M gln3Δ 9.1 [7.3-18.2] x 10-6 (127) nd nd 
pol3-L612M gln3Δ dun1Δ 3.1 [1.8-4.0] x 10-6 (43) nd nd 
pol3-L612M ura7Δ 1.6 [1.1-2.6] x 10-5 (218) nd nd 
pol3-L612M ura7Δ dun1Δ 1.8 [1.3-3.0] x 10-6 (26) nd nd 
* Median rates of inactivation of CAN1 gene (CanR) and lys2-10A (Lys+) and hom3-10 (Thr+) reversion with 95% confidence 
interval in square brackets and fold increase relative to the WT in parentheses. "nd" indicates not determined. Table was 
adapted from (Schmidt et al. 2017). 
 
The GATA transcription factor Gln3 activates genes upon glutamine limitation (BECK AND HALL 
1999; CRESPO et al. 2002). Glutamine is an important cellular metabolite for energy production, but 
also for purine and pyrimidine biosynthesis, among others. Thus, to test whether defects due to 
glutamine starvation in gln3 are responsible for the synergistic mutator interactions observed in 
gln3 double mutants, CAN1 mutation rates were measured in YPD medium or in YPD medium 
supplemented with 5 mM glutamine. Strikingly, glutamine supplementation suppressed the CAN1 
mutation rates by 70-75% in pol3-L612M gln3, pol2-04 gln3 and exo1 gln3 (Fig. 4.9E). Thus, 
at one stage during the growth of the culture glutamine becomes limiting, even if the culture is 
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grown in nutrient-rich YPD medium. Normally, cells would respond to glutamine limitation by 
activation of Gln3, but in the absence of Gln3 the cells cannot counteract the metabolic imbalance 
resulting in increased mutagenesis. 
4.3.4 Gln3 and Ura7 are critical to maintain balanced NTP and dNTP pools. 
The reported metabolic function of Gln3 (BECK AND HALL 1999; CRESPO et al. 2002) and Ura7 
(OZIER-KALOGEROPOULOS et al. 1991; OZIER-KALOGEROPOULOS et al. 1994), together with the 
activation of the DDR in the absence of both genes (Fig. 4.9B,C)(KOREN et al. 2010) and the 
suppression of the mutator phenotypes by inactivation of DUN1 (Table 4.8), suggested that 
inactivation of either one of these two genes may affect nucleotide pool homeostasis. To test this 
hypothesis, NTP and dNTP pools were measured by HPLC (Fig. 4.10, Table 4-9) (collaboration 
with Chabes lab, Umeå University). Inactivation of GLN3 and URA7 reduced CTP levels to 50% 
and 30%, respectively (Fig. 4.10A, Table 4.9A). Additionally, 1.7-fold increased UTP levels were 
measured in gln3 cells. In contrast, the NTP pools in the absence of Shm2 and in the presence of 
the active-site mutant DNA polymerase alleles did not strongly change.  
 
 
Fig. 4.10 Inactivation of GLN3 or URA7 induces an NTP and dNTP imbalance.  
(A) NTP and (B) dNTP concentration measurements in the indicated strains (Table 4.9). Error bars represent 
SD and the number on top of each bar indicates the folds over WT. Fold increases are colored in green, 
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whereas decreased levels are labeled red. NTP and dNTP concentrations were measured by the Chabes lab. 
Figure was adapted from (Schmidt et al. 2017). 
 
Table 4.9 NTP and dNTP concentrations measured in polymerase, gln3Δ, shm2Δ and ura7Δ mutants. 
A     
Relevant genotype CTP UTP ATP GTP 
WT 2360 ± 532 (1.0) 5384 ± 1406 (1.0) 12088 ± 2351 (1.0) 3705 ± 912 (1.0) 
pol1-L868M 2440 ± 483 (1.0) 5704 ± 942 (1.1) 12310 ± 2029 (1.0) 3719 ± 669 (1.0) 
pol2-M644G 2825 ± 1171 (1.2) 5959 ± 2511 (1.1) 15418 ± 6078 (1.3) 4443 ± 1902 (1.2) 
pol3-L612M 2870 ± 1085 (1.2) 6654 ± 2626 (1.2) 15524 ± 5465 (1.3) 4529 ± 1765 (1.2) 
gln3Δ 1267 ± 443 (0.5). 8957 ± 2458 (1.7) 13167 ± 3592 (1.1) 2929 ± 1130 (0.8) 
shm2Δ 3411 ± 1485 (1.4) 7302 ± 3243 (1.4) 17439 ± 7467 (1.4) 5243 ± 2429 (1.4) 
ura7Δ 808 ± 288 (0.3) 6575 ± 1225 (1.2) 13080 ± 1958 (1.1) 3587 ± 745 (1.0) 
dun1Δ gln3Δ* 1645 ± 172 (0.7) 7533 ± 2824 (1.4) 12246 ± 1371 (1.0) 3272 ± 246 (0.9) 
dun1Δ ura7Δ* 1160 ± 81 (0.5) 8338 ± 874 (1.5) 14723 ± 502 (1.2) 4151 ± 119 (1.1) 
B     
Relevant genotype dCTP dTTP dATP dGTP 
WT 75 ± 4 (1.0) 159 ± 14 (1.0) 102 ± 3 (1.0) 59 ± 0 (1.0) 
pol1-L868M 70 ± 1 (0.9) 214 ± 11 (1.3) 114 ± 1 (1.1) 63 ± 3 (1.1) 
pol2-M644G 292 ± 20 (3.9) 629 ± 37 (4.0) 450 ± 20 (4.4) 205 ± 9 (3.5) 
pol3-L612M 85 ± 25 (1.1) 149 ± 12 (0.9) 91 ± 4 (0.9) 54 ± 2 (0.9) 
gln3Δ 43 ± 3 (0.6) 641 ± 76 (4.0) 293 ± 20 (2.9) 141 ± 6 (2.4) 
shm2Δ 75 ± 2 (1.0) 178 ± 18 (1.1) 115 ± 12 (1.1) 62 ± 3 (1.1) 
ura7Δ 35 ± 6 (0.5) 517 ± 17 (3.3) 386 ± 3 (3.8) 158 ± 7 (2.7) 
dun1Δ gln3Δ* 27 ± 3 (0.4) 134 ± 65 (0.8) 71 ± 34 (0.7) 47 ± 20 (0.8) 
dun1Δ ura7Δ* 27 ± 14 (0.4) 134 ± 2 (0.8) 98 ± 2 (1.0) 42 ± 5 (0.7) 
NTP (A) and dNTP (B) concentrations (pmol per 108 cells) are the average of two biological replicates ± standard deviation 
with the fold increase over WT in parentheses. NTP and dNTP concentrations were measured by the Chabes lab. Table 
was adapted from (Schmidt et al. 2017). 
* NTP and dNTP concentrations were measured at a different time point and normalized according to a WT strain included 
in the same run.  
 
To examine whether the low CTP levels in gln3 and ura7 cells affect dCTP pools, dNTP 
concentrations were measured. The dCTP pools in gln3 and ura7 cells were reduced by 40% 
and 50%, respectively, in comparison to the WT, whereas the other dNTPs were strongly increased 
(2.4- to 4.0-fold over WT) (Fig. 4.10B, Table 4.9B). In agreement with a previous report (WILLIAMS 
et al. 2015), and the observed accumulation of cells in S phase (Fig. 4.9C), the pol2-M644G mutant 
strain showed an overall increase in dNTP pools. Moreover, neither SHM2 inactivation nor the 
lagging strand DNA polymerase alleles caused major dNTP pool alterations (Fig. 4.10B, Table 
4.9B). Taken together, loss of Gln3 or Ura7 causes low CTP pools for which neither RNR nor any 
mechanism downstream RNR can compensate, resulting in a severe dNTP imbalance which is 
characterized by limiting dCTP pools and elevated dTTP, dATP and dGTP pools. 
As the inactivation of DUN1 suppressed the CAN1 mutation rates in gln3 and ura7 double 
mutants, NTP and dNTP concentrations were also measured in dun1 gln3 and dun1 ura7. 
Whereas NTP pools in these double mutants were similar to the levels measured in gln3 and 
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ura7 single mutants (Fig. 4.10A, Table 4.9A), the overall dNTP pools were strongly decreased 
(Fig. 4.10B, Table 4.9B). The dCTP concentrations in dun1 double mutants were still comparable 
to the dCTP concentrations measured in the presence of Dun1 (40% to 60% of dCTP WT levels in 
dun1 gln3 to gln3 and 40% to 50% of dCTP WT levels in dun1 ura7 to ura7, respectively). 
However, the contribution of dCTP to the total dNTP pool was strongly increased in the dun1 
double mutants. For example, dCTP pools in ura7 contributed 3% to the total dNTP pool (19% in 
the WT), whereas dCTP in the dun1 ura7 double mutant contributed to 9% of the total dNTP 
pool. Moreover, the ratio between dCTP to dTTP changed from 1:15 in ura7 cells to 1:5 in dun1 
ura7 cells (1:2 in WT cells). Therefore, the lower overall dNTP pools and the less extreme ratios 
between the different dNTP pools might explain the observed increase in DNA replication fidelity 
upon inactivation of DUN1 in gln3 and ura7 double mutants.     
4.3.5 Inactivation of GLN3 or URA7 results in a CAN1 mutation spectrum dominated by G-
C to A-T transitions. 
In order to investigate whether the measured dNTP pool imbalance in the absence of Gln3 or Ura7 
impacts on the type of replication errors generated, CAN1 mutation spectra analysis was 
performed. Based on the results obtained in the mutator assay (Table 4.5 and 4.7), mostly base 
substitution events were expected in gln3, shm2 and ura7 mutations spectra. Therefore, and to 
avoid potential correction by MMR, the mutation spectra analysis was performed in the absence of 
Msh6, which forms together with Msh2 the mismatch recognition complex primarily responsible for 
the recognition of base pair substitutions (MARSISCHKY et al. 1996).  
 
Table 4.10 CAN1 mutation spectra analysis in WT, msh6Δ, msh6Δ gln3Δ, msh6Δ shm2Δ and msh6Δ 
ura7Δ mutants. 
 
WT msh6Δ 
msh6Δ 
gln3∆ 
msh6Δ 
shm2∆ 
msh6Δ 
ura7∆ 
CanR clones sequenced 91 110 94 95 110 
Mutations overall * 92 (100) 111 (100) 96 (100) 96 (100) 110 (100) 
Base substitutions 69 (75) 102 (92) 95 (99) 95 (99) 109 (99) 
A-T → G-C 6 (7) 9 (8) 1 (1) 1 (1) 0 (0) 
G-C → A-T 18 (20) 60 (54) 92 (96) 77 (80) 104 (95) 
G-C → T-A 29 (32) 27 (24) 0 (0) 14 (15) 5 (5) 
A-T → C-G 3 (3) 2 (2) 0 (0) 3 (3) 0 (0) 
A-T → T-A 7 (8) 1 (1) 0 (0) 0 (0) 0 (0) 
C-G → G-C 6 (7) 3 (3) 2 (2) 0 (0) 0 (0) 
Transitions 24 (26) 69 (62) 93 (97) 78 (81) 104 (95) 
Transversions 45 (49) 33 (30) 2 (2) 17 (18) 5 (5) 
One-base-pair frameshifts 15 (16) 7 (6) 1 (1) 1 (1) 1 (1) 
Complex mutations† 8 (9) 2 (2) 0 (0) 0 (0) 0 (0) 
Mutation spectra analysis based on DNA sequencing of the CAN1 gene in independent CanR mutants, shown as the 
number of clones containing the indicated mutations, and in parenthesis as the percentage relative to the total (Fig. S 7.1 
and Fig. S 7.3-6). Table was adapted from (Schmidt et al. 2017). 
*In few cases (about 1-2% of the sequenced clones) two simultaneous CAN1 mutations (more than 100 bp apart) were 
found. These mutations were included in the analysis and considered as independent mutational events. 
† includes: multiple mutations within 10 nucleotides, insertions or deletions of more than 1 nucleotide and duplication events. 
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Fig. 4.11 The CAN1 mutation spectrum in the absence of Ura7 or Gln3 is dominated by G-C to A-T 
transitions. 
(A) Independent CanR clones (n ≥ 91 per genotype) were sequenced for CAN1 mutations. The graphs 
represent the type of the identified mutations in percentage (Table 4.10). (B) The G-to-A mutational hotspot at 
nucleotide 788 was frequently found in msh6Δ gln3Δ, msh6Δ shm2Δ and msh6Δ ura7Δ strains. Predicted 
mutation is noted in red. Nucleotides marked in green are more abundant in gln3Δ and ura7Δ than in the WT 
and facilitate rapid extension of the mispair. (C) The G-to-A mutational hotspot at nucleotide 497 was 
frequently found in msh6Δ and msh6Δ shm2Δ, but not in msh6Δ gln3Δ or msh6Δ ura7Δ. Here, immediately 
after the predicted G-dT mispair a dCTP needs to be incorporated, which is less abundant in gln3Δ and ura7Δ 
strains and thus, unlikely to support rapid mismatch extension. Figure was adapted from (SCHMIDT et al. 2017) 
 
Sequencing of the CAN1 gene in independent canavanine resistant clones (CanR) (n ≥ 91 per 
genotype) revealed that the msh6 single and double mutant mutation spectra were dominated by 
base substitutions. In the WT 75% of all sequenced mutation events were base substitutions, 
whereas in msh6 and msh6 double mutants base substitutions were found in 92% and 99% of 
all sequenced events, respectively (Table 4.10). The msh6 CAN1 mutation spectrum was in 
comparison to the WT strongly enriched for G-C to A-T transitions (54.1% in msh6 compared to 
19.6% in WT), suggesting that this type of replication error is efficiently repaired by MMR in the WT 
background. The additional knockout of SHM2, URA7 or GLN3 in the msh6 background further 
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increased G-C to A-T mutations, which accounted for 80.2%, 94.5% and 95.8% of all sequenced 
CanR events, respectively. 
Statistical analysis of the CAN1 spectra revealed that the double mutant CAN1 mutation spectra 
were significantly different to the msh6 spectrum (Fisher’s exact test, p value 0.0005 for msh6 
shm2, 4.0 x 10-12 for msh6 gln3 and 1.3 x 10-10 for msh6 ura7). Further analysis revealed 
mutational hotspots, in which specific mutational events were observed at least in 5% of all 
sequenced clones (Table 4.11).  
 
Table 4.11 Mispair base substitution hotspots identified in msh6Δ gln3Δ, msh6Δ ura7Δ and msh6Δ 
shm2Δ mutants. 
Position Mutation No of occurrences  
(% of total) 
Mutation rate  
(x10-8) 
Fold increase  
over msh6Δ 
Predicted intermediate 
gln3Δ: 0.6 x dCTP, 4.0 x dTTP, 2.9 x dATP, 2.4 dGTP 
overall  96 2400 25.0  
788 G → A 15 (15.6) 375.0 434 
 
806 G → A 5 (5.2) 125.0 ≥145  
980 G → A 18 (18.8) 450.0 87 
 
1018 G → A 13 (13.5) 325.0 94  
1622 G → A 5 (5.2) 125.0 ≥145 
 
ura7Δ: 0.5 x dCTP, 3.3 x dTTP, 3.8 x dATP, 2.7 dGTP 
overall  110 3800 39.6  
268 C → T 6 (5.5) 207.3 240 
 
670 G → A 11 (10.0) 380.0 439 
 
788 G → A 16 (14.5) 552.7 633 
 
980 G → A 14 (12.7) 483.6 92 
 
1018 G → A 11 (10.0) 380.0 110  
shm2Δ: 1.0 x dCTP, 1.1 x dTTP, 1.1 x dATP, 1.1 dGTP 
overall  96 210 2.2  
497 G → A 6 (6.3) 13.1 2 
 
670 G → A 7 (7.3) 15.3 18 
 
788 G → A 7 (7.3) 15.3 18 
 
980 G → A 10 (10.4) 21.9 4  
Mutations are shown relative to the coding strand. The predicted mutation is noted in red. Nucleotides following the mutation 
and which dNTP pools are increased in the mutants in comparison to WT are noted in green. dNTP levels are shown as fold 
over the WT (Table 4.9B). The mutation spectra analysis was done in an msh6Δ background. A mutation hotspot is defined 
as a specific mutation found in more than 5% of all sequenced CANR clones in the indicated genotype. Mutation hotspots 
that are significant different to the msh6Δ control (Fisher’s exact test, p-value ≤ 0.05) are shown in bold. Table was adapted 
from (Schmidt et al. 2017). 
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All mutational hotspots in msh6 gln3 and msh6 ura7 strains were most likely driven by the 
altered dCTP to dTTP ratio (1:15 in the mutants in comparison to 1:2 in WT), which favored dTTP 
incorporation opposite of a template G. Furthermore, all identified hotspots in msh6 gln3 and 
msh6 ura7 are in agreement with a rapid mispair extension, promoted by increased dTTP, dATP 
and dGTP pools (Table 4.11). A frequent mutational hotspot in msh6 gln3 and msh6 ura7 
CAN1 mutation spectra was the misinsertion of dTTP opposite of the template G at position 788 
(Fig. 4.11B). In these backgrounds, the misinsertion is presumably driven by the dCTP to dTTP 
ratio and the high levels of the dNTPs required to extend the mispair (next-nucleotide effect). In 
contrast, misinsertion of a dTTP opposite of the template G at position 497 was frequently identified 
in the msh6 and msh6 shm2 CAN1 mutation spectra, but not in msh6 gln3 and msh6 
ura7 CAN1 mutation spectra (Fig. 4.11C). To continue DNA replication after the mispair at 
position 497, dCTP is required. Therefore, low dCTP pools, like in gln3 or ura7, may 
counterselect for rapid extension giving more time for DNA proofreading. Taken together, the 
absence of Gln3 or Ura7 induces a severe dNTP imbalance that favors G-C to A-T mutations and 
shapes the CAN1 mutation spectra. 
4.3.6 Pol  and Pol  contribute to DNA replication in the absence of Ura7. 
In the course of this work, an alternative model for DNA replication was proposed by the Prakash 
lab, in which Pol  replicates the leading and lagging DNA strands, and Pol  functions primarily 
during origin assembly, S-phase checkpoint activation and proofreading of the leading strand 
(JOHNSON et al. 2015). The here presented genome-wide screen identified a group of genes 
(GLN3, SHM2, URA7 and EXO1) that exclusively interacted with the proposed lagging strand DNA 
polymerase alleles pol1-L868M and pol3-L612M, but not with the leading strand allele pol2-M644G 
(Table 4.5). One explanation for the observed bias could be that pol2-M644G does not contribute 
to genome replication in the absence of the identified genes. To investigate this possibility and to 
further characterize the basis for the observed synergistic mutator interactions, CAN1 mutation 
spectra analysis was performed in WT, ura7, pol2-M644G, pol2-M644G ura7, pol3-L612M and 
pol3-L612M ura7 (Table 4.12). In agreement with the msh6 ura7 CAN1 mutation spectrum 
(Table 4.10), more base substitution events were observed in the ura7 CAN1 mutation spectrum 
(75% in WT and 87.1% in ura7). Even in the presence of high-fidelity DNA polymerases and 
functional MMR, G-C to A-T mutations in ura7 were 2 times more abundant than in the WT and 
represented 53% of all observed base pair substitution events (Table 4.12). Statistical comparison 
of WT and ura7 CAN1 mutation spectra revealed that the type of replication errors produced were 
significantly different in the presence and absence of Ura7 (Fisher’s exact test, p value 0.0016).  
In line with previous reports (PURSELL et al. 2007; NICK MCELHINNY et al. 2008) specific mutational 
signatures were observed in pol2-M644G and pol3-L612M expressing cells (Table 4.12). The pol2-
M644G allele favors T-T mispairs (PURSELL et al. 2007) and consequently A-T to T-A mutations 
were 9-fold more abundant in the pol2-M644G spectrum than in the WT (Table 4.12). In contrast, a 
3-fold increase in G-C to A-T mutations was detected in the pol3-L612M CAN1 mutation spectrum 
(Table 4.12)(NICK MCELHINNY et al. 2008).  
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Consistent with reduced dCTP levels in the absence of Ura7 (Table 4.9B), inactivation of URA7 in 
pol3-L612M further increased the fraction of G-C to A-T mutations from 58.3% in pol3-L612M to 
71.4% of all sequenced CanR events in pol3-L612M ura7. Interestingly, in the pol3-L612M ura7 
mutation spectrum one-base-pair frameshifts were also increased (23.1% in pol3-L612M ura7 in 
comparison to 12.5% in pol3-L612M). Moreover, the type of one-base-pair frameshifts varied 
between WT, pol3-L612M and pol3-L612M ura7. Whereas the one-base-pair frameshifts detected 
in the WT or pol3-L612M were dominated by A:T deletions or insertions (73% in WT and  92% in 
pol3-L612M), which were most frequently found in longer mononucleotide runs, the pol3-L612M 
ura7 CAN1 mutation spectrum showed an increased fraction of G:C one-base-pair frameshifts 
(68% of the total one-base-pair frameshifts). These G:C one-base-pair frameshifts were located all 
over the spectrum and were found primarily at single nucleotides or short mononucleotide runs (n  
3). Both, pol3-L612M and pol3-L612M ura7 shared the mutational hotspot at position 788 and 
1018 (Table 4.13). Interestingly, the mutational hotspot 671 was exclusively found in pol3-L612M 
but was not mutated in pol3-L612M ura7, which instead showed a mutational hotspot at position 
670 (Table 4.13). The difference can be explained by the mutational sequence context and the 
altered dNTP pools. Rapid mismatch extension at position 671 requires dCTP directly following the 
misinsertion.  
 
Table 4.12 CAN1 mutation spectra of ura7Δ and polymerase mutants. 
 
WT ura7Δ 
pol2-
M644G 
pol2-
M644G 
ura7Δ 
pol3-
L612M 
pol3-
L612M 
ura7Δ 
CanR clones 
sequenced 
91 91 94 95 96 95 
Mutations overall* 92 (100) 93 (100) 94 (100) 95 (100) 96 (100) 95 (100) 
Base substitutions 69 (75.0) 81 (87.1) 82 (87.2) 82 (86.3) 81 (84.4) 72 (75.8) 
A-T to G-C 6 (6.5) 4 (4.3) 2 (2.1) 1 (1.1) 12 (12.5) 2 (2.2) 
G-C to A-T 18 (19.6) 43 (46.2) 9 (9.6) 20 (21.1) 56 (58.3) 68 (71.4) 
G-C to T-A  29 (31.5) 19 (20.4) 5 (5.3) 10 (10.5) 8 (8.3) 1 (1.1) 
A-T to C-G  3 (3.3) 7 (7.5) 1 (1.1) 1 (1.1) 2 (2.1) 1 (1.1) 
A-T to T-A 7 (7.6) 1 (1.1) 62 (66.0) 49 (51.6) 2 (2.1) 0 (0.0) 
C-G to G-C 6 (6.5) 7 (7.5) 3 (3.2) 1 (1.1) 1 (1.0) 0 (0.0) 
Transitions 24 (26.1) 47 (50.5) 11 (11.7) 21 (22.1) 68 (70.8) 70 (73.6) 
Transversions 45 (48.9) 34 (36.6) 71 (75.5) 61 (64.2) 13 (13.5) 2 (2.2) 
One-base-pair 
frameshifts 
15 (16.3) 8 (8.6) 8 (8.5) 11 (11.6) 12 (12.5) 22 (23.1) 
Complex mutations† 8 (8.7) 4 (4.3) 4 (4.3) 2 (2.1) 3 (3.1) 1 (1.1) 
Mutation spectra analysis based on DNA sequencing of the CAN1 gene in independent CanR mutants, shown as the 
number of clones containing the indicated mutations, and in parenthesis as the percentage relative to the total. (Fig. S7.1 
and Fig. S7.7-11) 
*In few cases (about 1-2% of the sequenced clones) two simultaneous CAN1 mutations (more than 100 bp apart) were 
found. These mutations were included in the analysis and considered as independent mutational events. 
† includes: multiple mutations within 10 nucleotides, insertions or deletions of more than 1 nucleotide and duplication events. 
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Table 4.13 Mispair base substitution hotspots identified in ura7Δ and polymerase mutants. 
Position Mutation No of 
occurrences  
(% of total) 
 Mutation 
rate  
(x10-8) 
Fold increase  
over WT 
Predicted intermediate 
 ura7Δ: 0.5 x dCTP, 3.3 x dTTP, 3.8 x dATP, 2.7 dGTP 
overall  91  10 1.4  
1018 G → A 11 (12.1)  1.2 ≥15.3  
 pol2-M644G: 3.9 x dCTP, 4.0 x dTTP, 4.4 x dATP, 3.5 dGTP 
overall  94  84 11.7  
103 A → T 19 (20.2)  17.0 ≥214.6  
271 A → T 5 (5.3)  4.5 ≥56.5 
 
475 A → T 13 (13.8)  11.6 ≥146.8 
 
1417 A → T 14 (14.9)  12.5 158.1 
 
 ura7Δ pol2-M644G: not determined 
overall  95  110 15.3  
103 A → T 8 (8.4)  9.3 ≥117.1 
 
475 A → T 8 (8.4)  9.3 ≥117.1 
 
1018 G → A 6 (6.3)  6.9 ≥87.8  
1417 A → T 17 (17.9)  19.7 ≥248.8 
 
 pol3-L612M: 1.1 x dCTP, 0.9 x dTTP, 0.9 x dATP, 0.9 dGTP 
overall  96  93 12.9  
671 G → A 6 (6.3)  5.8 ≥73.5 
 
788 G → A 5 (5.2)  4.8 ≥61.2 
 
1018 G → A 14 (14.6)  13.6 ≥171.4 
 
 ura7Δ pol3-L612M: not determined 
overall  95  1560 218  
670 G → A 7 (7.4)  114.9 ≥1452.8 
 
788 G → A 14 (14.7)  229.9 ≥2905.6 
 
1018 G → A 13 (13.7)  213.5 ≥2698.1  
Mutations are shown relative to the coding strand. The predicted mutation is noted in red. Nucleotides following the mutation 
and which dNTP pools are increased in the mutants in comparison to WT are noted in green. dNTP levels are shown as fold 
over the WT (Table 4.9B). For ura7Δ double mutants, in which dNTP pools were not determined, the predicted 
intermediates are color-coded as if dCTP pools were limiting. A mutation hotspot is defined as a specific mutation found in 
more than 5% of all sequenced CANR clones in the indicated genotype. Mutation hotspots that are significant different to the 
WT control (Fisher’s exact test, Benjamini and Hochberg corrected p-value ≤ 0.05) are shown in bold. 
 
Therefore, the low dCTP levels in the absence of Ura7 presumably counteract rapid extension and 
facilitate proofreading. In contrast, rapid extension of a misinsertion at position 670 is supported on 
the expense of proofreading by the high abundance of dTTP, dATP and dGTP required for the 
synthesis of the next 11 nucleotides following the misinsertion (position 669-659). Thus, the dNTP 
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imbalance induced by the URA7 inactivation facilitates the existing mutational bias of the pol3-
L612M allele and this combination may cause the hypermutator phenotype. 
Inactivation of URA7 in pol2-M644G reduced the fraction of A-T to T-A mutations from 66% in pol2-
M644G to 51.6% of all identified events in pol2-M644G ura7. G-C to A-T mutations were 
increased 2-fold in the pol2-M644G ura7 double mutant in comparison to the pol2-M644G CAN1 
mutation spectrum, presumably due to the dNTP imbalance in ura7 cells (Table 4.9B). However, 
statistical analysis revealed that the pol2-M644G ura7 CAN1 mutation spectrum was not 
significantly different to the pol2-M644G spectrum (Fisher’s exact test, p value 0.155) supporting 
the role of pol2-M644G as replicating DNA polymerase even in the absence of Ura7. Furthermore, 
the strong A to T mutational hotspots at position 103, 475 and 1417 identified in pol2-M644G were 
also found in pol2-M644G ura7. However, the relative contribution of the individual hotspot to the 
total spectrum changed. For example, the hotspots at position 103 and 475 were identified less 
frequently in pol2-M644G ura7 than in pol2-M644G, presumably because dCTP levels are 
reduced in ura7 strains and dCTP is required at these hotspots for rapid mispair extension (even 
though not as direct adjacent nucleotide) (Table 4.13). Furthermore, as in the ura7 single mutant, 
a G to A mutation hotspot at position 1018 was detected that most likely originated from lagging 
strand replication and was presumably driven by low dCTP levels. Thus, the CAN1 mutation 
spectrum analysis of pol2-M644G ura7 suggests that the absence of a synergistic mutator 
interaction between pol2-M644G and ura7 is not due to absent DNA replication by pol2-M644G, 
but rather that the mutational bias of pol2-M644G is not supported by the ura7 induced dNTP 
imbalance. Nevertheless, the dNTP imbalance influences the relative frequency of mutational 
hotspots produced by pol2-M644G and impacts also on lagging-strand replication fidelity.  
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4.4  A RNR1 random mutagenesis screen reveals specific residues in RNR1 with 
crucial functions for dNTP homeostasis and uncovers a highly mutagenic 
dNTP imbalance. 
4.4.1 RNR1 screen identifies key residues for dNTP homeostasis and genome stability.  
The genome-wide screen had identified two genes GLN3 and URA7 that when absent caused a 
dNTP imbalance (Fig. 4.10B, Table 4.9B) by affecting the concentration of one substrate required 
for dNTP biosynthesis (Fig. 4.10A, Table 4.9A). The mutational potential of this dNTP imbalance 
was normally buffered by DNA polymerase nucleotide selectivity and proofreading as well as MMR 
but resulted in a hypermutator phenotype if any of the aforementioned processes were defective 
(Table 4.5 and 4.7). Similar synergistic mutator interactions between dNTP pool alterations and 
defects in other DNA replication fidelity mechanisms have been previously described. However, 
several open questions remain to be answered: Why certain dNTP pool alterations are more 
mutagenic than others? Which dNTP pool alterations favor frameshift mutations in vivo and which 
type of dNTP pool alteration is the most detrimental in S. cerevisiae? To address these questions 
and to further investigate the mutagenic potential of different dNTP pool alterations an RNR1 
random mutagenesis screen was conducted. Mutagenesis of RNR1 and mutator screening in an 
exo1 background was performed based on three lines of evidence: First, Rnr1 is the major large 
subunit of RNR, the master regulator of dNTP pools. Rnr1 does not only contain the C-site, but 
also the two allosteric regulatory sites making Rnr1 a critical determinant of dNTP pools 
homeostasis (Fig. 1.7) (NORDLUND AND REICHARD 2006). Second, previous studies have described 
a small number of rnr1 mutant alleles, some of them only viable in the presence of a second 
suppressed WT-RNR1 copy, with different dNTP pool alterations and effects on DNA replication 
fidelity (CHABES et al. 2003; KUMAR et al. 2010) suggesting that additional, previously unrecognized 
rnr1 alleles exist that affect dNTP pool homeostasis. Third, a chemical mutagenesis screen in 
budding yeast revealed besides MMR mutant alleles also one rnr1 allele (rnr1-G271S) as an 
exo1-dependent mutator. However, the rnr1-G271S allele was not characterized in detail at that 
time (AMIN et al. 2001). Taken together, these evidence suggested that the exo1 background 
might be used, similar to the low-fidelity DNA polymerase backgrounds in the genome-wide screen 
(SCHMIDT et al. 2017), as “sensitized mutator background” in a plasmid-based RNR1 random 
mutagenesis screen. This screen may reveal novel rnr1 alleles resulting in elevated mutator 
phenotypes driven by dNTP pool alterations.  
To identify novel rnr1 alleles that increase mutagenesis in an exo1 background, a library of 
different rnr1 alleles was generated using error-prone PCR followed by in vivo gap repair and 
screening for increased mutagenesis using three different mutator assays (CAN1 inactivation 
assay and hom3-10 and lys2-10A frameshift reversion assay) (Fig. 4.12A). In this plasmid-based 
screen approximately 39,000 Leu+ transformants were tested. Finally, 24 different rnr1 alleles were 
identified that conferred an increased mutator phenotype in the absence of Exo1 (Fig. 4.12B and C, 
Table 4.14). 11 of the 24 alleles were found more than once. For example, the rnr1-S269P, rnr1-
Y285C and rnr1-K243E alleles were found 14, 10 and 10 times, respectively.  
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Fig. 4.12 rnr1 mutations identified in a RNR1 random mutagenesis screen cluster in the S-site. 
(A) Schematic representation of the rnr1 random mutagenesis screening strategy. Briefly, a PCR-mutagenized 
rnr1 was co-transfected with a linearized plasmid (CEN6, ARSH4, LEU2) in HHY6555 for in vivo gap repair. 
The WT-RNR1-URA3 plasmid was counterselected by replica-plating on SD media containing 5-FOA followed 
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by screening for increased papillation on three mutator assay plates (hom3-10, lys2-10A and CAN1 
inactivation assay). (B) Schematic representation of the Rnr1 protein. The positions of identified mutations are 
shown as red arrows. Loop 1 and loop 2 are shown as light blue and violet boxes, respectively. Below a 
sequence alignment of S. cerevisiae Rnr1 (aa 223-294) with human, mouse and E. coli homologs is shown. 
Identified mutations are colored red. Mutated residuals that are conserved from E. coli to human are labeled 
with an asterisk. (C) Model of the Rnr1-Rnr1 homodimer based on crystal structure (PDB 2vvv in green and 
3hne superimposed in white). Identified mutations are shown as blue spheres in one subunit. (D) and (E) 
Zoom-in in the S-site (PDB 2cvv). Mutated amino acids are shown as balls and sticks model. (F) Zoom-in in 
the A-site (PDB 3hne). The mutated Phe15 and the previously described Asp57 are shown as balls and sticks 
model. 
 
This indicates a good saturation of the screen and suggests that under the screening conditions 
used not many other rnr1 alleles can be identified. 
Interestingly, most of the identified mutations (21 of the 24) clustered between amino acid (aa) 226 
and 291 of Rnr1 (Fig. 4.12B,C). This region forms the S-site and based on the available crystal 
structure of S. cerevisiae Rnr1 (XU et al. 2006a) some of the identified residuals form direct or 
indirect interactions with the bound effector nucleotide (Fig. 4.12C-E). Furthermore, two mutations 
(A245V and S425L) were located closer to the C-site and two mutations (G8D and F15S) were 
identified at the N-terminal A-site (Fig. 4.12 F).  
Taken together, this comprehensive rnr1 random mutagenesis screen identified 24 different 
mutagenic rnr1 alleles, most of them affecting residues located at the S-site between aa 226 and 
291.   
4.4.2 rnr1 mutant alleles confer exo1-dependent and exo1-independent mutator 
phenotypes. 
To validate the mutator phenotypes of the identified rnr1 alleles, mutation rates of exo1 rnr1 cells 
expressing the rnr1 alleles on a centromeric plasmid were determined using the CAN1 inactivation 
assay as well as the lys2-10A and hom3-10 frameshift reversion assay (Table 4.14). Some rnr1 
alleles like rnr1-A245V, rnr1-I262V, rnr1-G271S, rnr1-M275T, and rnr1-T282A conferred only a 
weak mutator phenotype (CAN1 inactivation rate  10-fold). Others, like rnr1-D226G/V/N, rnr1-
K243E, rnr1-I262V,M275T and rnr1-S269P caused strongly increased mutator phenotypes with up 
to 80-fold increases in the CAN1 mutation rates (Table 4.14). Remarkably, some of the rnr1 alleles 
in the absence of Exo1 were even stronger mutators than a completely MMR-deficient strain 
(msh2 + WT-RNR1) (Table 4.14).  
To examine whether the rnr1 alleles conferred a mutator phenotype in the presence of Exo1, rnr1 
alleles were expressed on a centromeric plasmid in WT-EXO1 rnr1 strains and the lys2-10A 
frameshift mutator phenotype was qualitatively evaluated (Fig. 4.13). Most of the rnr1 alleles did 
not cause increased lys2-10A reversion (as evaluated by increased papillation on -lysine mutator 
plates). However, three rnr1 alleles rnr1-K243E, rnr1-I262T,M275I and rnr1-I262V,N291D resulted 
in strongly increased lys2-10A mutator phenotypes even in the presence of Exo1. This finding 
suggests that the presumed dNTP pool alteration in the presence of these alleles is extremely 
mutagenic and overwhelms the buffer capacity of the cellular DNA replication fidelity machinery.  
Moreover, to test whether the identified rnr1 alleles also increase mutagenesis in other partially 
MMR-defective backgrounds (MARSISCHKY et al. 1996), the WT-RNR1 and four rnr1 alleles (rnr1-  
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Table 4.14 Mutation rates caused by rnr1 mutations expressed on a centromeric plasmid in the exo1Δ 
rnr1Δ mutant. 
 Mutation Rate (fold increase)* 
Allele† CanR Thr+ Lys+ 
+ RNR1-WT 1.7 [1.5-3.0] x 10-6 (1) 2.4 [1.8-3.2] x 10-8 (1) 2.2 [1.6-3.0] x 10-7 (1) 
+ rnr1-G8D,V278A 3.5 [3.1-4.9] x 10-6 (2) 2.5 [1.6-3.5] x 10-7 (10) 4.0 [2.8-8.6] x 10-6 (19) 
+ rnr1-F15S 2.6 [1.9-3.9] x 10-5 (16) 3.8 [2.7-5.0] x 10-6 (158) 3.2 [2.6-5.8] x 10-6 (15) 
+ rnr1-D226G 1.3 [0.4-1.8] x 10-4 (80) 1.8 [0.9-3.5] x 10-4 (7523) 9.3 [5.3-25.9] x 10-5 (424) 
+ rnr1-D226V 1.1 [0.5-1.7] x 10-4 (66) 1.9 [0.7-3.2] x 10-4 (7737) 1.6 [0.7-2.8] x 10-4 (753) 
+ rnr1-S117P‡,D226N 4.5 [3.0-9.0] x 10-5 (27) 1.1 [0.4-2.8] x 10-4 (4612) 1.4 [1.0-1.9] x 10-4 (645) 
+ rnr1-I231T,T244A 8.4 [6.9-11.0] x 10-6 (5) 3.3 [2.3-5.2] x 10-6 (137) 3.3 [2.9-4.5] x 10-5 (150) 
+ rnr1-S242T 4.5 [3.1-7.7] x 10-5 (27) 9.5 [6.4-16.3] x 10-6 (396) 1.6 [1.3-2.8] x 10-4 (750) 
+ rnr1-K243E 1.0 [0.7-1.2] x 10-4 (63) 3.9 [2.6-8.1] x 10-5 (1613) 2.6 [1.8-4.9] x 10-4 (1185) 
+ rnr1-T244I,V278A 1.4 [0.9-2.5] x 10-5 (8) 1.0 [0.8-2.1] x 10-5 (423) 5.7 [1.3-11.0] x 10-5 (262) 
+ rnr1-A245V 1.3 [0.9-2.3] x 10-5 (8) 5.0 [2.8-11.7] x 10-6 (207) 3.4 [2.1-6.6] x 10-6 (16) 
+ rnr1-R256H,Y779C 2.3 [1.3-3.6] x 10-5 (14) 2.9 [1.9-5.6] x 10-5 (1214) 1.6 [0.9-2.4] x 10-4 (741) 
+ rnr1-I262T,M275I 1.1 [0.8-1.9] x 10-5 (69) 2.0 [0.7-2.6] x 10-4 (8165) 4.5 [3.0-11.2] x 10-4 (2077) 
+ rnr1-I262V,N291D 6.4 [4.5-9.6] x 10-5 (39) 1.7 [1.0-2.8] x 10-5 (711) 1.8 [1.2-2.8] x 10-4 (815) 
+ rnr1-I262V 2.8 [2.1-3.4] x 10-6 (2) 2.8 [2.2-3.1] x 10-7 (12) 3.3 [1.8-6.3] x 10-6 (15) 
+ rnr1-T265A 6.3 [3.9-7.9] x 10-6 (4) 1.9 [0.9-4.1] x 10-6 (81) 3.3 [1.1-5.9] x 10-5 (153) 
+ rnr1-G267C 3.9 [2.2-7.8] x 10-5 (23) 1.0 [0.6-2.0] x 10-5 (428) 2.1 [1.8-2.8] x 10-4 (957) 
+ rnr1-S269P 8.4 [6.6-13.0] x 10-5 (51) 2.1 [1.2-4.1] x 10-4 (8595) 2.8 [2.0-4.3] x 10-4 (1276) 
+ rnr1-G271S 3.7 [3.4-4.5] x 10-6 (2) 1.1 [0.9-1.3] x 10-6 (47) 1.7 [1.4-3.6] x 10-6 (8) 
+ rnr1-P274L 5.9 [3.9-10.2] x 10-6 (4) 9.4 [5.5-11.5] x 10-7 (39) 2.7 [1.7-3.9] x 10-5 (123) 
+ rnr1-M275T 1.8 [1.0-2.4] x 10-6 (1) 2.6 [2.0-4.1] x 10-7 (11) 2.1 [1.3-6.3] x 10-6 (9) 
+ rnr1-T282A 2.9 [2.4-4.6] x 10-6 (2) 1.0 [0.8-1.5] x 10-7 (4) 2.0 [1.6-2.2] x 10-6 (9) 
+ rnr1-T282S 3.3 [2.4-6.4] x 10-6 (2) 3.3 [2.3-6.4] x 10-7 (14) 3.0 [1.5-5.5] x 10-5 (138) 
+ rnr1-A283V,S425L 8.2 [6.4-9.4] x 10-6 (5) 1.1 [0.9-1.5] x 10-6 (48) 3.1 [2.1-6.4] x 10-5 (140) 
+ rnr1-Y285C 1.1 [0.8-1.3] x 10-5 (7) 4.5 [3.5-7.1] x 10-6 (187) 7.7 [6.4-13.0] x 10-5 (35) 
msh2Δ + RNR1-WT 4.0 [2.4-6.2] x 10-5 (24) 4.3 [2.4-7.9] x 10-5 (1792) 2.3 [1.5-2.7] x 10-4 (1045) 
* Median rates for the CAN1 (CanR) inactivation assay and for hom3-10 (Thr+) and lys2-10A (Lys+) frameshift reversion 
assays with 95% confidence interval in square brackets and fold increase in parentheses, relative to rnr1Δ exo1Δ strain 
complemented with the WT-RNR1 plasmid. † Allele expressed on a low-copy number plasmid in an rnr1Δ exo1Δ strain. As 
reference for total MMR deficiency an rnr1Δ msh2Δ strain complemented with the WT-RNR1 plasmid was included. Site 
directed mutagenesis (or subcloning) was used to independently generate rnr1 single point mutants for all plasmids 
containing more than one mutation. Passenger mutations are indicated with ‡.  
 
F15S, rnr1-S242T, rnr1-I262V,N291D and rnr1-Y285C) that differed in the strength of the mutator 
phenotypes in exo1 and EXO1 backgrounds, were expressed on centromeric plasmids in msh3 
rnr1 and msh6 rnr1 cells and mutation rates were determined (Table 4.15). In comparison to 
the WT-RNR1 increased mutation rates were measured for all tested rnr1 alleles in these partially 
mismatch recognition-compromised backgrounds. In agreement with a primary role of Msh6 in 
mispair recognition and Msh3 in the detection of insertions and deletions (MARSISCHKY et al. 1996), 
increased CAN1 inactivation were predominantly found in msh6 double mutants and hom3-10 
reversions were more abundant in msh3 double mutants 
Thus, the here identified rnr1 alleles presumably induce dNTP pool alterations that not only 
facilitates misinsertions, but also slippage events, leading to increased mutagenesis in MMR-
compromised backgrounds. Remarkably, three rnr1 alleles caused presumably such a mutagenic 
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dNTP pool alteration that increased frameshift mutations were detected even in an MMR-proficient 
WT background.  
 
 
Fig. 4.13 rnr1 mutation screen identifies exo1Δ-dependent and independent mutator phenotypes. 
Qualitative patch test of rnr1Δ strains expressing WT-RNR1 or rnr1 mutant alleles on a centromeric LEU2 
plasmid. Increased papillation is indicative for an elevated frameshift mutator phenotype. Three colonies per 
genotype were patched. rnr1 alleles which confer a strong frameshift mutator phenotype in the WT rnr1Δ 
background are colored in red. Passenger mutations are labeled with asterisks. As positive mutator control 
rnr1Δ exo1Δ complemented with rnr1-G271S expressed from a centromeric LEU2 plasmid was used. 
 
Table 4.15 Mutation rates of rnr1 mutants expressed from a centromeric plasmid in an msh3Δ rnr1Δ 
and msh6Δ rnr1Δ background. 
 Mutation Rate (fold increase)* 
Allele† CanR Thr+ Lys+ 
WT + RNR1-WT 2.8 [1.9-3.2] x 10-7 (1) 5.3 [3.5-7.1] x 10-9 (1) 1.6 [0.9-3.2] x 10-8 (1) 
msh2Δ + RNR1-WT 4.0 [2.4-6.2] x 10-5 (145) 4.3 [2.4-7.9] x 10-5 (8090) 2.3 [1.5-2.7] x 10-4 (14470) 
msh3Δ + RNR1-WT 8.4 [6.6-13.1] x 10-7 (3) 2.4 [2.0-3.7] x 10-7 (46) 1.1 [0.9-2.3] x 10-6 (72) 
msh3Δ + rnr1-F15S 4.4 [2.6-6.1] x 10-6 (16) 9.0 [6.4-14.4] x 10-7 (169) 1.3 [0.7-1.6] x 10-6 (81) 
msh3Δ + rnr1-S242T 6.3 [3.5-11.2] x 10-6 (23) 3.9 [2.3-6.8] x 10-6 (726) 5.7 [3.6-8.2] x 10-6 (365) 
msh3Δ + rnr1-I262V,N291D 1.9 [1.4-2.4] x 10-5 (69) 1.2 [0.8-1.5] x 10-5 (2332) 3.1 [2.0-4.2] x 10-5 (2011) 
msh3Δ + rnr1-Y285C 1.5 [1.1-2.5] x 10-5 (55) 2.0 [1.6-2.6] x 10-6 (385) 2.5 [1.2-3.7] x 10-6 (160) 
msh6Δ + RNR1-WT 1.3 [1.0-2.0] x 10-5 (47) 1.2 [0.6-1.5] x 10-7 (22) 2.6 [1.5-4.3] x 10-6 (169) 
msh6Δ + rnr1-F15S 8.3 [6.0-12.0] x 10-5 (298) 5.9 [2.9-9.4] x 10-7 (111) 1.8 [1.2-4.1] x 10-6 (116) 
msh6Δ + rnr1-S242T 6.4 [4.2-11.8] x 10-5 (232) 2.7 [1.6-6.4] x 10-6 (514) 2.4 [1.2-3.7] x 10-5 (1564) 
msh6Δ + rnr1-I262V,N291D 1.2 [0.4-1.5] x 10-4 (436) 1.3 [0.9-2.4] x 10-6 (248) 4.4 [1.4-5.7] x 10-5 (2827) 
msh6Δ + rnr1-Y285C 1.3 [1.0-1.7] x 10-4 (453) 2.6 [1.9-3.5] x 10-6 (495) 9.4 [6.8-24.9] x 10-6 (606) 
* Median rates of inactivation of CAN1 gene (CanR) and lys2-10A (Lys+) and hom3-10 (Thr+) frameshift reversion with 95% 
confidence interval in square brackets and fold increase in parentheses, relative to the WT-RNR1 plasmid.  
† Allele expressed from a low copy number plasmid in rnr1Δ msh3Δ or rnr1Δ msh6Δ background. 
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4.4.3 rnr1 mutant alleles rely differentially on DNA damage response, DNA proofreading 
and MMR.  
Mutations in RNR1 can severely compromise RNR catalytic activity, so that cells depend on an 
active S-phase checkpoint and expression of the alternative large RNR subunit RNR3 to produce 
sufficient amounts of dNTP for DNA replication (KUMAR et al. 2010). Moreover, as observed for the 
ura7 + pol3-01 (Fig. 4.8), the combination of mutagenic dNTP pool alterations and the absence of 
DNA proofreading or MMR can result in hypermutator phenotypes that severely impair viability 
leading to growth defects (GD) or even synthetic lethality (SL). Thus, the dependency of the rnr1 
mutants on functional DDR, as well as potential GD/SL genetic interactions with DNA proofreading 
and MMR mutants were investigated using plasmid shuffling (Fig. 4.14, 4.15).  
 
 
Fig. 4.14 Specific rnr1 mutant alleles depend on DNA damage checkpoint for survival.  
(A) Schematic representation of the experimental outline to investigate genetic interactions by plasmid 
shuffling. Centromeric LEU2 plasmids encoding the WT and mutant rnr1 alleles were transformed in WT and 
DNA damage checkpoint- or DNA replication fidelity-compromised rnr1Δ backgrounds complemented with 
WT-RNR1-URA3 plasmid. Overnight cultures were spotted in serial dilution on SD medium lacking Leu and 
containing 5-FOA to counterselect for the WT-RNR1-URA3 plasmid and screened for synthetic interactions.  
(B) Representative images of yeast strains of the indicated genotypes (complemented by WT or mutant rnr1 
plasmids), serially diluted and spotted onto Leu- +5-FOA containing media. Images were taken after 4 days at 
30 °C. 
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In the absence of Rnr3 SL interactions were observed in the rnr1-D226G/V/N, rnr1-R256H,Y779C 
and rnr1-I262T,M275I and a GD was detected for rnr1-S269P (Fig. 4.14B). Similar dependency of 
these alleles was observed for the DDR kinase Dun1, which is required to inactivate the negative 
regulators of RNR. Previous reports suggested two branches of the S-phase checkpoint, one 
Rad9- and the other Mrc1-dependent (PARDO et al. 2017). To test, whether the identified rnr1 
alleles relied more on one or the other branch, plasmid shuffling was performed in backgrounds 
either deficient for Rad9 or Mrc1. No rnr1 allele conferred severe GD in the absence of Rad9 or 
Mrc1 suggesting that both checkpoint mediators can compensate for each other and support 
growth of the Rnr3-dependent rnr1 alleles even if one of them is absent (Fig. 4.14B).  
 
 
 
The identified genetic interactions between the rnr1 alleles and DNA polymerase proofreading-
defective strains (pol3-01 and pol2-04) and MMR-deficient mutant (msh2) (Fig. 4.15), in 
combination with the mutator phenotypes in the presence (Fig. 4.13) or absence of Exo1 (Table 
4.14) were used to categorize the identified rnr1 alleles in four groups (summarized in Table 4.16).  
Fig. 4.15 Specific rnr1 mutant alleles depend on DNA 
proofreading or DNA mismatch repair for survival. 
A) and (B) Representative images of yeast strains of the 
indicated genotypes (complemented by WT or mutant rnr1 
plasmids), serially diluted and spotted onto Leu- +5-FOA 
containing media. Images were taken after 4 days at 30 °C. 
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Table 4.16 Summary of rnr1 mutant alleles identified in this study, including their genetic interactions 
and mutator phenotypes. 
 synthetic growth defect/lethality CAN1 
mutator 
phenotype 
in exo1Δ (1) 
frameshift 
mutator 
phenotype 
in EXO1-
WT (2) 
Allele* rnr3Δ‡ pol3-01 pol2-04 msh2Δ 
group 1 (no interaction or just with pol3-01) 
rnr1-G8D,V278A - - - - weak - 
rnr1-F15S - - - - strong - 
rnr1-I231T,T244A - - - - weak - 
rnr1-T244I,V278A - SL - - moderate - 
rnr1-I262V - - - - weak - 
rnr1-T265A - GD - - weak - 
rnr1-P274L - GD - - weak - 
rnr1-M275T - - - - weak - 
rnr1-T282A - - - - weak - 
rnr1-T282S - - - - weak - 
rnr1-A283V,S425L - SL - - weak - 
group 2 (interaction with pol2-04 and pol3-01) 
rnr1-A245V - SL GD - moderate - 
rnr1-G271S - SL GD - weak - 
rnr1-Y285C - SL GD - moderate - 
group 3 (interaction with pol2-04, pol3-01 and msh2Δ) 
rnr1-D226G SL GD GD GD strong - 
rnr1-D226V SL GD GD GD strong - 
rnr1- D226N‡,S117P SL GD GD GD strong - 
rnr1-S242T - SL GD GD strong - 
rnr1-R256H,Y779C SL SL GD GD strong - 
rnr1-G267C - SL GD GD strong - 
rnr1-S269P GD SL GD GD strong - 
group 4 (interaction with pol2-04, pol3-01 and msh2Δ and mutator in EXO1-WT) 
rnr1-K243E - SL GD GD strong mutator 
rnr1-I262T,M275I SL SL GD GD strong mutator 
rnr1-I262V,N291D - SL GD GD strong mutator 
* Indicated allele expressed on a low-copy number plasmid was used for complementation studies in strains lacking the 
chromosomal RNR1 gene in addition to the indicated mutations. Passenger mutations are marked with †. "-" indicates 
growth similar to WT-RNR1; "GD", growth defect; "SL", synthetic lethality. ‡rnr1 alleles showing GD or SL in the absence of 
RNR3 also showed GD or SL in the absence of DUN1. 
(1) mutator phenotype according to the CAN1 inactivation rate (Table 1) fold increase over WT-RNR1 (in rnr1Δ exo1Δ): 2-5 
= weak; 6-10 = moderate; ≥ 11 = strong. 
(2) frameshift mutator phenotype (lys2-10A assay) in EXO1-WT rnr1Δ background (Fig. 4.13). 
 
Group 1 consists of rnr1 alleles that did not interact with any of the tested alleles or just with pol3-
01 (rnr1-G8D,V278A, rnr1-F15S, rnr1-I231T,T244A, rnr1-T244I,V278A, rnr1-I262V, rnr1-T265A, 
rnr1-P274L, rnr1-M275T, rnr1-T282A, rnr1-T282S and rnr1-A283V,S425L). Most of the rnr1 alleles 
in this group caused weak mutator phenotypes in the absence of Exo1 (5-fold in CAN1 
inactivation). Group 2 rnr1 alleles showed GD/SL exclusively with the DNA proofreading defective 
alleles (pol3-01 and pol2-04), but not in the absence of MMR (rnr1-A245V, rnr1-G271S and rnr1-
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Y285C). These rnr1 alleles conferred weak or moderate mutator phenotypes in the absence of 
Exo1 (10-fold in CAN1 inactivation). Group 3 contains the rnr1 alleles that showed GD/SL in the 
absence of DNA proofreading and MMR (rnr1-D226G/V/N, rnr1-S242T, rnr1-R256H,Y779C, rnr1-
G267C and rnr1-S269P). The mutator phenotype of the rnr1 alleles in this group was strong in the 
absence of Exo1, but no elevated frameshift mutator phenotype was observed in the presence of 
Exo1. Finally, group 4 includes the rnr1 alleles that showed GD/SL in the absence of DNA 
proofreading and MMR and strongly increased mutagenesis in the absence and presence of Exo1 
(rnr1-K243E, rnr1-I262T,M275I and rnr1-I262V,N291D). This distinct dependencies on DNA 
proofreading and MMR suggest that replication errors caused by the potentially dNTP pool 
alterations rely differentially on DNA proofreading and MMR for repair.  
4.4.4 rnr1 mutants cause either overall increased or imbalanced dNTP pools. 
To validate that the measured increased mutator phenotypes and the detected genetic interactions 
of the rnr1 alleles were caused by altered dNTP pools, NTP and dNTP concentrations were 
measured by HPLC (collaboration with Chabes lab, Umeå University) for those rnr1 alleles above a 
defined mutator threshold (5-fold increase in CAN1 assay or 40-fold increase in hom3-10 assay 
 
Table 4.17 NTP concentrations in strains expressing rnr1 mutant alleles on a centromeric plasmid. 
 NTP concentration (pmol per 108 cells)* 
Allele CTP UTP ATP GTP 
+ WT-RNR1 2139 ± 165 (1.0) 4249 ± 130 (1.0) 13792 ± 870 (1.0) 3232 ± 197 (1.0) 
group 1 (no interaction or just with pol3-01) 
+ rnr1-F15S 2073 ± 50 (1.0) 3926 ± 8 (0.9) 14255 ± 40 (1.0) 2753 ± 86 (0.9) 
+ rnr1-I231T,T244A 2105 ± 72 (1.0) 3734 ± 36 (0.9) 14223 ± 34 (1.0) 2854 ± 81 (0.9) 
+ rnr1-T244I,V278A 2066 ± 7 (1.0) 3810 ± 32 (0.9) 14108 ± 8 (1.0) 2888 ± 15 (0.9) 
+ rnr1-T265A 2122 ± 1 (1.0) 3912 ± 197 (0.9) 14480 ± 448 (1.0) 2947 ± 42 (0.9) 
+ rnr1-A283V,S425L 2143 ± 37 (1.0) 4050 ± 118 (1.0) 13975 ± 383 (1.0) 2610 ± 61 (0.8) 
group 2 (interaction with pol2-04 and pol3-01) 
+ rnr1-A245V 1930 ± 56 (0.9) 4132 ± 119 (1.0) 15154 ± 182 (1.1) 3450 ± 37 (1.1) 
+ rnr1-G271S 2267 ± 39 (1.1) 4218 ± 6 (1.0) 15307 ± 11 (1.1) 3674 ± 50 (1.1) 
+ rnr1-Y285C 2100 ± 105 (1.0) 3904 ± 80 (0.9) 14817 ± 173 (1.1) 2907 ± 62 (0.9) 
group 3 (interaction with pol2-04, pol3-01 and msh2Δ) 
+ rnr1-D226G 2202 ± 61 (1.0) 3913 ± 114 (0.9) 14276 ± 518 (1.0) 2870 ± 56 (0.9) 
+ rnr1-D226V 2096 ± 26 (1.0) 3809 ± 33 (0.9) 13770 ± 124 (1.0) 2921 ± 47 (0.9) 
+ rnr1-S117P,D226N 2029 ± 70 (0.9) 3728 ± 281 (0.9) 13955 ± 1034 (1.0) 3047 ± 81 (0.9) 
+ rnr1-S242T 2185 ± 14 (1.0) 3849 ± 193 (0.9) 14395 ± 462 (1.0) 2915 ± 55 (0.9) 
+ rnr1-R256H,Y779C 2103 ± 60 (1.0) 4101 ± 88 (1.0) 13750 ± 58 (1.0) 3005 ± 41 (0.9) 
+ rnr1-G267C 2182 ± 2 (1.0) 4068 ± 8 (1.0) 14103 ± 105 (1.0) 2828 ± 15 (0.9) 
+ rnr1-S269P 1922 ± 35 (0.9) 4154 ± 136 (1.0) 14738 ± 1198 (1.1) 3013 ± 233 (0.9) 
group 4 (interaction with pol2-04, pol3-01 and msh2Δ and mutator in EXO1-WT) 
+ rnr1-K243E 2173 ± 9 (1.0) 4177 ± 114 (1.0) 14350 ± 222 (1.0) 2703 ± 18 (0.8) 
+ rnr1-I262T,M275I 2075 ± 22 (1.0) 3905 ± 54 (0.9) 13932 ± 242 (1.0) 2843 ± 52 (0.9) 
+ rnr1-I262V,N291D 2110 ± 15 (1.0) 4432 ± 136 (1.0) 15045 ± 131 (1.1) 2970 ± 51 (0.9) 
* NTP concentrations (pmol per 108 cells) are the average of two biological replicates ± standard deviation with the fold 
increase over WT in parentheses. NTP concentrations were measured by the Chabes lab. 
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or 150-fold increase in the lys2-10A assay (the difference in the mutator thresholds takes into 
consideration the different linear range of the used assays)). In agreement with a function of Rnr1 
downstream of NTP biosynthesis, NTP concentrations were largely unchanged in comparison to 
the WT (Table 4.17). All rnr1 alleles caused altered dNTP pools (Fig. 4.16A, Table 4.18) supporting 
the idea that the observed phenotypes in DNA replication fidelity-compromised backgrounds were 
due to dNTP pool alterations. Except for one rnr1 allele (rnr1-F15S) that caused overall increased 
dNTP levels (in average 6.5-fold over WT), all other alleles induced dNTP pool imbalances. All 
dNTP imbalances were characterized by elevated pyrimidine levels, relatively low dATP levels and 
either low or increased dGTP pools. In contrast to the dCTP/dTTP ratio, which was relatively stable 
(0.9-1.6 fold) between the different mutants, the rnr1 alleles differed strongly in the dGTP/dATP 
ratio (0.6-13.4 fold), which was primarily a consequence of the altered dGTP levels (Table 4.18). 
 
Table 4.18 dNTP concentrations in strains expressing rnr1 mutant alleles on a centromeric plasmid. 
 dNTP concentration (pmol per 108 cells)* 
Allele dCTP dTTP dATP dGTP 
+ WT-RNR1 117 ± 17 (1.0) 260 ± 17 (1.0) 170 ± 20 (1.0) 73 ± 4 (1.0) 
group 1 (no interaction or just with pol3-01) 
+ rnr1-F15S 866 ± 34 (7.4) 1439 ± 129 (5.5) 1125 ± 156 (6.6) 461 ± 31 (6.3) 
+ rnr1-I231T,T244A 525 ± 17 (4.5) 1065 ± 78 (4.1) 287 ± 59 (1.7) 256 ± 24 (3.5) 
+ rnr1-T244I,V278A 783 ± 12 (6.7) 1377 ± 22 (5.3) 352 ± 2 (2.1) 255 ± 7 (3.5) 
+ rnr1-T265A 436 ± 62 (3.7) 833 ± 61 (3.2) 205 ± 0 (1.2) 164 ± 7 (2.3) 
+ rnr1-A283V,S425L 370 ± 17 (3.2) 741 ± 61 (2.8) 314 ± 19 (1.8) 682 ± 49 (9.4) 
group 2 (interaction with pol2-04 and pol3-01) 
+ rnr1-A245V 524 ± 84 (4.5) 1005 ± 105 (3.9) 123 ± 21 (0.7) 30 ± 7 (0.4) 
+ rnr1-G271S 711 ± 106 (6.1) 1426 ± 97 (5.5) 343 ± 59 (2.0) 101 ± 10 (1.4) 
+ rnr1-Y285C 950 ± 76 (8.1) 1662 ± 43 (6.4) 166 ± 40 (1.0) 74 ± 4 (1.0) 
group 3 (interaction with pol2-04, pol3-01 and msh2Δ) 
+ rnr1-D226G 521 ± 43 (4.5) 896 ± 73 (3.4) 204 ± 18 (1.2) 238 ± 22 (3.3) 
+ rnr1-D226V 565 ± 11 (4.8) 945 ± 8 (3.6) 200 ± 0 (1.2) 235 ± 8 (3.2) 
+ rnr1-S117P,D226N 338 ± 44 (2.9) 599 ± 66 (2.3) 149 ± 4 (0.9) 169 ± 23 (2.3) 
+ rnr1-S242T 559 ± 30 (4.8) 1033 ± 39 (4.0) 87 ± 3 (0.5) 358 ± 51 (4.9) 
+ rnr1-R256H,Y779C 1155 ± 80 (9.9) 1771 ± 80 (6.8) 121 ± 3 (0.7) 303 ± 13 (4.2) 
+ rnr1-G267C 548 ± 18 (4.7) 1030 ± 28 (4.0) 141 ± 7 (0.8) 583 ± 39 (8.0) 
+ rnr1-S269P 2135 ± 273 (18.3) 3032 ± 338 (11.6) 340 ± 70 (2.0) 312 ± 2 (4.3) 
group 4 (interaction with pol2-04, pol3-01 and msh2Δ and mutator in EXO1-WT) 
+ rnr1-K243E 765 ± 36 (6.6) 1331 ± 76 (5.1) 259 ± 7 (1.5) 968 ± 61 (13.3) 
+ rnr1-I262T,M275I 720 ± 50 (6.2) 1163 ± 87 (4.5) 168 ± 6 (1.0) 536 ± 86 (7.4) 
+ rnr1-I262V,N291D 404 ± 35 (3.5) 852 ± 22 (3.3) 140 ± 14 (0.8) 780 ± 16 (10.7) 
* dNTP concentrations (pmol per 108 cells) are the average of two biological replicates ± standard deviation with the fold 
increase over WT in parentheses. dNTP concentrations were measured by the Chabes lab.  
 
To examine whether the observed genetic interactions could be correlated to the measured dNTP 
pools, the log2 of the dGTP/(dCTP+dTTP) ratio normalized to the WT was plotted against the 
relative fraction of dATP to the total dNTP pool (Fig. 4.16B). As all rnr1 alleles, except rnr1-F15S, 
showed a relative decrease in the fraction of dATP to the total dNTP pool in comparison to the WT, 
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the ratio between dGTP and pyrimidines can discriminate between an equal increase and a 
relatively stronger increase in either dGTP or pyrimidines. Thus, alleles, which caused an equal 
increase in dGTP and pyrimidines were plotted on the x-axis (y = 0), whereas alleles that resulted 
in relatively stronger increases of dGTP or pyrimidines were plotted above (y  0) and below (y  0) 
the x-axis, respectively. Interestingly, rnr1 alleles that interacted exclusively with the proofreading-
deficient alleles (group 2, colored in blue) caused at least a 4-fold stronger increase in pyrimidines 
than in dGTP (y  -2). In contrast, the rnr1 alleles that showed GD/SL in DNA proofreading and 
MMR-deficient backgrounds (group 3 (orange) and group 4 (red)) clustered in a region defined by 
less than 12% dATP of the total dNTP pool and a dGTP/pyrimidine ratio  0.25. In comparison to 
group 3, group 4 mutants, that additionally caused a frameshift mutator phenotype in the presence 
of Exo1, showed the strongest increases in the dGTP pools. One exception is the rnr1-G267C 
allele, which was almost indistinguishable from the rnr1-I262T,M275I allele in terms of dNTP pool 
alterations, but did not caused a frameshift mutator phenotype in the presence of Exo1. This 
discrepancy might be explained by differences in cell cycle progression and Rnr3 dependency (Fig. 
4.14B, Table 4.16). 
 
 
Fig. 4.16 Identified rnr1 mutant alleles cause increased dNTP pools or dNTP pool imbalances. 
(A) dNTP concentration measurement in the indicated rnr1Δ strains after plasmid shuffling (Table 4.18). Data 
is shown as fold over WT. The numbers on top represent the fold over WT. Fold increases are colored in 
green, whereas decreased levels are labeled red. rnr1 alleles are grouped and color-coded according to 
genetic interactions (Table 4.16). (B) Graphical representation of the log2 of the ratio between dGTP and the 
sum of dCTP and dTTP normalized to the WT against the %dATP of the total dNTP pool. rnr1 alleles are 
color-coded according to genetic interactions (Table 4.16) 
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Taken together, the rnr1 alleles identified in the RNR1 random mutagenesis screen caused four 
different types of dNTP pool alterations with distinct genetic interactions: First, overall increased but 
balanced dNTP pools (rnr1-F15S) did not cause any genetic interactions (part of group 1, grey). 
Second, a dNTP imbalance characterized by elevated pyrimidine pools and low purine pools (“low 
purines” or “2 out of 4”) depended on DNA proofreading but not MMR for survival (group 2, blue). 
Third, low dATP pools and increased pyrimidine and dGTP pools (“low dATP” or “3 out 4”) 
characterized the rnr1 alleles that were dependent on DNA proofreading and MMR (group 3, 
orange). Fourth, dNTP imbalances with low dATP pools, elevated pyrimidines and strongly 
increased dGTP pools (“low dATP + high dGTP” or “3 out 4 + high dGTP”). These alleles were 
dependent on DNA proofreading and MMR for survival and conferred a mutator phenotype in the 
presence of Exo1 (group 4, red).  
4.4.5 rnr1 alleles expressed at the endogenous locus cause dNTP pool alteration, 
checkpoint activation and increased mutagenesis.  
To further characterize the identified rnr1 alleles and their dNTP pool alterations, two 
representative examples of each type of dNTP pool alteration were integrated at the endogenous 
chromosomal locus. As only one rnr1 allele (rnr1-F15S) was identified in the screen that caused an 
overall increased dNTP pool, the previously reported rnr1-D57N allele, which is refractory to dATP 
inhibition at the A-site, resulting in overall increased dNTPs (CHABES et al. 2003), was included in 
the analysis. For the “low purine” type of dNTP imbalance the rnr1 alleles with the lowest purine 
pools were selected (rnr1-A245V and rnr1-Y285C). For the “low dATP” type of dNTP imbalance the 
rnr1-S242T and rnr1-R256H,Y779C were chosen, representing a Rnr3-independent and -
dependent allele, respectively. Finally, for the “low dATP + high dGTP” type of dNTP pool 
imbalance the two alleles (rnr1-K243E and rnr1-I262V,N291D) with the highest increases in dGTP 
were integrated at the endogenous locus. Next, mutation rates were determined in the presence 
and absence of Exo1 (Table 4.19). Only mild mutator phenotypes were measured in the WT 
background (1-4 fold increase in CAN1 inactivation rate), except for rnr1-K243E and rnr1-
I262V,N291D. The latter mutants caused 92- and 164-fold higher CAN1 inactivation rates 
compared to WT, respectively. Remarkably, these high CAN1 mutation rates are 1.5- and 2.6-fold 
higher than in a completely MMR-deficient msh2 strain (Table 4.19). Moreover, both rnr1 alleles 
caused strong frameshift mutator phenotype in the range of a complete MMR-defect. Thus, in line 
with the results obtained with rnr1 alleles expressed on centromeric plasmids (Fig. 4.13), only rnr1-
K243E and rnr1-I262V,N291D caused strong mutator phenotypes in a WT background and the 
mutagenic potential of the other rnr1 alleles was buffered by other DNA replication fidelity 
mechanisms.   
In the absence of Exo1, strong increases in all three mutator assays were observed for all rnr1 
alleles except for the rnr1-D57N allele (Table 4.19). Even though rnr1-F15S and rnr1-D57N caused 
similar increases in the CAN1 inactivation assay in the presence of Exo1 (4- and 3-fold, 
respectively), only rnr1-F15S showed synergistically increased mutation rates in combination with 
exo1 suggesting that the dNTP pool alteration in rnr1-F15S is more severe in comparison to rnr1-
D57N. Furthermore, the rnr1-K243E exo1 double mutant could not be obtained by mating in 
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several attempts presumably due to the high mutational load in the double mutant or due to DNA 
replication-independent defects. 
 
Table 4.19 Mutation rates caused by rnr1 mutations integrated at the RNR1 genomic locus in Exo1-
proficient and Exo1-deficient backgrounds. 
 Mutation Rate (fold increase)* 
Relevant genotype CanR Thr+ Lys+ 
WT 8.7 [7.2-10.0] x 10-8 (1) 2.0 [1.1-3.0] x 10-9 (1) 2.1 [1.8-2.3] x 10-8 (1) 
exo1Δ 7.4 [6.3-9.8] x 10-7 (9) 8.7 [6.1-15.0] x 10-9 (4) 1.4 [0.9-1.8] x 10-7 (7) 
msh2Δ 5.4 [4.4-7.2] x 10-6 (62) 6.4 [5.2-12.9] x 10-6 (3200) 9.9 [8.1-10.8] x 10-5 (4714) 
“overall increased” 
rnr1-F15S 3.5 [2.8-4.2] x 10-7 (4) 5.3 [4.4-7.6] x 10-9 (3) 2.0 [1.6-2.6] x 10-8 (1) 
rnr1-F15S exo1Δ 5.1 [3.9-6.3] x 10-6 (59) 6.5 [4.0-8.9] x 10-7 (330) 1.9 [1.3-2.3] x 10-6 (93) 
rnr1-D57N  2.2 [2.0-3.7] x 10-7 (3) 4.2 [2.5-7.5] x 10-9 (2) 1.6 [1.3-2.3] x 10-8 (1) 
rnr1-D57N exo1Δ 6.5 [4.0-9.1] x 10-7 (7) 1.6 [1.2-1.8] x 10-8 (8) 4.6 [3.5-6.4] x 10-8 (2) 
“low purines” 
rnr1-A245V 1.1 [0.8-1.4] x 10-7 (1) 3.1 [2.1-4.2] x 10-8 (16) 3.8 [2.2-5.3] x 10-8 (2) 
rnr1-A245V exo1Δ 2.0 [1.1-3.7] x 10-6 (22) 1.1 [0.6-2.1] x 10-5 (5405) 1.3 [0.8-3.1] x 10-5 (634) 
rnr1-Y285C 3.2 [1.8-5.1] x 10-7 (4) 4.8 [3.7-8.7] x 10-8 (24) 1.6 [0.9-2.0] x 10-7 (8) 
rnr1-Y285C exo1Δ 1.6 [1.1-3.2] x 10-5 (184) 4.6 [3.0-7.8] x 10-5 (23037) 1.9 [1.6-5.5] x 10-4 (9139) 
“low dATP” 
rnr1-S242T 2.6 [2.0-5.1] x 10-7 (3) 1.6 [1.1-3.1] x 10-8 (8) 1.3 [0.8-2.7] x 10-7 (6) 
rnr1-S242T exo1Δ 2.4 [1.9-4.0] x 10-5 (273) 9.4 [5.8-18.5] x 10-6 (4743) 1.7 [1.3-3.0] x 10-4 (8017) 
rnr1-R256H,Y779C 9.5 [7.1-16.0] x 10-8 (1) 2.6 [1.4-4.0] x 10-8 (13) 9.2 [7.2-11.6] x 10-8 (4) 
rnr1-R256H,Y779C exo1Δ 2.2 [1.5-3.3] x 10-6 (25) 3.2 [2.1-3.2] x 10-6 (1619) 7.3 [5.4-8.8] x 10-6 (351) 
“low dATP + high dGTP” 
rnr1-K243E† 8.1 [4.4-11.3] x 10-6 (92) 1.5 [1.1-2.4] x 10-5 (7362) 2.7 [2.0-4.6] x 10-5 (1319) 
rnr1-I262V,N291D 1.4 [0.9-2.4] x 10-5 (164) 5.4 [3.8-8.3] x 10-6 (2731) 6.7 [4.5-10.8] x 10-5 (3216) 
rnr1-I262V,N291D exo1Δ 4.3 [3.1-7.1] x 10-5 (489) 1.9 [0.7-3.0] x 10-5 (9366) 2.1 [0.9-3.4] x 10-4 (10103) 
* Median rates of inactivation of CAN1 gene (CanR) and hom3-10 (Thr+) and lys2-10A (Lys+) frameshift reversion, with 95% 
confidence interval in square brackets and fold increase relative to WT strain in parentheses. Strains with partial or total loss 
of mismatch repair activity (exo1Δ and msh2Δ, respectively) were included as reference.  
† The rnr1-K243E exo1Δ strain could not be obtained by mating. 
 
Next, NTP and dNTP concentrations of the rnr1 mutant alleles integrated at the endogenous RNR1 
locus were measured by HPLC (Table 4.20). NTP levels were indistinguishable from WT levels 
(Table 4.20A). The dNTP concentration of rnr1 mutant alleles integrated at the endogenous RNR1 
locus (Fig. 4.17A, Table 4.20B) were in agreement with the dNTP concentrations measured in cells 
expressing rnr1 alleles on a centromeric plasmid (Table 4.18). Minor changes might be based on 
the difference between the expression from the endogenous chromosomal locus and from a low 
copy number plasmid. In line with the literature report (CHABES et al. 2003), the rnr1-D57N allele 
showed an overall increase in dNTP pools (in average 3.6-fold over WT), but the increase was 
approximately 50% weaker than in rnr1-F15S suggesting indeed that the lack of interaction with 
exo1 is due to the less severe dNTP pool alteration. 
In some of the rnr1 mutants, like rnr1-A245V and rnr1-R256H,Y779C, dNTP pools below the WT 
levels were found (Figure 4.17A, Table 4.20B). To evaluate the cell cycle and DDR activation, the 
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DNA content and induction of RNR subunits were analyzed in logarithmically growing cells. DNA 
content analysis by flow cytometry revealed that overall increased dNTP pools did not severely 
alter the cell cycle, whereas reductions of 30% and more in one individual dNTP pool resulted in an 
accumulation of cells in S phase (Fig. 4-17A,B). Furthermore, cells with a “low dATP and high 
dGTP” type of dNTP imbalance did not accumulate in S phase, but nevertheless showed an altered 
cell cycle distribution and an accumulation of cells in G2 phase (Fig. 4.17B). 
 
Table 4.20 NTP and dNTP concentrations in strains containing rnr1 mutant alleles integrated at the 
endogenous RNR1 locus 
A  
Relevant genotype CTP UTP ATP GTP 
WT 2195 ± 18 (1.0) 5449 ± 93 (1.0) 11386 ± 363 (1.0) 3473 ± 10 (1.0) 
“overall increased”     
rnr1-F15S 2110 ± 103 (1.0) 5411 ± 111 (1.0) 11773 ± 169 (1.0) 3519 ± 42 (1.0) 
rnr1-D57N 2167 ± 12 (1.0) 5376 ± 212 (1.0) 11754 ± 178 (1.0) 3455 ± 64 (1.0) 
“low purines”     
rnr1-A245V 1997 ± 33 (0.9) 5384 ± 152 (1.0) 11725 ± 165 (1.0) 3730 ± 4 (1.1) 
rnr1-Y285C 2004 ± 34 (0.9) 5322 ± 84 (1.0) 11916 ± 77 (1.0) 3702 ± 132 (1.1) 
“low dATP”     
rnr1-S242T 2125 ± 14 (1.0) 5804 ± 62 (1.1) 11751 ± 96 (1.0) 3246 ± 47 (0.9) 
rnr1-R256H, Y779C 2325 ± 22 (1.1) 5094 ± 124 (0.9) 11370 ± 251 (1.0) 3468 ± 30 (1.0) 
“low dATP + high dGTP”    
rnr1-K243E 2283 ± 6 (1.0) 5312 ± 803 (1.0) 12946 ± 1484 (1.1) 2953 ± 85 (0.9) 
rnr1-I262V,N291D 1907 ± 435 (0.9) 5039 ± 333 (0.9) 14892 ± 12222 (1.3) 3152 ± 118 (0.9) 
B     
Relevant genotype dCTP dTTP dATP dGTP 
WT 146 ± 18 (1.0) 292 ± 27 (1.0) 158 ± 17 (1.0) 80 ± 7 (1.0) 
“overall increased”     
rnr1-F15S 972 ± 99 (6.7) 1672 ± 116 (5.7) 1151 ± 145 (7.3) 522 ± 58 (6.6) 
rnr1-D57N 521 ± 181 (3.6) 984 ± 250 (3.4) 640 ± 236 (4.0) 294 ± 99 (3.7) 
“low purines”     
rnr1-A245V 1057 ± 71 (7.2) 1712 ± 130 (5.9) 69 ± 2 (0.4) 54 ± 4 (0.7) 
rnr1-Y285C 1304 ± 48 (8.9) 2226 ± 62 (7.6) 139 ± 2 (0.9) 114 ± 2 (1.4) 
“low dATP”     
rnr1-S242T 935 ± 44 (6.4) 1596 ± 66 (5.5) 133 ± 14 (0.8) 762 ± 45 (9.6) 
rnr1-R256H, Y779C 481 ± 20 (3.3) 784 ± 16 (2.7) 80 ± 3 (0.5) 221 ± 3 (2.8) 
“low dATP + high dGTP”    
rnr1-K243E 1796 ± 123 (12.3) 2891 ± 292 (9.9) 536 ± 7 (3.4) 1656 ± 28 (20.8) 
rnr1-I262V,N291D 404 ± 88 (2.8) 869 ± 10 (3.0) 190 ± 1 (1.2) 1365 ± 290 (17.1) 
NTP (A) and dNTP (B) concentrations (pmol per 108 cells) are the average of two biological replicates ± standard deviation 
with the fold increase over WT in parentheses. NTP and dNTP concentrations were measured by the Chabes lab. 
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Fig. 4.17 rnr1 mutant alleles expressed at the endogenous chromosomal locus cause dNTP pool 
alterations and DNA damage checkpoint activation. 
(A) dNTP concentration measurement in the indicated strains (Table 4.20B). Data is shown as fold over WT. 
The numbers on top of each bar represent the fold over WT. Fold increases are colored in green, whereas 
decreased levels are labeled red. The blue number represents the fold over WT in the CAN1 mutation rate 
measured in the rnr1 WT-EXO1 strains (Table 4.19). rnr1 alleles are grouped and color-coded according to 
genetic interactions, type of dNTP pool alteration and mutator phenotype (Table 4.16). (B) DNA content 
profiles of logarithmically growing strains of the indicated genotypes in A. Cells in S phase were approximated 
using FlowJo’s cell cycle plugin. (C) Whole cell lysates of logarithmically growing indicated strains were 
analyzed by SDS-PAGE and immunoblotting against Rnr1-4 and tubulin. As positive control for the activation 
of the DNA damage response, WT cells treated for 3 h with 200 mM HU were used. 
 
In agreement with the strongest accumulation of cells in S phase, the highest RNR subunit 
expression levels were found in rnr1-R256H,Y779C and though to a lesser extend in rnr1-A245V 
expressing cells (Fig. 4.17C). No RNR induction was observed for cells expressing the rnr1-F15S, 
rnr1-D57N, rnr1-S242T or rnr1-Y285C alleles. All of them had in common that no individual dNTP 
was reduced more than 20% compared to WT levels (Fig. 4.17A) and no strong accumulation of 
cells in S phase was observed (Fig. 4.17B). Interestingly, the rnr1-K243E expressing cells activated 
the DDR (Fig. 4.17C) showing neither dNTP levels below the WT (Fig. 4.17A, Table 4.20B) nor 
strong accumulation of cells in S phase (Fig. 4.17B). Moreover, rnr1-I262V,N291D belonging to the 
same type of dNTP imbalance with low dATP and very high dGTP pools, slightly induced Rnr3, but 
not Rnr1, Rnr2 or Rnr4. Thus, the altered DNA content profiles and the DDR activation in these 
mutants might suggest that the very high dGTP pools in these mutants interfere with processes 
outside S phase. 
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Taken together, the analysis of rnr1 alleles expressed from the endogenous RNR1 locus revealed 
first, that dNTP imbalances characterized by low dATP and high dGTP (3 out of 4 + high dGTP) 
were the most mutagenic dNTP imbalances resulting in very high mutation rates even in the 
presence of high-fidelity DNA polymerases and functional MMR and second, that limitation in one 
individual dNTP pool of at least 30% activated the DDR. 
4.4.6 Elevation of “3 out of 4” dNTPs promotes base pair mutations and frameshifts.  
To examine whether the three different types of dNTP imbalances influence the type of replication 
error generated, CAN1 mutation spectra analysis in WT, rnr1-Y285C, rnr1-R256H,Y779C and rnr1-
I262V,N291D strains was performed (Fig. 4.18A, Table 4.21). All rnr1 mutation spectra were 
significantly different to the WT (Fisher’s exact test, p value 2.5 x 10-11 for rnr1-Y285C, 0.0029 for 
rnr1-R256,Y779C and 2.2 x 10-16 for rnr1-I262V,N291D).  
 
Table 4.21 CAN1 mutation spectra in strains carrying rnr1 mutant alleles. 
 WT‡ rnr1-Y285C 
rnr1- 
R256H,Y779C 
rnr1- 
I262V,N291D 
Mutants sequenced 91 93 96 96 
Mutations total* 92 (100) 94 (100) 96 (100) 98 (100) 
Base substitutions 69 (75.0) 80 (85.1) 55 (57.3) 18 (18.4) 
A-T → G-C 6 (6.5) 14 (14.9) 9 (9.4) 13 (13.3) 
G-C → A-T 18 (19.6) 9 (9.6) 17 (17.7) 2 (2.0) 
G-C → T-A 29 (31.5) 5 (5.3) 6 (6.3) 0 (0.0) 
A-T → C-G 3 (3.3) 20 (21.3) 6 (6.3) 1 (1.0) 
A-T → T-A 7 (7.6) 28 (29.3) 6 (6.3) 2 (2.0) 
C-G → G-C 6 (6.5) 4 (4.3) 11 (11.5) 0 (0.0) 
Transitions 24 (26.1) 23 (24.5) 26 (27.1) 15 (15.3) 
Transversions 45 (48.9) 57 (60.6) 29 (30.2) 3 (3.1) 
One-base-pair frameshifts 15 (16.3) 12 (12.8) 30 (31.3) 80 (81.6) 
ΔA/T 5 (5.4) 9 (9.6) 25 (26.0) 79 (80.6) 
ΔG/C 3 (3.3) 3 (3.2) 4 (4.2) 0 (0.0) 
+A/T 6 (6.5) 0 (0.0) 1 (1.0) 1 (1.0) 
+G/C 1 (1.1) 0 (0.0) 0 (0.0) 0 (0.0) 
Complex† 8 (8.7) 2 (2.1) 11 (11.5) 0 (0.0) 
Mutation spectra analysis based on DNA sequencing of the CAN1 gene in independent CanR mutants, shown as the 
number of clones containing the indicated mutations, and in parenthesis as the percentage relative to the total. (Fig. 
S7.1 and Fig. S7.12-14) 
*In few cases (about 1-2% of the sequenced clones) two simultaneous CAN1 mutations (more than 100 bp apart) 
were found. These mutations were included in the analysis and considered as independent mutational events. 
† includes: multiple mutations within ten nucleotides, insertions or deletions of more than one nucleotide and 
duplication events. 
‡CAN1 mutation spectrum of WT strain was taken from (SCHMIDT et al. 2017). 
 
In the rnr1-Y285C mutant with low purine and elevated pyrimidine pools increased base pair 
substitutions were detected in comparison to the WT (85.1% vs. 75.0%). The CAN1 spectrum was 
dominated by A-T to C-G and A-T to T-A mutations, which were 6.5 and 3.9 times more frequently 
found than in WT and approximately detected in half of all sequenced CanR clones (10.9% in WT). 
Hotspots at position 538, 680 and 946 were frequently mutated in rnr1-Y285C (Table 4.22). For 
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example, hotspot 538 is presumably driven by low levels of dATP and increased dCTP pools, 
which result in a dATP/dCTP ratio of 1:9 (1:0.9 in WT) supporting the misincorporation of dCTP 
opposite of the template T. The elevated dCTP and dTTP levels present in rnr1-Y285C facilitate 
rapid mispair extension over proofreading (Fig. 4.18B).  
 
 
Fig. 4.18 dNTP imbalances caused by rnr1 mutants shape mutation spectra. 
(A) Independent CanR clones (n ≥ 91 per genotype) were sequenced for CAN1 mutations. The graphs 
represent the type of the identified mutations in percentage (Table 4.21). (B) The A-to-C mutation hotspot at 
nucleotide 538 identified in rnr1-Y285C. Predicted mutation is noted in red. Nucleotides marked in green are 
more abundant in rnr1-Y285C than in the WT and facilitate rapid extension of the mispair. (C) The ΔA 
mutation at nucleotide 964-969 was frequently identified in rnr1-I262V,N291D. Predicted slippage event is 
noted in red. Nucleotides marked in green are more abundant in rnr1-I262V,N291D than in the WT and 
facilitate rapid extension of the mismatch. (D) Independent 5-FOAR clones (n ≥ 99 per genotype) were 
sequenced for URA3 mutations. The graphs represent the type of the identified mutations in percentage 
(Table 4.23). WT mutational spectrum was taken from (LANG AND MURRAY 2008). 
 
The CAN1 mutation spectra in rnr1-R256H,Y799C and rnr1-I262V,N291D strains one-base-pair 
frameshifts were 3.5 and 9.3 times more frequently detected than in the WT and consisted in large 
of A:T deletion events (Table 4.21). Moreover, the only hotspots identified in those two mutants 
were in two 6 A:T mononucleotide runs at position 964-969 and 1381-1386, the latter only identified 
in rnr1-R256H,Y779C (Table 4.22). The A mutation hotspot at position 964-969 is presumably 
facilitated by low dATP pools in rnr1-R256H,Y779C and rnr1-I262V,N291D, which favor 
polymerase slippage events in the mononucleotide run of 6 A, followed by insertion of a dGTP 
directly after the mononucleotide run, strand misalignment and rapid extension due to elevated 
dCTP, dTTP and dGTP levels (Fig. 4.18C). Remarkably, the mutational hotspot at position 964-969 
was detected in about 2/3 of all sequenced rnr1-I262V,N291D clones, suggesting that under the 
dNTP imbalance present in rnr1-I262V,N291D DNA polymerases are especially error-prone at this 
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sequence context. Even though base substitution events contributed only 18.4% to all observed 
CanR events in rnr1-I262V,N291D, 72% of the base pair substitutions were A-T to G-C mutations 
presumably as consequence of the increased dGTP:dATP ratio (7:1 in rnr1-I262V,N291D to 0.5:1 
in WT). To investigate the effect of the “low dATP + high dGTP” dNTP imbalance on the generation 
of replication errors in more detail the URA3 gene of individual 5-FOA resistant rnr1-I262V,N291D 
clones was sequenced and the URA3 mutation spectra was analyzed (Table 4.23). As already 
observed in the CAN1 mutations spectrum, base pair substitutions in the rnr1-I262V,N291D URA3 
mutation spectrum were dominated by A-T to G-C mutations (53% of all observed mutations and 
75% of all base pair substitutions). In comparison to the WT (LANG AND MURRAY 2008), the rnr1-
I262V,N291D URA3 mutation spectrum was significantly different (Fisher’s exact test, p value  2.2 
x 10-16)  and A-T to G-C mutations were detected 28 times more frequent in rnr1-I262V,N291D. 
Remarkably, also in the URA3 mutation spectrum one-base-pair deletions and A/T frameshifts 
were found 2.5 and 4.7 times more frequent in rnr1-I262V,N291D than in WT. Thus, the “low dATP 
+ high dGTP” type of dNTP imbalance facilitates not only base pair substitutions, but also one-
base-pair deletions independently of the used mutational reporter. 
 
Table 4.22 CAN1 mutation hotspots identified in strains carrying rnr1 mutant alleles. 
Position Mutation 
No of occurrences 
/ total 
Mutation rate 
(x10-8) 
Fold increase 
over WT 
Predicted intermediate 
rnr1-Y285C: 8.9 x dCTP, 7.6 x dTTP, 0.9 x dATP, 1.4 dGTP; CANR = 3.2 x 10-7 (4) 
538 A → C 10 / 94 3.4 ≥36 
 
680 A → T 10 / 94 3.4 ≥36 
 
946 T → C 5 / 94 1.7 ≥18 
 
rnr1-R256H,Y779C: 3.3 x dCTP, 2.7 x dTTP, 0.5 x dATP, 2.8 dGTP; CANR = 9.5 x 10-8 (1) 
964-969 ΔA 6 / 96 0.6 6 
 
1381-1386 ΔT 9 / 96 0.9 9 
 
rnr1-I262V,N291D: 2.8 x dCTP, 3.0 x dTTP, 1.2 x dATP, 17.1 dGTP; CANR = 1.4 x 10-5 (164) 
964-969 ΔA 63 / 98 900 9517 
 
Mutations are shown relative to the coding strand. The predicted mutation is noted in red. Nucleotides incorporated after the 
mutation from dNTPs at higher concentrations than WT, are shown in green. dNTP levels are shown as fold over WT and 
CAN1 inactivation rate as median, with fold increase relative to WT in parentheses. A mutation hotspot is defined as a 
specific mutation found in more than 5% of all sequenced CANR clones in the indicated genotype. Mutation hotspots that are 
significant different to the WT control (Fisher’s exact test, Benjamini and Hochberg corrected p-value ≤ 0.05) are shown in 
bold. 
 
Taken together, mutation spectra analysis of rnr1 alleles revealed that distinct dNTP pool 
imbalances shape the mutation spectra in agreement with the observed genetic interactions (Table 
4.16). The “low purines” type of dNTP pool imbalances generated primarily base pair substitutions 
(Table 4.21) and exclusively relied on DNA proofreading, but not on MMR for survival (Table 4.16). 
In contrast, “low dATP” and “low dATP + high dGTP” type of dNTP pool imbalances favored base 
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pair substitutions and one-base-pair deletions (Table 4.21 and 4.23). Consequently, these types of 
dNTP pool imbalances relied on DNA proofreading and MMR for survival (Table 4.16).  
 
Table 4.23 URA3 mutation spectrum in rnr1-I262V,N291D mutant strain. 
 WT‡ rnr1-I262V,N291D 
Mutants sequenced 207 131 
Mutations total* 207 (100) 100 (100) 
Base substitutions 167 (80.7) 71 (71.0) 
A-T → G-C 4 (1.9) 53 (53.0) 
G-C → A-T 42 (20.3) 2 (2.0) 
G-C → T-A 68 (32.9) 1 (1.0) 
A-T → C-G 11 (5.3) 2 (2.0) 
A-T → T-A 22 (10.6) 10 (10.0) 
C-G → G-C 20 (9.7) 3 (3.0) 
Transitions 46 (22.2) 55 (55.0) 
Transversions 121 (58.5) 16 (16.0) 
One-base-pair frameshifts 25 (12.1) 26 (26.0) 
ΔA/T 11 (5.3) 25 (25.0) 
ΔG/C 11 (5.3) 1 (1.0) 
+A/T 2 (1.0) 0 (0.0) 
+G/C 1 (0.5) 0 (0.0) 
Complex† 15 (7.2) 3 (3.0) 
Mutation spectra analysis based on DNA sequencing of the URA3 gene independent 5-FOAR mutants, shown as the 
number of clones containing the indicated mutations, and in parenthesis as relative percentage (Fig. S7.15). 
*In few cases (about 1-2% of the sequenced clones) two simultaneous URA3 mutations (more than 100 bp apart) were 
found. These mutations were included in the analysis and were considered as independent mutational events.  
† includes: multiple mutations within ten nucleotides, insertions or deletions of more than one nucleotide and duplication 
events.  
‡ URA3 mutation spectrum of WT strain was taken from (LANG AND MURRAY 2008). 
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5 DISCUSSION 
5.1 A genome-wide screen identifies genes that prevent the accumulation of 
mutations. 
Genome-wide screens in S. cerevisiae are powerful tools to uncover genetic interactions as well as 
to investigate phenotypes on a genome-wide level. Here, the yeast non-essential gene deletion 
collection was screened in a “semi-high-throughput” 96-well format for increased mutagenesis 
using the CAN1 forward inactivation assay and the frameshift-specific lys2-10A reporter. The 
screen was performed in a WT background as well as in the presence of low-fidelity active-site 
mutants (pol1-L866M, pol2-M644G, pol3-L612M) of the three major eukaryotic DNA polymerases 
(Fig. 4.1). In the WT background, 39 single-gene deletions were identified that caused increased 
mutator phenotypes (Table 4.1). With the exception of MET7, all other identified genes have known 
roles in DNA replication and repair and have been previously linked to increased mutagenesis. In 
comparison to a previous screen scoring for increased CAN1 inactivation in a WT background 
(HUANG et al. 2003), only two of the reported genes (SOD1 and SKN7) were not identified in the 
here presented screen, whereas both screens share 28 genes. Moreover, the here performed 
screen unraveled 11 additional genes that have not been identified in the first screen (HUANG et al. 
2003). However, with the exception of MET7, all other gene deletions were previously linked to 
increased mutagenesis (TISHKOFF et al. 1997; BERTRAND et al. 1998; FLORES-ROZAS AND KOLODNER 
1998; SCOTT et al. 1999; BRUSKY et al. 2000; HOWLETT AND SCHIESTL 2004; SMITH et al. 2004; 
COLLURA et al. 2012). By making use of the lys2-10A frameshift reversion assay all known MMR 
components, except of mlh2 that shows a mutator phenotype almost indistinguishable from WT 
(HARFE et al. 2000; CAMPBELL et al. 2014), were identified. Consistent with a previous report 
(HUANG et al. 2003), inactivation of ELG1, that promotes the unloading of PCNA (KUBOTA et al. 
2013), also caused increased frameshift mutations most likely by affecting PCNA levels on 
chromatin. Thus, these findings suggest that the here performed screen not only in large 
recapitulated previous results obtained by different genome-wide screens (HUANG et al. 2003; 
SMITH et al. 2004) and other studies (TISHKOFF et al. 1997; BERTRAND et al. 1998; FLORES-ROZAS 
AND KOLODNER 1998; SCOTT et al. 1999; BRUSKY et al. 2000; HOWLETT AND SCHIESTL 2004; 
COLLURA et al. 2012) but also was sensitive enough to identify one previously unrecognized gene 
(MET7). A potential explanation why MET7 has not been identified in previous screens may lay in 
the severe growth defect characteristic of met7Δ strains (DESOUZA et al. 2000). Thus, the 
identification of MET7 in this screen suggest that in the subset of genes present in the yeast non-
essential gene deletion collection used, no additional unrecognized gene deletions may exist that 
confer a CAN1 and/or lys2-10A mutator phenotype in a WT background. Nevertheless, it cannot be 
excluded that additional genes may exist that prevent the accumulation of mutations due to the 
following reasons: First, some gene deletions may cause similar to met7 severe growth defects 
(MERZ AND WESTERMANN 2009). The initial qualitative mutator phenotype screening depends on 
growth so that mutants may not be detected due to severely compromised growth. Second, some 
gene deletions have reported defects in mating and sporulation (DEUTSCHBAUER et al. 2002; 
ENYENIHI AND SAUNDERS 2003), so that their mutator phenotype cannot be investigated because the 
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finally tested strains cannot be generated by the SGA protocol. Third, approximately 8.5% of the 
non-essential genes have a homologue in the yeast genome (GIAEVER et al. 2002) and this 
homologue may compensate the defect of the gene deletion. Fourth, the used collection may lack 
the gene deletion. The budding yeast genome consists of approximately 6131 genes of which 4803 
are inactivated in the BY4742 non-essential gene deletion collection (GIAEVER et al. 2002). During 
the construction of the collection the deletion of roughly 215 genes failed and consequently these 
genes are not part of the deletion collection (GIAEVER et al. 2002). To screen a more 
comprehensive collection, 65 of those genes were manually inactivated by the Hombauer lab and 
included in the screen. Fifth, as part of this screen, only non-essential gene deletions were 
investigated, remaining essential genes excluded from the analysis. Indeed, a screen that tested 
813 mutant alleles of 525 essential genes revealed 47 alleles in 38 essential genes that conferred 
increased CAN1 inactivation (STIRLING et al. 2014) highlighting that both non-essential and 
essential genes prevent genome instability. As a frameshift mutational reporter has not been used 
systematically in the subset of essential genes it might be informative to screen alleles of essential 
genes (temperature sensitive-, DAmP- or Tet-OFF-collections)(MNAIMNEH et al. 2004; BEN-AROYA 
et al. 2008; BRESLOW et al. 2008) for increased frameshift mutator phenotypes. Sixth, some gene 
deletions may cause increased mutator phenotypes but are not supporting growth on canavanine 
containing mutator plates or plates lacking lysine and are therefore not found in this screen. For 
example, CanR mutants require a functional arginine biosynthesis pathway to grow on canavanine 
containing mutator plates, which lack arginine. Similarly, lys2-10A mutator plates lack lysine and 
cells that require external lysine supplementation will not grow even in the presence of a reverted 
lys2-10A allele. One example for this is CCS1 (previously called LYS7 (CULOTTA et al. 1997)), a 
copper chaperone for SOD1 playing a role in the oxidative stress response (LAMB et al. 2000). In 
the absence of CCS1 and in the presence of oxygen, cells require lysine and methionine for growth 
(CULOTTA et al. 1997). Inactivation of CCS1 results in an increased CAN1 mutator phenotype 
(Table 4.1) (HUANG et al. 2003) and a mildly increased frameshift reversion rate (3-fold increase 
over WT in hom3-10 frameshift reversion rate (HUANG et al. 2003)). However, as ccs1 cells 
require lysine in the presence of oxygen, no conclusion about the lys2-10A frameshift mutator 
phenotype in this mutant can be made under standard growth conditions. Consequently, CCS1 
was not found in the screen as a gene that suppresses frameshift mutations. To avoid these 
potential restrictions for the frameshift assay, initially the SGA generated mutants should be tested 
for increased frameshift mutations not only in the lys2-10A but also in the hom3-10 frameshift 
reversion assay. For this, a HIS3 cassette was integrated downstream of the hom3-10 reporter in 
all four SGA query strains. However, as a subset of the non-essential gene deletion collection was 
HIS3 and not his31, the HIS3 selection marker could not be used to follow the hom3-10 reporter. 
Consequently, the mutator phenotype of the SGA generated mutants were exclusively evaluated 
based on the lys2-10A and the CAN1 reporter. Thus, to complement the here performed screen in 
the subset of non-essential genes, a second screen using the hom3-10 frameshift reversion assay 
and the URA3 forward inactivation assay that scores for 5-FOA resistant events (BOEKE et al. 
1984) could be performed. However, it is questionable whether additional previously unrecognized 
genes that suppress mutations might be identified in a WT background using these two alternative 
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mutator assays. Due to the shorter mononucleotide run in the hom3-10 reporter, the hom3-10 
frameshift reversion rate in a WT strain is approximately 7-fold lower than the lys2-10A frameshift 
reversion rate (Table 4.7). Therefore, to be detected as mutator in a qualitative hom3-10 mutator 
screening, mutants have to confer a relatively strong frameshift mutator phenotype. This makes it 
in comparison to the lys2-10A assay less likely to identify weak mutators with the hom3-10 assay. 
All in all, it is therefore unlikely that within the used non-essential gene deletion collection additional 
single gene deletions exist that cause base pair substitutions and frameshift mutations in a WT 
background.  
An additional approach to screening in a WT background is to use DNA replication fidelity-
compromised backgrounds as “sensitized mutator backgrounds”. In the here described genome-
wide screen low-fidelity active-site mutants of the three major DNA polymerases were successfully 
used as “sensitized mutator backgrounds” to identify gene deletions (gln3, rrm3, shm2 and 
ura7) that showed strong synergistic mutator interactions with some of the DNA polymerase 
alleles (Table 4.5) (discussed in section 5.3). Importantly, inactivation of none of the four genes 
conferred a mutator phenotype in the presence of high-fidelity DNA polymerases suggesting that 
the defects are buffered under WT conditions by DNA polymerases and MMR (Table 4.5). Thus, 
screening in different DNA replication fidelity-compromised backgrounds may reveal additional 
mutational enhancers and improve the understanding of this second layer of genome stability 
genes, which become critically important for genome stability when DNA replication fidelity is 
compromised. 
5.2 The folylpolyglutamate synthetase Met7 suppresses dUTP accumulation and 
genome instability. 
5.2.1 Genomic uracil is a prerequisite, but not sufficient to cause GCRs in S. cerevisiae. 
The genome-wide screen performed in the WT background identified Met7 as a suppressor of 
mutations according to the CAN1 inactivation assay (Table 4.2). Furthermore, the absence of Met7 
not only resulted in increased CAN1 inactivation, but also in elevated GCRs (Table 4.2). Thus, this 
work showed that the yeast folylpolyglutamate synthetase (FPGS) Met7 is an integral part of the 
cellular genome stability network and characterized how Met7 suppresses mutation and GCRs. 
Moreover, this study highlights how metabolic defects due to the absence of Met7 cause a complex 
genome instability phenotype characterized by increased mutations and GCRs as well as short 
telomeres (Fig. 5.1). Met7 catalyzes the polyglutamylation of folates in budding yeast (DESOUZA et 
al. 2000) which increases the cellular retention of folates and their affinity to folate-metabolizing 
enzymes (SCHIRCH AND STRONG 1989). Consequently, in the absence of FPGS intracellular folate 
pools are depleted (MCBURNEY AND WHITMORE 1974; RAZ et al. 2016). Folates serve as cofactors in 
different metabolic pathways including dTMP, purine and methionine biosynthesis (APPLING 1991; 
DUCKER AND RABINOWITZ 2017). In agreement with a previous study (RUBINSTEIN et al. 2014), 
inactivation of MET7 caused a dNTP imbalance that is characterized by low dTTP and dGTP pools 
and elevated dCTP and dATP pools (Fig. 4.5A, Table 4.3B). Given that dNTP levels peak during S 
phase (CHABES et al. 2003) and met7 cells showed in comparison to the WT an accumulation of 
cells in S phase (Fig. 4.3B)(KOREN et al. 2010), dNTP pools measured in met7 cells are 
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approximately 2-3-fold overrepresented. This suggests that normalized to a WT cell cycle 
distribution, the dTTP and dGTP pool reductions would be even more severe in met7 cells. Thus, 
cells lacking Met7 present a severe dNTP imbalance with strongly reduced dTTP and dGTP pools. 
Remarkably, dNTP pool measurements in mammalian cells treated with either the antifolate 
methotrexate or the antimetabolites 5-fluorouracil or 5-fluorodeoxyuridine (the latter two both 
targeting thymidylate synthase), revealed very similar dNTP pool imbalances as Met7-deficient 
yeast cells. In the presence of these drugs, dTTP and dGTP pools were strongly reduced, dATP 
pools were elevated and dCTP pools were either stable or increased (TATTERSALL AND HARRAP 
1973; RITTER et al. 1980; YOSHIOKA et al. 1987). Thus, these measurements suggest that the dNTP 
pool alteration observed in the absence of Met7 is likely a consequence of folate deficiency. Due to 
the absence of folate polyglutamylation in met7 cells, folate pools are depleted. Consequently, 
dTMP biosynthesis, as one major folate requiring metabolic pathway (FOX AND STOVER 2008), is 
reduced resulting in low dTTP levels. Interestingly, binding of dTTP to the allosteric S-site in RNR 
primes RNR’s C-site for reduction of GDP to dGDP (BROWN AND REICHARD 1969), suggesting that 
the low dGTP concentrations in the absence of Met7 or upon antifolate treatment might be a 
consequence of low dTTP levels that may not be sufficient to trigger dGDP production. This idea is 
further supported by dNTP pool measurements in fission yeast cells deficient for the dCMP 
deaminase DCD1 (SANCHEZ et al. 2012). In agreement with converting dCMP to dUMP, which is 
further metabolized to dTTP (Fig. 1.6), dCTP pools were 30-fold increased and dTTP pools were 4-
fold decreased in the absence of Dcd1. Moreover, dGTP pools were decreased ~2-fold and dATP 
levels were 2.5-fold increased suggesting that the decrease in dGTP and presumably also the 
increase in dATP is a general consequence of reduced dTTP levels. 
Inhibition of dTMP biosynthesis not only results in reduced dTTP pools and a dNTP imbalance, but 
also in an accumulation of the thymidylate synthase substrate dUMP and of the upstream 
metabolite dUTP (VAN TRIEST et al. 2000; LONGLEY et al. 2003). Indeed, dUTP strongly 
accumulated in the absence of Met7 (Fig. 4.5). WT yeast counteract the accumulation of dUTP by 
the action of the dUTPase Dut1 (GADSDEN et al. 1993; GUILLET et al. 2006) and consequently dUTP 
pools under normal growth conditions are extremely small and difficult to quantify (ZHANG et al. 
2011). The finding that dUTP was no longer detectable in met7 cells that overexpress the 
dUTPase DUT1 (Fig. 4.5A), suggests that the dUTP accumulation in the absence of Met7 is so 
severe that the catalytic capacity of endogenous Dut1 is saturated. Consequently, the dUTP/dTTP 
ratio in the absence of Met7 is dramatically shifted and dUTP contributes to 7% of the total dUTP 
and dTTP pool (Fig. 4.5B). This is in particular detrimental for DNA replication fidelity, as DNA 
polymerases cannot discriminate between dTTP and dUTP as substrates (SHLOMAI AND KORNBERG 
1978; WARNER et al. 1981; TINKELENBERG et al. 2002). Thus, the ratio between dUTP and dTTP 
directly determines which nucleotide is incorporated opposite of a template A during DNA 
replication. Therefore, under the assumption that nucleotides are randomly distributed according to 
their average occurrence in the budding yeast genome (approximately 31% As and Ts, and 19% 
Gs and Cs) (GOFFEAU et al. 1996), in the absence of Met7 in average two dUTPs will be 
incorporated every 100 nucleotides polymerized. In line with the increased dUTP/dTTP ratio in the 
absence of Met7 (Fig. 4.5B), strong uracil accumulation was detected in an uracil accumulation 
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assay, in which the observed fragments ranged from high molecular weight species to fragments 
below 250 nt (Fig. 4.5C). Reasons for the difference in fragment size can be for example different 
nucleotide distributions within the genetic sequence, like GC-rich regions, preferential incorporation 
of dUTP in actively-transcribed genes (KIM AND JINKS-ROBERTSON 2009) and the acquisition of 
suppressor mutations during the growth of the culture in a subset of cells, which than accumulate 
less uracil. Overexpression of DUT1 in met7 cells not only suppressed dUTP accumulation (Fig. 
4.5A) and genomic uracil incorporation (Fig. 4.5C), but also the GCR phenotype (Table 4.2). This 
finding suggests that GCRs in the absence of Met7 are triggered by dUTP accumulation. Moreover, 
the GCR phenotype in met7 cells could be partially suppressed by the inactivation of Ung1 (Table 
4.2). This indicates that first, accumulation of genomic uracil alone is a prerequisite but not 
sufficient to induce GCRs in budding yeast and second, that processing of genomic uracil and 
presumably subsequent futile-repair cycles contribute to the GCR phenotype in the absence of 
Met7. This idea is further supported by the finding that cells expressing the dut1-1 allele, a DUT1 
allele with reduced dUTPase activity (~95% reduction in dUTPase activity) (GUILLET et al. 2006), 
conferred neither a CAN1 mutator nor a GCR phenotype (Table 4.2) despites showing strong 
genomic uracil accumulation (Fig. 4.5C). The absence of any mutator phenotype in the presence of 
dut1-1 was unexpected as a previous study (GUILLET et al. 2006) reported a 45-fold increase over 
WT in the CAN1 mutation rate. Furthermore, the dut1-1 expressing cells of the previous report 
showed a growth defect and altered cell cycle progression (GUILLET et al. 2006), phenotypes that 
were not observed for the here investigated dut1-1 expressing cells (Fig.4.6C,D). The discrepancy 
between the previous study and the here presented results may originate from additional mutations 
present in the initially dut1-1 expressing cells. The former study identified the dut1-1 allele in a UV 
mutagenesis screen. As result of this random mutagenesis screen, it is possible that the identified 
clone carrying the dut1-G82S mutation (dut1-1) contains additional mutations that may contribute 
to the observed phenotype. In contrast to this previous study, in the here presented work the dut1-
G82S mutation was integrated at the endogenous DUT1 locus using a non-mutagenic approach 
(pop-in/pop-out strategy) followed by mating. Neither the initial dut1-1 strain nor spores obtained 
from different individual crosses showed increased mutagenesis or growth defects. Thus, it is likely 
that the mutator phenotype and growth defect described in the previous study result from a 
combinational effect of the dut1-G82S mutation and other co-occuring mutations. Alternatively, it is 
also possible that the observed differences are the result of different yeast backgrounds used in 
both studies.  
5.2.2 A DSB repair defect is required for dUTP-driven GCRs. 
The observations that first, the GCR phenotype in met7 cells is triggered by dUTP accumulation 
and second, dut1-1 expressing cells show no GCR phenotype despite uracil accumulation in 
genomic DNA, argues for additional requirements to induce a dUTP-driven GCR phenotype in 
budding yeast. In comparison to cells lacking Met7, dut1-1 expressing cells neither induced a dNTP 
imbalance nor activated the DNA damage checkpoint. Moreover, dut1-1 cells did not accumulate in 
S phase and did not show increased sensitive to phleomycin or a petite phenotype (Fig. 4.6). 
Despite dut1-1 cells accumulated uracil into the genome (Fig. 4.5C), dUTP concentrations were 
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below the detection limit of the used HPLC method, suggesting that dUTP levels in dut1-1 cells are 
lower than in met7 cells. Moreover, in addition to increased dUTP pools also reduced dTTP pools 
were found in met7 cells, resulting in a presumably more severe dUTP/dTTP ratio. To investigate 
the effect of a higher dUTP/dTTP ratio on genome stability, the dCMP deaminase DCD1 was 
inactivated in dut1-1, which should presumably result in lower dTTP pools (SANCHEZ et al. 2012). 
Supporting this idea, similar to met7 strain, the dut1-1 dcd1 double mutant showed an elevated 
GCR phenotype in a qualitative patch test (Fig. 4.6D), increased sensitivity to phleomycin and a 
petite phenotype (Fig. 4.6E). However, dut1-1 dcd1 double mutant cells neither activated the DDR 
(Fig. 4.6B) nor accumulated in S phase (Fig. 4.6C). The latter findings suggest that the presumed 
reduction in either dTTP or any other dNTP is not severe enough to active the DDR. Analysis of 
dNTP pools and S-phase checkpoint activation in gln3, ura7 (Fig. 4.9B-C, Table 4.9B) and rnr1 
mutant cells (Fig. 4.17, Table 4.20B) revealed that a reduction of dCTP or dATP to levels below 
dGTP concentrations in WT cells were required to activate the S-phase checkpoint. This would 
suggest that the dTTP concentration in dut1-1 dcd1 cells is still higher than the dGTP 
concentrations measured in WT or in other words dTTP pools are reduced less than 60%. 
Moreover, the finding that dut1-1 dcd1 cells accumulate in G1 phase may hint to a problem in G1 
to S phase transition. A delayed G1 to S phase transition has been previously linked to increased 
dNTP pools in G1 (CHABES AND STILLMAN 2007; FRANZOLIN et al. 2013) suggesting that dut1-1 
dcd1 cells presumably showed elevated dNTP pools in G1. Thus, to complement these 
observations it would be informative to measure dNTP concentrations in dut1-1 dcd1 cells.  
Interestingly, as met7 cells, dut1-1 dcd1 cells also showed a petite phenotype (Fig. 4.6E). A 
previous study proposed that the reduced dTTP production in the absence of Met7 results in 
dysfunctional mitochondria based on the finding that the petite phenotype in a special met7 
background could be suppressed by external supplementation of the media with dTMP (DESOUZA 
et al. 2000). Potential reasons for the rescue of the petite phenotype of met7 with constant dTMP 
supplementation are: First, incorporation and processing of mitochondrial uracil results in the petite 
phenotype of met7 cells. Thus, dTMP supplementation of met7 cells decreases the dUTP/dTTP 
ratio leading to less uracil incorporation in genomic and mitochondrial DNA, preventing loss of 
mitochondrial DNA. Second, low dGTP levels interfere with mitochondrial genome stability. dTMP 
supplementation increases dTTP pools. dTTP binds to RNR’s S-site and promotes dGTP 
production. In contrast to the nucleus where dGTP pools represent the smallest dNTP pool, dGTP 
is the most abundant dNTP pool in mitochondria (SONG et al. 2005; NIKKANEN et al. 2016) 
suggesting that high dGTP pools, presumably due to the oxidative environment, are required for 
mitochondrial genome maintenance. Third, dTMP supplementation allows the production of fMet-
tRNA and mitochondrial protein biosynthesis. In contrast to mammalian cells, budding yeast cells 
can synthesize folates de novo (CHEREST et al. 2000). Thus, supplementation with dTMP may 
reduce the cellular need for folates dramatically, so that the de novo generated folates are 
sufficient to produce enough fMet-tRNA to maintain mitochondrial protein biosynthesis and 
consequently functional mitochondria. For cells lacking Met7, none of the possibilities can be 
excluded and eventually several of these explanations may contribute to the petite phenotype. 
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However, for dut1-1 dcd1 cells it is rather unlikely that defects in mitochondrial protein 
biosynthesis are accounting for the observed petite phenotype as neither Dut1 nor Dcd1 directly 
affect the cellular folate pools (Fig. 1.6). Thus, the petite phenotype of dut1-1 dcd1 cells suggests 
that altered dNTP pools, most likely an increased dUTP/dTTP ratio, are sufficient to induce 
mitochondrial dysfunction, presumably also in cells lacking Met7.  
Both, cells in the absence of Met7 and dut1-1 dcd1 cells showed increased sensitivity to the DSB 
inducing agent phleomycin (Fig. 4.6E) suggesting that both mutant backgrounds have problems in 
DSB repair. The finding that met7 cells either overexpressing DUT1 or deficient for Ung1 were as 
sensitive as met7 cells to phleomycin (Fig. 4.7C) argues for the hypothesis that the phleomycin 
sensitivity of met7 cells is not driven by dUTP accumulation and processing of genomic uracil. 
Upon DNA damage, such as DSB, budding yeast cells activate the DDR which results among 
others, in elevated dNTP pools (PARDO et al. 2017). In met7 and met7 pGPD-DUT1 cells, the 
DDR is constantly activated (Fig. 4.7A-B) still dTTP and dGTP pools were reduced (Fig. 4.5A, 
Table 4.3B). Thus, one explanation for the observed phleomycin sensitivity in the absence of Met7 
may be that met7 cells are unable to increase dTTP and dGTP pools to sufficiently high levels to 
facilitate DSB repair. However, dut1-1 dcd1 cells did not show a constitutively activated 
checkpoint (Fig. 4.6B). Presumably, dut1-1 dcd1 cells can increase dNTP pools by activating the 
DDR, but were anyway sensitive to phleomycin. Thus, at least in dut1-1 dcd1 cells the inability to 
increase dNTP pools is most likely not the cause for the detected phleomycin sensitivity. An 
alternative explanation for the phleomycin sensitivity in met7 and dut1-1 dcd1 cells may be the 
petite phenotype. Mitochondrial dysfunction has been previously shown to cause defects in iron-
sulfur cluster biogenesis (LILL AND MÜHLENHOFF 2008). Iron-sulfur clusters are required for various 
proteins including DNA polymerases and DNA repair proteins (VEATCH et al. 2009) and 
consequently for genome stability (DIRICK et al. 2014). Thus, inactivation of MET7 (or dut1-1 
dcd1) causes, most likely induced by the increased dUTP/dTTP ratio, the loss of mitochondrial 
DNA that results in a petite phenotype and defective iron-sulfur cluster biogenesis. Defects in the 
biosynthesis of iron-sulfur clusters compromises the activity of DNA polymerases and DNA repair 
proteins, which results in DSB repair defects and sensitivity to phleomycin. Moreover, the DSB 
repair defects induced by iron-sulfur cluster deficiency may explain why in met7 cells uracil 
incorporation into DNA is toxic and causes increased GCRs, whereas dut1-1 expressing cells can 
handle genomic uracil accumulation without compromising genome stability (Table 4.2). Thus, to 
test the hypothesis that the GCR phenotype of met7 cells is caused by the combination of uracil 
incorporation into DNA and a DSB defect due to the petite phenotype, it would be interesting to 
investigate the GCR phenotype of dut1-1 expressing cells depleted of mitochondrial DNA (e.g. rho0 
cells obtained after treatment with high doses of ethidium bromide (DIRICK et al. 2014)).  
5.2.3 DDR activation and short telomeres in the absence of Met7 are not driven by dUTP 
accumulation. 
Similar to the phleomycin sensitivity, the DDR activation and the telomere phenotype of met7 was 
neither suppressed by overexpression of DUT1 nor by inactivating UNG1 (Fig. 4.7). This findings 
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suggest that the DDR activation in met7 cells is not driven by uracil-induced damage, but as 
met7 and met7 pGPD-DUT1 cells showed reduced dTTP and dGTP levels (Fig. 4.5A, Table 
4.3B) rather by limiting dTTP and/or dGTP pools. This is in agreement with other mutants 
characterized in this study (gln3, ura7 and rnr1 mutants), which induced dNTP pool imbalances 
with limiting dNTPs (Fig. 4.10B, 4.17A) and DDR activation  (Fig. 4.9B,C, 4.17C). 
 
 
Fig. 5.1 Met7 prevents folate depletion and genome instability. 
The absence of Met7 results in folate depletion, a dNTP imbalance characterized by low dTTP and dGTP 
levels, dUTP accumulation and an increase in the dUTP/dTTP ratio, which favors dUTP incorporation into 
DNA. Processing of genomic uracil by Ung1 results in transient abasic sites causing under these conditions 
either futile-repair cycles or double-strand breaks (DSB) and finally due to potential DNA double strand repair 
defect gross-chromosomal rearrangements (GCRs). Moreover, the dNTP imbalance and the low dGTP pools 
cause increased replication errors and short telomeres, respectively. 
 
The increased uracil incorporation into the genome did not account for the short telomere 
phenotype in the absence of Met7 because neither overexpression of DUT1 nor inactivating UNG1 
increased the telomere length (Fig. 4.7D). Previous reports have correlated increased dGTP pools 
with increased telomere length (GUPTA et al. 2013; MAICHER et al. 2017). According to the model 
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low dGTP pools reduce telomerase activity and prevent re-elongation of short telomeres. Strikingly, 
the dGTP levels of met7 and met7 pGDP-DUT1 cells were reduced (Fig. 4.5A, Table 4.3B) 
suggesting that the short telomere phenotype in the absence of Met7 is indeed a consequence of 
the very low dGTP pools. 
Taken together, this work on Met7 emphasizes the importance of folate polyglutamylation for the 
cellular metabolism and characterizes the detrimental consequences on genome stability when this 
process is compromised (Fig. 5.1). As the absence of Met7 in yeast mimics folate depletion and 
antifolate treatment, inhibitors of human FPGS might be an interesting alternative drug to target the 
folate-one-carbon metabolism in cancer cells. Moreover, this work may help to dissect different 
consequences of therapeutically applied antifolates. For example, based on the observed 
phleomycin sensitivity of met7 cells, the combination therapy of antifolates and DSB-inducing 
drugs or ionizing radiation may be beneficial for the treatment outcome. Indeed, these 
combinations are already in use in the clinics and are more potent than the single therapies 
(LONGLEY et al. 2003). Unfortunately, inactivation of FPGS is a common resistance mechanism of 
human cancer cells upon antifolate treatment (RAZ et al. 2016). Thus, it would be interesting to 
investigate whether FPGS-deficient cancer cells induced upon classical antifolate treatment are 
more sensitive to certain drugs or treatments, which could then be applied in targeted therapies. 
5.3 Nucleotide precursor pool imbalances induced by the inactivation of GLN3 or 
URA7 cause dNTP pool imbalances and hypermutator phenotypes. 
5.3.1 Exo1, Gln3, Shm2 and Ura7 contribute to lagging-strand DNA replication fidelity. 
Similar as reported for Exo1 (HOMBAUER et al. 2011a; LIBERTI et al. 2013), inactivation of GLN3, 
SHM2 or URA7 exclusively increases the mutator phenotypes in the presence of the lagging-strand 
DNA polymerase alleles pol1-L868M and pol3-L612M, but not in combination with the leading-
strand DNA polymerase allele pol2-M644G (Table 4.5). In contrast, inactivation of MMR (msh2) 
causes synergistic increases in mutation rates in both the leading-strand (pol2-M644G) and the 
lagging-strand (pol3-L612M) DNA polymerase-compromised background (NICK MCELHINNY et al. 
2008; HOMBAUER et al. 2011a). There are four not mutually exclusive possible explanations for the 
Pol /lagging-strand bias observed in combination with exo1, gln, shm2 and ura7 mutations: 
First, higher replication fidelity of the leading-strand is achieved by the activation of the S-phase 
checkpoint (NAVAS et al. 1995; PURSELL et al. 2007; KUMAR et al. 2011). This may give more time 
for DNA proofreading and repair. Second, compared to Pol , Pol  conferred an approximately 10-
fold higher nucleotide selectivity (ST CHARLES et al. 2015). Third, there are intrinsic differences 
between the low-fidelity active-site DNA polymerase mutant alleles (PURSELL et al. 2007; NICK 
MCELHINNY et al. 2008) and presumable also how they compromise leading- and lagging-strand 
DNA replication fidelity. Fourth, as proposed by a highly controversial report (JOHNSON et al. 2015), 
Pol  may be the major lagging- and leading-strand DNA polymerase. Based on the data presented 
here, none of the possibilities can be ultimately excluded. However, the CAN1 mutation spectra 
analysis of strains expressing the WT or low-fidelity active-site DNA polymerase alleles pol2-
M644G or pol3-L612M in the presence or absence of Ura7 supports a role for Pol  as one of the 
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two major DNA polymerases and thus the “division of labor” model (LUJAN et al. 2016). So, the 
pol2-M644G CAN1 spectra in the presence or absence of Ura7 were not significantly different from 
each other (Table 4.12). Moreover, the same pol2-M644G-specific mutation hotspots were 
detected independent whether Ura7 was present or not (Table 4.13). Thus, the CAN1 mutation 
spectra analysis supports the “division of labor” model and argues against Pol  as major DNA 
polymerase. Moreover, the CAN1 mutation spectra analysis rather suggests that the synergistic 
mutator bias is based on either the different mutational signature of the used DNA polymerase 
alleles or a more general difference in the leading- and lagging-strand DNA replicases. Mutation 
spectra of mutational reporters, like CAN1 or URA3 mutation spectra, are informative and relatively 
inexpensive proxies for the general mutational landscape present in specific backgrounds. 
However, only mutations resulting in a specific event, for example CAN1 inactivation conferring 
resistance to the drug canavanine, are detected using this type of analysis. Thus, to examine the 
global mutational landscape and the effect of a defined dNTP imbalance on DNA replication fidelity 
in an unbiased way, whole-genome sequencing of these mutants has to be performed. To avoid 
any editing of MMR, the analysis should be also performed in the absence of MMR. For this, 
homozygous diploids expressing the WT, pol2-M644G or pol3-L612M DNA polymerase alleles in 
the presence or absence of Ura7 and/or Msh2 were generated to investigate in collaboration with 
the Kunkel lab (NIH, US) the mutational landscape of these strains using whole-genome 
sequencing.  
Interestingly, a previously reported rnr1 allele (rnr1-Q288A) caused increased mutagenesis, 
activation of DDR, a dNTP pool imbalance characterized by very low dCTP pools and a 
consequently strongly increased dTTP/dCTP ratio (KUMAR et al. 2010). The CAN1 mutation 
spectrum analysis in the presence of the rnr1-Q288A allele revealed several mutational hotspots 
(G670A, G788A and G1018A) that were also detected in the msh6 ura7 CAN1 mutation 
spectrum (G788A and G1018A hotspots were as well detected in msh6 gln3) (Table 4.11). In the 
previous report the observed mutational hotspots in rnr1-Q288A expressing cells were predicted to 
originate from replication errors occurring during lagging-strand replication. Therefore, the 
observed common bias for lagging-strand infidelity in the absence of Gln3 or Ura7 or in the 
presence of rnr1-Q288A might be due to the dNTP imbalance with reduced dCTP pools. Upon 
limiting dNTP pools, the leading-strand DNA polymerase Pol  activates the S-phase checkpoint 
(NAVAS et al. 1995), which may facilitate replication fidelity preferentially on the leading-strand by 
increasing the time for DNA proofreading and/or MMR. To comprehensively address the observed 
lagging-strand bias, common to most of the here identified mutational enhancers, further studies, 
like the analysis of the mutational landscape on a genome-wide scale, will be required.  
5.3.2 Rrm3 and Shm2 suppress the accumulation of mutations. 
The helicase Rrm3 facilitates replication fork progression through difficult to replicate genomic 
regions with natural replication fork barriers (IVESSA et al. 2003; MOHANTY et al. 2006; AZVOLINSKY 
et al. 2009). Here, Rrm3 was found to preferentially prevent mutations generated by the low-fidelity 
active-site mutant alleles of the two major DNA polymerases (pol2-M644G and pol3-L612M) (Table 
4.5), which together synthesize approximately 98.5% of the S. cerevisiae genome (REIJNS et al. 
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2015). Moreover, compared to Pol α, Pol  and Pol  replicate also longer DNA stretches. 
Therefore, Pol  and Pol  are presumably more prone to fork pausing and consequently more 
dependent on Rrm3 for high-fidelity replication. Alternatively, it is also possible that the increased 
dNTP pools measured in the absence of Rrm3 (O'ROURKE et al. 2005; POLI et al. 2012) promote 
fork progression on the expense of DNA proofreading. In contrast to Pol α, Pol  and Pol  confer a 
DNA proofreading function (LUJAN et al. 2016). Thus, the combination of reduced nucleotide 
selectivity in the presence of the active-site DNA polymerase allele and compromised DNA 
proofreading due to the increased dNTP pools may cause the observed elevated mutator 
phenotype. A third possibility is that replication fidelity is increased by a helicase-independent 
function of Rrm3. This function has been described to restrict DNA replication in situations of 
replication stress (SYED et al. 2016). To clarify, if Rrm3’s role facilitating replication fidelity in the 
context of low-fidelity active-site DNA polymerase alleles is or not dependent on Rrm3’s helicase-
activity, it would be interesting to investigate the effect on replication fidelity of the reported rrm3 
separation-of-function mutant alleles in combination with the low-fidelity active-site mutant alleles. 
The cytoplasmic serine hydroxymethyltransferase Shm2 is part of the folate-one-carbon 
metabolism (Fig. 1.8) and catalyzes the production of 5,10-methylene-THF (5,10-CH2-THF), a 
precursor for the purine and pyrimidine biosynthesis (MCNEIL et al. 1994; KASTANOS et al. 1997). 
This study identified that inactivation of SHM2 in the presence of low-fidelity DNA polymerase 
alleles (pol1-L868M, pol3-L612M or pol2-04), but not in a WT background or an MMR-deficient 
background (msh2) cause an increase in CAN1 mutation rate (Table 4.5, 4.7). These findings 
suggest that mutations induced upon inactivation of SHM2 are not repaired by MMR and are 
efficiently counteracted by WT DNA polymerases. Despite the known function in the production of a 
precursor for purine and pyrimidine biosynthesis (MCNEIL et al. 1994; KASTANOS et al. 1997), 
surprisingly, inactivation of SHM2 caused neither an NTP nor dNTP pool imbalance (Fig. 4.10, 
Table 4.9) and did also not activate the DDR (Fig. 4.9B-C). One possible explanation is that the 
absence of Shm2 results in increased oxidative damage. Under these oxidizing conditions, 
modified pyrimidine bases might be incorporated during DNA replication and eventually undergo 
deamination events that frequently drive C-T transitions. In agreement with this model, a report in 
mammalian cells using quantitative metabolic fluctuation analysis identified that approximately 40% 
of the cellular NADPH production is based on oxidation of 5,10-CH2-THF (FAN et al. 2014). 
Alternatively, it is possible that the absence of Shm2 may cause dUTP accumulation and increased 
mutagenesis. Shmt1, the mammalian homolog of budding yeast Shm2, has been reported to 
prevent genomic uracil accumulation in mice (MACFARLANE et al. 2008; MACFARLANE et al. 2011) 
and in human lung cancer cells (PAONE et al. 2014). Moreover, mammalian Shmt1 was shown to 
function as a scaffold protein for DHFR and thymidylate synthase at the nuclear lamina and to 
support de novo dTMP biosynthesis (ANDERSON et al. 2012). However, in S. cerevisiae inactivation 
of SHM2 neither caused altered NTP and dNTP pools nor DDR activation. Furthermore, in contrast 
to the dUTP-driven mutator phenotype upon MET7 inactivation, the pol3-L612M shm2 mutator 
phenotype was neither suppressed by the overexpression of DUT1 nor by inactivating UNG1 (data 
not shown). Taken together, these findings suggest that if dUTP accumulate in shm2 cells, the 
accumulation is much milder than in met7Δ cells. Alternatively, the consequence of inactivating the 
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cytoplasmic serine hydroxymethyltransferase might be different in S. cerevisiae and mammalian 
cells. 
5.3.3 Low dCTP pools are an Achilles’s heel of DNA replication fidelity.   
Within the identified mutants, loss of the transcription factor Gln3 or the CTP synthetase Ura7 
resulted in the strongest mutator interactions with low-fidelity polymerase, partial or complete MMR 
defects (Table 4.4, 4.7). CAN1 mutation spectra analysis in msh6 gln3 and msh6 ura7 cells 
revealed that the absence of Gln3 or Ura7 causes primarily base pair substitutions (Table 4.10). 
Nevertheless, in exo1 and msh6 backgrounds, but not in the absence of Msh2 or Msh3, 
inactivation of GLN3 or URA7 resulted in a small increase in frameshift mutations (Table 4.7). 
However, the increase in frameshift mutations was relatively small about 10% of the increase 
observed in a completely MMR defective msh2 strain (Table 4.7). Therefore, the increased 
frameshift phenotype is most likely not a direct consequence of the altered dNTP pools in gln3 
and ura7 cells, but rather indirect due to the saturation of MMR.  
Ura7 is the major CTP synthetase, which contributes to 70-80% of the total CTP biosynthesis in 
budding yeast (OZIER-KALOGEROPOULOS et al. 1991; OZIER-KALOGEROPOULOS et al. 1994)(Table 
4.9A). However, the consequences of reduced CTP biosynthesis on dNTP pool homeostasis has 
not been previously investigated. This study showed for the first time, that inactivation of Ura7 
reduced not only the CTP pools, but also caused a severe dNTP imbalance characterized by a 
50% reduction in dCTP and increased levels in the other three dNTPs (Fig. 4.10, Table 4.9). 
Surprisingly, not only the absence of Ura7, but also loss of the transcription factor Gln3 induced an 
NTP and dNTP pool imbalance characterized by low CTP and dCTP levels (Fig. 4.10, Table 4.9). 
The GATA-transcription factor Gln3 is negatively regulated by TOR and is activated upon 
glutamine limitation (COURCHESNE AND MAGASANIK 1988; BECK AND HALL 1999; CRESPO et al. 2002). 
However, a role of Gln3 in dNTP homeostasis has not been previously described. The finding that 
the severe mutator phenotype in gln3 double mutants could be suppressed by supplementing 
media with glutamine (Fig. 4.9E) suggests that the mutator synergies in the absence of Gln3 are 
largely driven by glutamine deficiency. Glutamine is an important cellular metabolite that is required 
not only for protein biosynthesis but also as nitrogen source for the de novo purine and pyrimidine 
biosynthesis. Moreover, some cancer cell lines depend on external glutamine for survival 
(“glutamine addiction”) (WISE AND THOMPSON 2010; HENSLEY et al. 2013). Consequently, glutamine 
analogs counteract cancer cell proliferation by inhibiting glutamine-requiring enzymes like CTP 
synthetase (DENTON et al. 1982; WEBER et al. 1982). Interestingly, although glutamine is required 
for purine and pyrimidine de novo biosynthesis, glutamine limitation due to GLN3 inactivation in 
budding yeast or inhibition of glutamine-requiring enzymes by the glutamine analog Acivicin in 
mammalian cells result in decreased CTP and dCTP pools and increased UTP levels (Fig. 4.10, 
Table 4.9)(NEIL et al. 1979; DENTON et al. 1982). Thus, in eukaryotes CTP synthetase and 
consequently CTP/dCTP pools seem to be most sensitive to glutamine limitations. It would be 
interesting to examine whether a low glutamine condition, either induced by glutamine analogs or 
as previously described for the central core of solid tumors (PAN et al. 2016), causes increased 
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mutagenesis in cancer cells and so facilitates tumor evolution and adaptation to cancer drug 
treatments. 
The observation that the inactivation of DUN1 suppressed the strong mutator phenotypes 
measured in double mutants carrying gln3 or ura7 mutations in DNA replication fidelity-
compromised backgrounds suggests that the DDR contributes in part to the observed mutator 
phenotypes (Fig. 4.9D, Table 4.8). dNTP pool measurement in dun1 gln3 and dun1 ura7 cells 
revealed that the inactivation of DUN1 in gln3 and ura7 cells suppressed dTTP, dATP and dGTP 
below WT levels, whereas dCTP levels remained almost unchanged in comparison to dCTP 
concentrations measured in the absence of Gln3 or Ura7 (Fig. 4.10B, Table 4.9B). Thus, the 
inactivation of DUN1 reduces the severity of the dNTP pool imbalance and “normalizes” the ratio 
between dCTP to the other dNTP by inhibiting RNR induction (Fig. 4.10B, Table 4.9B).  
The DNA content profiles of dun1 gln3 and dun1 ura7 strains are in agreement with the 
different functional requirements for Gln3 and Ura7. Ura7 as major CTP synthetase (OZIER-
KALOGEROPOULOS et al. 1994) is required primarily during S phase (KOREN et al. 2010) where the 
demand for dCTP is highest (CHABES et al. 2003). Consequently, dun1 ura7 cells that not only 
lack the major CTP synthetase, but also confer overall reduced dNTP biosynthesis due to DUN1 
inactivation (Fig 4.10B, Table 4.9B) (FASULLO et al. 2010), progress slower though S phase and 
therefore show a stronger accumulation of cells in S phase compared to the single mutants (Fig. 
4.9C). In contrast, Gln3 activity is primarily required in situations of glutamine limitations (CRESPO et 
al. 2002). In the absence of Dun1 the dNTP production is reduced (FASULLO et al. 2010). 
Therefore, it might be that the cellular demand for glutamine in the absence of Dun1 is lower than 
in the presence of Dun1. Consequently, dun1 cells are less prone to generate a situation of 
glutamine limitation, in which the presence of Gln3 becomes critical. Thus, it could be that dun1 
gln3 cells did not strongly accumulate in S phase (Fig. 4.9C) because in the absence of Dun1 
glutamine pools are not severely depleted and therefore cells do not require Gln3 activity. 
RNR is considered the master regulator of dNTP pool homeostasis (NORDLUND AND REICHARD 
2006). RNR possess two allosteric sites, one that controls the overall enzymatic activity (A-site) 
(Fig. 1.7C) and a second that regulates the substrate specificity (S-site) (Fig. 1.7B). Surprisingly, 
the absence of either Gln3 or Ura7 causes limitations in the dNTP precursor pool which result in a 
dNTP imbalance for which neither RNR nor any other mechanism downstream of RNR can 
compensate. Interestingly, RNR binds at the S-site all dNTPs except dCTP, consequently it can not 
respond to changes in dCTP concentrations (Fig. 1.7B)(BROWN AND REICHARD 1969). Instead, 
budding yeast cells compensate high dCTP pools through the activity of Dcd1, which converts 
dCMP into dUMP (Fig.1.6)(MCINTOSH AND HAYNES 1984; SANCHEZ et al. 2012). However, no 
compensatory mechanism for low CTP/dCTP pools exists in budding yeast cells, suggesting that 
low dCTP pools are the blind spot of dNTP pool homeostasis regulation (Fig. 1.6). Low dCTP pools 
due to the absence of Gln3 or Ura7 results in replication stress and activation of the DDR (Fig. 
4.9B,C)(KOREN et al. 2010). However, as in cells lacking Gln3 or Ura7 the dCTP precursor pool is 
limiting, the increased activity of RNR due to DDR activation is unable to generate more dCDP. 
Thus, instead of compensating for the low dCTP pools, the DDR increases the severity of the 
dNTP pool imbalance (Fig. 4.10B, Table 4.9B). 
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Presumably additional gene deletions exist that may interfere with the synthesis of substrates 
required for dNTP biosynthesis. However, they might not be mutagenic as dNTP imbalances may 
have been buffered by RNR. In these cases, RNR is able to senses the limiting dNTP pools and 
prevent that the limiting substrate manifests in a dNTP imbalance. Thus, given the sophisticated 
allosteric regulation of RNR (Fig. 1.7)(BROWN AND REICHARD 1969), gene deletions affecting CTP 
biosynthesis are most likely the only ones that not only induce a precursor pool alteration but also 
cause a dNTP imbalance that compromises DNA replication fidelity.  
In agreement with the altered dNTP imbalance, CAN1 mutation spectra analysis revealed that the 
dNTP pool imbalance largely shapes the mutation spectra. So, the msh6 gln3 and msh6 ura7 
CAN1 mutation spectra were dominated by G-C to A-T mutations (Table 4.10). These mutations 
originate most likely from dTTP misinsertions opposite of a template G and were driven by the 
severe dCTP:dTTP ratio of 1:15 present in gln3 or ura7 cells (Table 4.9B). Moreover, the 
manifestation of replication errors at all mutational hotspots was supported by the next-nucleotide 
effect (KUNKEL 1992; REHA-KRANTZ 2010) as each mutational hotspot was followed by at least 
three nucleotides that were more abundant than WT concentrations.  
 
  
 
Taken together, loss of the transcription factor Gln3 or the CTP synthetase Ura7 results in 
decreased CTP levels, which leads to reduced dCTP pools and activation of the DDR (Fig. 5-2). 
Paradoxically, activation of the DDR instead of counteracting the low dCTP pools induces RNR 
activity creating an even more severe dNTP imbalance. Interestingly, this severe dNTP imbalance 
does not trigger increased mutagenesis in the presence of WT DNA polymerases and functional 
MMR, highlighting once more the superb buffer capacity of the eukaryotic DNA replication fidelity 
 
Fig. 5.2 Gln3 or Ura7 promote DNA replication fidelity by 
counteracting dNTP pool imbalances. 
Inactivation of GLN3 or URA7 results in low CTP and dCTP 
pools, checkpoint activation, increased RNR levels and a 
severe dNTP pool imbalance. If combined with defects in 
DNA polymerase fidelity, proofreading or MMR, this dNTP 
pool imbalances cause a hypermutator phenotype. Figure 
was adapted from (Schmidt et al. 2017). 
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system. However, the combination of this severe dNTP pool imbalance with either compromised 
DNA polymerase or MMR function results in a hypermutator phenotype. 
5.4 A RNR1 random mutagenesis screen reveals specific residues in RNR1 with 
crucial functions in dNTP homeostasis and uncovers a highly mutagenic 
dNTP imbalance. 
5.4.1 A RNR1 screen identifies novel rnr1 alleles inducing mutagenic dNTP pool 
alterations. 
Screening a library of mutant rnr1 alleles for increased mutagenesis in an exo1 background 
revealed 24 rnr1 alleles (Fig. 4.12) that conferred different mutator phenotypes in the CAN1 
inactivation and the two frameshift reversion assays lys2-10A and hom3-10 (Table 4.14). The 
identified mutations were located either at the A-site, in the surrounding of the S-site (but not 
restricted to the previously mutagenized loop 2 (KUMAR et al. 2010)), at the Rnr1-Rnr1 interface or 
close to the C-site (Fig. 4.12). dNTP concentration measurements showed that all tested alleles 
either caused overall increased dNTP pools or imbalanced dNTP pools (Fig. 4.16, Table 4.18), 
indicating that the measured mutator interactions between the rnr1 alleles and the absence of Exo1 
are driven by dNTP pool alterations. All rnr1 alleles that resulted in synthetic lethality in the 
absence of Rnr3, the alternative DNA-damage inducible RNR subunit, or the checkpoint kinase 
Dun1 (Table 4.16) and presented a constitutive S-phase checkpoint activation (Fig. 4.17B-C) had 
at least one limiting dNTP concentration. Further analysis of the rnr1 alleles expressed from the 
endogenous RNR1 chromosomal locus revealed that a reduction of up to 20% in the dATP levels 
cause neither DDR activation (Fig. 4.17C) nor strong accumulation of cells in S phase (Fig. 4.17B). 
However, a 50% reduction in dATP levels resulted in a constitutive S-phase checkpoint activation 
(Fig. 4.17B-C). Interestingly, in budding yeast 50% of dATP levels correspond approximately to the 
dGTP concentration in WT cells, the smallest dNTP pool in budding yeast (CHABES et al. 2003) but 
also in mammalian cells (MATHEWS AND JI 1992; MARTOMO AND MATHEWS 2002). Furthermore, 
inactivation of GLN3 or URA7 caused reduced dCTP concentrations below the WT dGTP 
concentration (Fig. 4.10B, Table 4.9B) that also triggered DDR activation (Fig. 4.9B-C). Therefore, 
the results obtained in the presence of rnr1 alleles or absence of either Gln3 or Ura7 argue for the 
existence of a dNTP limitation threshold for S-phase checkpoint activation in budding yeast. Thus, 
it is very likely that reductions in the levels of any of the four dNTPs resulting in concentrations 
below this threshold (determined by dGTP levels in WT cells) will activate the S-phase checkpoint. 
Given the screening strategy, in which mutations were introduced randomly into RNR1 using 
mutagenic PCR the here presented approach is unbiased and not restricted to certain domains or 
regions of Rnr1. Furthermore, screening for mutator phenotypes using three different mutator 
assays in an exo1 background allowed the identification of key residues in Rnr1 with important 
consequences on dNTP pool homeostasis (the limitations of the used mutator assays are 
discussed below). Moreover, as the used screening strategy depends on cell growth, all identified 
rnr1 alleles expressed on a centromeric plasmid had to confer sufficient catalytic activity to 
complement the rnr1 background and support cell viability.  
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Previous studies introduced mutations in the highly conserved loop 2 based on the Rnr1 crystal 
structure (KUMAR et al. 2010; KUMAR et al. 2011). Characterization of these alleles in budding yeast 
revealed that some of the alleles, like rnr1-Q288A and rnr1-R293A, caused severe dNTP pool 
imbalances and growth defects, but were only viable in the presence of a suppressed WT-RNR1 
allele (KUMAR et al. 2010; KUMAR et al. 2011). Thus, the here-described screening strategy 
overcomes limitations of previous studies characterizing rnr1 alleles. 
A previous mutator screen of NrdA and NrdB, the large and small subunit of E. coli RNR, identified 
NrdA and NdrB alleles that conferred increased mutagenesis and dNTP pool alterations 
(AHLUWALIA et al. 2012). As observed with the here described rnr1 mutations, NrdA mutations also 
cluster at the A-site and S-site. Although S. cerevisiae Rnr1 and E. coli NrdA share 29% protein 
sequence identity, none of the here identified mutated residues in Rnr1 have been found mutated 
previously in the NrdA screen. This was unexpected as some of the here identified residues, like 
Asp226 or Arg256 and others, directly coordinate the specificity effector (Fig. 4.12D-E) and are 
conserved from E. coli up to humans (Fig. 4.12B). The discrepancy between both screens may 
originate at least in part from the screening strategies using different mutator assays and in case of 
the S. cerevisiae RNR1 screen use of the exo1 as “sensitized mutator background”. Importantly, 
one advantage of screening in S. cerevisiae over screening in E. coli is the high protein sequence 
conservation (67% protein sequence identity) between budding yeast RNR1 and human RRM1. 
So, in contrast to the E. coli NrdA screen in which 6 out of the 15 identified residues were 
conserved in human (AHLUWALIA et al. 2012), 21 out of the 22 identified residues in the S. 
cerevisiae RNR1 screen were conserved in humans (Fig. 4.12B). The high degree of protein 
conservation suggest that mutating these residues in human RRM1 may have similar 
consequences for dNTP pool homeostasis as observed in budding yeast.  
In the E. coli screen not only mutations in E. coli NrdA, but also in the small E. coli RNR subunit 
NrdB were found to cause dNTP pool alterations and increased mutagenesis (AHLUWALIA et al. 
2012). Based on this previous observation, a similar screen as the one described here for RNR1 
was conducted, but in which a RNR2 randomly mutagenized library was screened for increased 
mutagenesis in an exo1 rnr2 strain. Surprisingly, no rnr2 alleles could be identified that resulted 
in increased mutagenesis (data not shown). This discrepancy may argue for structural differences 
or different regulatory requirements between E. coli and S. cerevisiae RNR. 
One unpredicted finding of the RNR1 screen was that all dNTP pool imbalances shared relatively 
low dATP pools (Fig. 4.16A, Table 4.18). In part, this communality can be rationalized by the 
frameshift mutator assays, which were used in addition to the CAN1 forward inactivation assay to 
identify the rnr1 alleles. The lys2-10A mutator assays scores for a single A:T deletion event in a 
defined 10 A:T long mononucleotide run (TRAN et al. 1997), whereas the hom3-10 frameshift 
reversion assay is reverted by a single T:A deletion event in a 7 T:A long mononucleotide run 
(MARSISCHKY et al. 1996). Thus, low dATP pools may facilitate slippage events in A:T or T:A 
mononucleotide runs and therefore, rnr1 alleles causing a dNTP imbalance characterized by low 
dATP are likely to be identified with the used screening approach. However, low dTTP pools 
should, similar to low dATP pools, support the reversion of both frameshift mutator assays, 
however, none of the identified rnr1 alleles caused low dTTP levels (Table 4.18). One possible 
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explanation for the absence of dNTP imbalances with low dTTP may rely in the activity of Dcd1, 
which converts dCMP to dUMP and compensates dTTP levels downstream of RNR (MCINTOSH AND 
HAYNES 1984; SANCHEZ et al. 2012). Given that the overall RNR activity is negatively regulated by 
dATP at the A-site (Fig. 1.7C) (CHABES et al. 2003; FAIRMAN et al. 2011), it is likely that low dATP 
pools allow more severe dNTP imbalances independently of DDR activation, like in rnr1-S242T or 
rnr1-Y285C. Thus, it would be interesting to perform a rnr1-F15S screen, in which not the WT-
RNR1 but the rnr1-F15S allele is randomly mutagenized. By screening in a rnr1-F15S background 
that is most likely refractory to dATP inhibition at the A-site (see 5.4.2) and thus showed in average 
6.5x increased dNTP pools (Table 4.18, 4.20B), presumably more severe dNTP pool alterations 
and eventually dNTP imbalances with high dATP pools might be detected. Furthermore, similar to 
the here presented RNR1 random mutagenesis screen, additional screens making use of other 
frameshift reporters scoring for example for single G:C deletion or insertion events (e.g. (TRAN et al. 
1997)) and/or general forward inactivation assays (e.g. (WHELAN et al. 1979; BOEKE et al. 1984)) 
could be performed. It would be interesting to evaluate which type of dNTP pool alteration is 
facilitating the reversion or inactivation of these reporters. Moreover, this analysis would 
complement the understanding of how different dNTP pool alterations shape the mutational 
landscape in vivo. 
5.4.2 rnr1-F15S interferes with A-site regulation. 
The rnr1-F15S allele was the only allele identified in the RNR1 screen that did not result in a dNTP 
pool imbalance, but an overall increase in dNTPs (in average 6.5-fold higher than WT) (Table 
4.18). The F15S mutation is located at the ATP cone of the A-site in a region that propably affects 
RNR hexamerzation (Fig. 4.12F). Interestingly, the Phe15 is directly adjacent to the Asp16 
residual, which was mutated by the Dealwis group to investigate the eukaryotic RNR’s A-site 
regulation (FAIRMAN et al. 2011). In their study, purified human rrm1-D16R was unable to form 
catalytic inactive dATP-dependent hexamers and showed in comparison to the WT increased 
catalytic activity in the presence of dATP (FAIRMAN et al. 2011). Due to the position and analogy, it 
is therefore likely that the F15S mutation also prevents dATP-dependent hexamerization and is 
refractory to dATP inhibition at the A-site. This may explain the increased, balanced dNTP pools 
measured in the presence of this mutation (Table 4.18 and 4.20B). These overall increased dNTP 
pools due to the rnr1-F15S allele resulted in no synthetic growth defect or synthetic lethal 
interaction (Table 4.16) and a 4-fold and 59-fold increase over WT in the CAN1 inactivation rates in 
the presence and absence of Exo1, respectively (Table 4.19). Thus, overall increased dNTP pools 
most likely do not promote the generation of more replication errors by the DNA polymerases, but 
rather prevent the correction of errors by DNA proofreading due to a strong next-nucleotide effect 
(KUNKEL 1992; REHA-KRANTZ 2010). However, most replication errors that escape DNA 
proofreading are then subsequently repaired by MMR (Fig. 5.3).  
5.4.3 Two potential mechanisms for rnr1 mutants that cause low purine dNTP imbalances. 
Three identified rnr1 alleles (rnr1-A245V, rnr1-G271S and rnr1-Y285C) caused a dNTP imbalanced 
characterized by high pyrimidine and low purine pools (Fig. 4.16 A, Table 4.18). Interestingly, in a 
S. cerevisiae Rnr1 crystal structure two of the identified residues (Gly271 and Tyr285) indirectly 
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interact with the effector bound to the S-site (XU et al. 2006a). Both, the backbone oxide of Gly271 
and the side chain of Tyr285 form a hydrogen-bond with a water molecule that interacts with the 2’-
hydroxy group of the bound AMP-PNP effector suggesting that similar interactions might be 
possible with ATP, but not with dNTP effectors. Additionally, a previous study postulated that the 
Tyr244 in Salmonella typhimurium, which is the homolog residue of Tyr285 in S. cerevisiae, 
prevents NTP binding to the S-site because of a steric clash between the 2’-hydroxy group of the 
ribonucleotides and the tyrosine side-chain (UPPSTEN et al. 2003). According to this hypothesis and 
as NTP concentrations in budding yeast are in average 50-times higher than dNTP concentrations, 
mutating Tyr285 will favor the binding of the most abundant NTP at the S-site, which correspond to 
ATP. Under these special conditions, increased ATP binding at the S-site may result primarily in 
the reduction of pyrimidine nucleotides. The importance of the Tyr285 side chain for dNTP 
homeostasis is further supported by the observation that not only the here characterized rnr1-
Y285C allele (Table 4.18 and 4.20B), but also the previously described rnr1-Y285A allele and to a 
lesser extend the rnr1-Y285F allele, resulted in low purine and elevated pyrimidine pools (KUMAR et 
al. 2010). Thus, Tyr285 and most likely also the Gly271 are both critical for the discrimination of 
dNTP over NTP binding at the S-site and mutating those residues results in an ATP-driven 
increase in pyrimidine pools.  
In contrast to Gly271 and Tyr285 that are located at the S-site, Ala245 is located closer to the C-
site. Interestingly, replacing the alanine at position 245 with valine resulted in a 60% and 30% 
reduction in dATP and dGTP pools, respectively and elevated pyrimidine pools (Fig. 4.17A, Table 
4.20B). The bulkier side chain of valine in respect to alanine may decrease the space at the C-site, 
facilitating the binding of smaller pyrimidine NDPs over larger-size purine NDPs, leading to a dNTP 
imbalance characterized by low purines and elevated pyrimidines. In conclusion, two different 
mechanisms resulting in the same type of dNTP imbalance characterized by low purines and 
elevated pyrimidines are proposed: In the first one, low purine and elevated pyrimidine pools are 
the consequence of missing ATP discrimination at the S-site due to mutations in Gly271 or Tyr285, 
whereas in the second one, a mutation in Ala245 results in a smaller C-site, which favors 
pyrimidine NDP over purine NDP reduction at the C-site. 
5.4.4 Different dNTP pool alterations rely differentially on DNA proofreading and MMR. 
Most of the identified dNTP alterations caused strong mutator phenotype and/or synthetic genetic 
interactions only in DNA polymerase- or MMR-compromised backgrounds. These findings, similar 
to the results obtained with GLN3 or URA7 deficient strains (Fig. 5-2), highlight the remarkable 
buffer capacity and robustness of the DNA replication fidelity machinery. Moreover, the collection of 
rnr1 mutant alleles and their systematic characterization allows evaluating the in vivo requirements 
for high-fidelity DNA replication in the presence of different dNTP pool alterations. 
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Fig. 5.3 Specific dNTP pool alterations rely differentially on DNA polymerase proofreading and MMR 
for mutation avoidance. 
The funnels below each dNTP pool alteration represent DNA replication errors that are corrected by DNA 
polymerase proofreading and/or MMR. dNTP pool alterations and funnels are color-coded based on their 
genetic interactions, dNTP pool alteration and mutator phenotype as in Fig. 4.17. dNTP imbalances 
characterized by low dATP levels and high dGTP levels cause a mutator phenotype even in the presence of 
high-fidelity DNA polymerase and functional MMR. 
 
Overall increased dNTP pools with unchanged ratios between the different dNTPs do not increase 
the amount of replication errors generated by the DNA polymerases. However, overall increased 
dNTP pools cause a strong next-nucleotide effect that interferes with the proofreading of the 
generated DNA replication errors. Thus, more DNA replication errors escape DNA proofreading 
and these replication errors depend on MMR for repair. However, as the amount of generated DNA 
replication errors in the presence of overall increased dNTP pools is low, MMR can to in large 
extent correct replication errors that escaped DNA polymerase proofreading. Consistently, overall 
increased dNTP pools did neither cause a mutator phenotype in a WT background nor synthetic 
growth defects or synthetic lethality in the absence of DNA proofreading or MMR (Table 4.16). 
Furthermore, in agreement with the next-nucleotide effect being most detrimental for base 
substitution replication errors or indels in short mononucleotide runs (KROUTIL et al. 1996; KUNKEL 
2009), increased mutation rates in the presence of overall increased dNTP pools were primarily 
observed in the CAN1 forward inactivation assay and to a lesser degree in the two frameshift-
specific reporters (Table 4.19). 
In contrast to the overall increased dNTP pools, imbalanced dNTP pools facilitate the generation of 
DNA replication errors by DNA polymerases as altered ratios between the different dNTPs directly 
affect DNA polymerases’ nucleotide selectivity. Interestingly, different dNTP pool alterations rely 
differentially on DNA proofreading and MMR. The “low purines” (or “2 out of 4”) dNTP imbalances 
characterized by low purines and elevated pyrimidines showed synthetic growth defects or lethality 
in the presence of DNA polymerase proofreading-defective alleles, but not in the absence of MMR 
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(Table 4.16). Moreover, CAN1 mutation spectrum analysis in rnr1-Y285C expressing cells revealed 
that the mutation spectrum is dominated by base substitutions (Table 4.21). Thus, the “low purines” 
dNTP imbalance supports primarily the generation of base substitutions and is therefore more 
dependent on DNA polymerase proofreading than on MMR for survival. This bias for base pair 
substitutions can be further rationalized by the ratios between the different dNTPs, which strongly 
affects the nucleotide selectivity of the replicating DNA polymerases. Assuming that the increase in 
the elevated dNTP pools are similar, a dNTP imbalance with “2 out of 4” elevated dNTP pools, like 
a “low purines” dNTP imbalance, confers altered ratios in 4 of the 6 dNTP ratios, whereas a dNTP 
imbalance in which “3 out of 4” dNTPs being elevated, like the “low dATP” dNTP imbalance, has 3 
out of the 6 dNTP ratios altered and an overall increase in dNTP pools does not change the dNTP 
ratios at all. Thus, theoretically a “2 out of 4” dNTP imbalance is most challenging for DNA 
polymerase nucleotide selectivity and consequently more prone for the generation of base 
substitutions. 
In comparison to a “low purines” dNTP imbalance, the “low dATP” or “low dATP + high dGTP” 
dNTP imbalances showed increased amount of one-base-pair deletions in the mutation spectra 
analysis and relied on DNA polymerase proofreading as well as on MMR for survival (Table 4.21 
and 4.23). This suggests in line with in vitro DNA replication experiments (BEBENEK et al. 1992) that 
limitation in one of the dNTP pools and an increase in the remaining three dNTP pools (“low dATP” 
or “low dATP + high dGTP”) not only facilitates the generation of base substitutions but also DNA 
polymerase slippage events, in particular at mononucleotide runs requiring for their replication the 
limiting dNTP. Moreover, the increase in three out of four dNTPs result in a strong next-nucleotide 
effect, which favors mismatch extension over polymerase proofreading leading to more replication 
errors and a strong dependency on MMR for mutation avoidance. Interestingly, the dNTP pool 
precursor imbalance upon GLN3 or URA7 inactivation also results in a “3 out of 4” dNTP imbalance 
with one limiting dNTP (dCTP) and three elevated dNTP pools (Table 4.9B). Although strong 
mutator phenotypes were measured in the absence of Gln3 or Ura7 in DNA replication fidelity-
compromised backgrounds (Table 4.5,4.7) and a growth defect in the ura7 pol3-01 double mutant 
was observed (Fig. 4.8 and data not shown), the consequences for DNA replication fidelity of a 
“low dCTP” dNTP imbalance were less severe as a “low dATP” dNTP imbalance. One possible 
explanation may be the composition of the budding yeast genome, which consists out of 
approximately 31% As and Ts, and 19% Gs and Cs (GOFFEAU et al. 1996). So, a “3 out of 4” dNTP 
imbalance that is low in dATP or dTTP may have more severe consequences for DNA replication 
fidelity, simply because of the higher representation of the former bases in the budding yeast 
genome. 
An exception among the identified rnr1 alleles were those alleles that caused a dNTP imbalance 
characterized by low dATP pools, elevated pyrimidine pools and strongly increased dGTP pools 
(“low dATP + high dGTP”) (Fig. 4.16A, 4.17A, Table 4.18, 4.20B). This type of dNTP imbalance 
resulted in strong CAN1 inactivation and frameshift mutator phenotypes even in the presence of 
DNA proofreading and functional MMR (Fig. 4.13, Table 4.19). For example, strains expressing the 
rnr1-K245E or rnr1-I262V,N291D alleles at the endogenous chromosomal RNR1 locus, presented 
CAN1 mutation rates and frameshift reversion rates similar to a strain with a complete MMR 
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deficiency (msh2) (Table 4.19). These findings suggest that in the context of the “low dATP” type 
of dNTP imbalance strongly elevated dGTP levels confer a high mutagenic potential and are 
extremely detrimental for DNA replication fidelity. Why are “low dATP + high dGTP” dNTP 
imbalances so mutagenic? Three not mutually exclusive, potential explanations are: First, strongly 
elevated dGTP levels in the context of a “low dATP” dNTP imbalance enhance the mutagenic 
potential of the dNTP imbalance, resulting in increased DNA replication errors and consequently 
saturation of MMR. As dGTP is the smallest dNTP pool under WT conditions (MATHEWS AND JI 
1992; MARTOMO AND MATHEWS 2002; CHABES et al. 2003), changes in the dGTP concentration 
have the strongest impact on the ratios between the different dNTPs, which directly influence DNA 
polymerase nucleotide selectivity. Second, dGTP as smallest dNTP pool functions as an intrinsic 
brake during DNA replication. Low dGTP pools may slow down DNA replication, giving so more 
time for DNA proofreading and potentially also for repair. In contrast, high dGTP concentrations 
may facilitate DNA polymerization at expenses of DNA proofreading and repair. Third, elevated 
dGTP concentrations could cause inhibition of DNA polymerase proofreading. During DNA 
proofreading, dNMPs are excised from the nascent DNA strand. These dNMPs can bind to the 
exonuclease active site and inhibit DNA proofreading to prevent excessive excision. Earlier studies 
on DNA replication have shown that dNMPs (as dGMP) cause inhibition of DNA polymerase 
proofreading in vitro (QUE et al. 1978; FERSHT AND KNILL-JONES 1983). Despite the fact that in vivo 
dNMPs concentrations are extremely low (ZHANG et al. 2011), it is possible that dGMP levels may 
accumulate when dGTP levels are severely increased. Thus, the accumulation of dGMP may 
potentially inhibit DNA proofreading and in combination with a dNTP imbalance cause a severe 
mutator phenotype. 
To better understand the molecular mechanism causing this severe mutator phenotype additional 
experiments are required. So, it would be very interesting to investigate whether DNA replication 
forks are progressing faster in the presence of the “low dATP + high dGTP” dNTP imbalances in 
comparison to WT and ”low dATP” dNTP pools. Moreover, dGMP concentration measurements in 
the presence or absence of a “low dATP + high dGTP” dNTP imbalance may support the third 
previously mentioned scenario.  
Interestingly, both chromosomally integrated rnr1 alleles that induce the “low dATP + high dGTP” 
dNTP imbalance, showed an altered DNA content profile and an accumulation of cells in G2/M 
(Fig. 4.17B) suggesting that very high dGTP pools may affect also other cellular processes outside 
S phase. This idea is supported by the in vitro observation that dGTP facilitates tubulin nucleation 
better than GTP (HAMEL et al. 1984). As dGTP pools represent up to 50% of the GTP pools 
measured in these strains (Table 4.20), dGTP may interfere with microtubule dynamics and 
chromosome segregation. Furthermore, two studies positively correlate the dGTP concentrations 
with telomere length (GUPTA et al. 2013; MAICHER et al. 2017), suggesting that dGTP, as smallest 
dNTP pool, may not only play an important role for DNA replication fidelity but also in the regulation 
of other genome maintenance pathways. 
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5.5 Concluding remarks 
The here presented genome-wide screen identified genes that prevent the accumulation of 
mutations. Among others, the folylpolyglutamate synthetase Met7 as well as the transcription factor 
Gln3 and the major CTP synthetase Ura7 were identified as novel important factors for genome 
stability.  
In the absence of Met7, cells accumulate and incorporate dUTP during DNA replication given the 
altered dUTP/dTTP ratio. Increased uracil incorporation in combination with a DSB repair defect 
seems to trigger increased genome instability (GCRs) (Fig. 5-1).  
The absence of the CTP synthetase Ura7 or upon glutamine limitation due to the lack of the 
transcription factor Gln3, both cause reduced de novo CTP biosynthesis resulting in a mutagenic 
dNTP imbalance (Fig. 5-2). This can neither be compensated by RNR nor by any other mechanism 
downstream of RNR. Thus, the here presented data emphasizes the importance of the dNTP 
precursor metabolism for dNTP homeostasis and uncovers CTP/dCTP levels as blind spot in dNTP 
regulation. 
The systematic characterization of different mutagenic dNTP pool alterations induced by rnr1 
alleles revealed differential requirements on DNA proofreading and MMR for cellular survival (Fig. 
5-3). In line with in vitro data (BEBENEK et al. 1992), dNTP imbalances with one limiting dNTP 
facilitate DNA polymerase slippage events resulting in frameshift mutations in vivo. Within the 
examined dNTP pool alterations, a “low dATP + high dGTP” dNTP imbalance was most detrimental 
for DNA replication fidelity and caused base substitutions and frameshift mutations even in the 
presence of WT DNA polymerases and functional MMR. Moreover, the comparison of different 
dNTP pool alterations and DDR activation argues for a dNTP limitation threshold for S-phase 
checkpoint activation in budding yeast, which is defined by approximately the dGTP concentration 
reported in WT cells.  
Taken together, this work highlights the pivotal role of the cellular metabolism and dNTP pool 
homeostasis on DNA replication fidelity. The here identified genes and mutant alleles might act as 
mini-drivers during human cancer evolution and might represent interesting candidates for future 
drug target or prognostic markers.  
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7 SUPPLEMENT 
7.1 Supplementary data 
 
Fig. S 7.1 CAN1 mutation spectrum of the WT. 
Genomic DNA of individual CanR clones was purified, the CAN1 gene amplified and sequenced. Individual 
mutations are shown.  
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Fig. S 7.2 CAN1 mutation spectrum of met7.  
Genomic DNA of individual CanR clones was purified, the CAN1 gene amplified and sequenced. Individual 
mutations are shown.  
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Fig. S 7.3 CAN1 mutation spectrum of msh6.  
Genomic DNA of individual CanR clones was purified, the CAN1 gene amplified and sequenced. Individual 
mutations are shown. Mutational hotspots are indicated in blue. 
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Fig. S 7.4 CAN1 mutation spectrum of msh6 gln3.  
Genomic DNA of individual CanR clones was purified, the CAN1 gene amplified and sequenced. Individual 
mutations are shown. Mutational hotspots are indicated in blue. 
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Fig. S 7.5 CAN1 mutation spectrum of msh6 shm2.  
Genomic DNA of individual CanR clones was purified, the CAN1 gene amplified and sequenced. Individual 
mutations are shown. Mutational hotspots are indicated in blue. 
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Fig. S 7.6 CAN1 mutation spectrum of msh6 ura7.  
Genomic DNA of individual CanR clones was purified, the CAN1 gene amplified and sequenced. Individual 
mutations are shown. Mutational hotspots are indicated in blue. 
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Fig. S 7.7 CAN1 mutation spectrum of ura7.  
Genomic DNA of individual CanR clones was purified, the CAN1 gene amplified and sequenced. Individual 
mutations are shown. Mutational hotspots are indicated in blue. 
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Fig. S 7.8 CAN1 mutation spectrum of the pol2-M644G.  
Genomic DNA of individual CanR clones was purified, the CAN1 gene amplified and sequenced. Individual 
mutations are shown. Mutational hotspots are indicated in blue. 
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Fig. S 7.9 CAN1 mutation spectrum of pol2-M644G ura7.  
Genomic DNA of individual CanR clones was purified, the CAN1 gene amplified and sequenced. Individual 
mutations are shown. Mutational hotspots are indicated in blue. 
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Fig. S 7.10 CAN1 mutation spectrum of pol3-L612M.  
Genomic DNA of individual CanR clones was purified, the CAN1 gene amplified and sequenced. Individual 
mutations are shown. Mutational hotspots are indicated in blue. 
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Fig. S 7.11 CAN1 mutation spectrum of pol3-L612M ura7 
Genomic DNA of individual CanR clones was purified, the CAN1 gene amplified and sequenced. Individual 
mutations are shown. Mutational hotspots are indicated in blue. 
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Fig. S 7.12 CAN1 mutation spectrum of rnr1-Y285C.  
Genomic DNA of individual CanR clones was purified, the CAN1 gene amplified and sequenced. Individual 
mutations are shown. Mutational hotspots are indicated in blue. 
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Fig. S 7.13 CAN1 mutation spectrum of rnr1-R256H,Y779C.  
Genomic DNA of individual CanR clones was purified, the CAN1 gene amplified and sequenced. Individual 
mutations are shown. Mutational hotspots are indicated in blue. 
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Fig. S 7.14 CAN1 mutation spectrum of rnr1-I262V,N291D.  
Genomic DNA of individual CanR clones was purified, the CAN1 gene amplified and sequenced. Individual 
mutations are shown. Mutational hotspots are indicated in blue. 
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Fig. S 7.15 URA3 mutation spectrum of the WT and rnr1-I262V,N291D. 
Genomic DNA of individual 5-FOAR clones was purified, the URA3 gene amplified and sequenced. Individual 
mutations are shown. Mutational hotspots are indicated in red. The WT spectrum was taken from (LANG AND 
MURRAY 2008). 
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